No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, d4qzwY_, 1.0000, 0.00, 1.000, 212, 212, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2, d4qzwK_, 0.9999, 0.02, 1.000, 212, 212, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3, d4r00Y_, 0.9998, 0.08, 1.000, 212, 212, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
4, d4r00K_, 0.9998, 0.08, 1.000, 212, 212, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
5, d4qv8Y_, 0.9996, 0.10, 1.000, 212, 212, YCP BETA5-C52F MUTANT
6, d4qv8K_, 0.9996, 0.10, 1.000, 212, 212, YCP BETA5-C52F MUTANT
7, d5d0vY_, 0.9994, 0.13, 0.991, 212, 212, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
8, d5d0vK_, 0.9994, 0.13, 0.991, 218, 212, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
9, d4qzzY_, 0.9994, 0.12, 0.995, 212, 212, YCP IN COMPLEX WITH OMURALIDE
10, d4qzzK_, 0.9994, 0.12, 0.995, 212, 212, YCP IN COMPLEX WITH OMURALIDE
11, d5cz6K_, 0.9992, 0.15, 0.991, 212, 212, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
12, d5cz6Y_, 0.9991, 0.16, 0.991, 212, 212, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
13, d4qv5Y_, 0.9991, 0.15, 0.991, 212, 212, YCP BETA5-M45I MUTANT
14, d4qv5K_, 0.9991, 0.15, 0.991, 212, 212, YCP BETA5-M45I MUTANT
15, d4qv4Y_, 0.9991, 0.16, 0.991, 212, 212, YCP BETA5-M45T MUTANT
16, d4qv4K_, 0.9991, 0.15, 0.991, 212, 212, YCP BETA5-M45T MUTANT
17, d4qv1Y_, 0.9991, 0.16, 0.991, 212, 212, YCP BETA5-M45A MUTANT
18, d4qv1K_, 0.9991, 0.16, 0.991, 212, 212, YCP BETA5-M45A MUTANT
19, d4qv7Y_, 0.9990, 0.17, 0.991, 212, 212, YCP BETA5-A50V MUTANT
20, d4qv7K_, 0.9990, 0.17, 0.991, 212, 212, YCP BETA5-A50V MUTANT
21, d4qv3Y_, 0.9990, 0.17, 0.991, 212, 212, YCP BETA5-M45V MUTANT
22, d4qv3K_, 0.9990, 0.16, 0.991, 212, 212, YCP BETA5-M45V MUTANT
23, d4quxY_, 0.9990, 0.17, 0.991, 212, 212, YCP BETA5-A49T-MUTANT
24, d4quxK_, 0.9990, 0.16, 0.991, 212, 212, YCP BETA5-A49T-MUTANT
25, d4qv6Y_, 0.9989, 0.17, 0.991, 212, 212, YCP BETA5-A49V MUTANT
26, d4qv6K_, 0.9989, 0.17, 0.991, 212, 212, YCP BETA5-A49V MUTANT
27, d5fgaY_, 0.9988, 0.18, 0.991, 212, 212, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
28, d5fgaK_, 0.9988, 0.18, 0.991, 212, 212, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
29, d5fg9K_, 0.9988, 0.19, 0.995, 212, 212, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
30, d5d0wY_, 0.9988, 0.18, 0.991, 212, 212, YEAST 20S PROTEASOME BETA5-T1S MUTANT
31, d5d0wK_, 0.9988, 0.18, 0.991, 212, 212, YEAST 20S PROTEASOME BETA5-T1S MUTANT
32, d5czaY_, 0.9988, 0.19, 0.991, 212, 212, YEAST 20S PROTEASOME BETA5-D166N MUTANT
33, d5czaK_, 0.9988, 0.19, 0.991, 212, 212, YEAST 20S PROTEASOME BETA5-D166N MUTANT
34, d5bxlY_, 0.9988, 0.18, 0.995, 212, 212, YEAST 20S PROTEASOME BETA2-G170A MUTANT
35, d5bxlK_, 0.9988, 0.18, 0.995, 212, 212, YEAST 20S PROTEASOME BETA2-G170A MUTANT
36, d4y9yY_, 0.9988, 0.18, 0.995, 212, 212, YEAST 20S PROTEASOME BETA2-H116E MUTANT
37, d4y9yK_, 0.9988, 0.18, 0.995, 212, 212, YEAST 20S PROTEASOME BETA2-H116E MUTANT
38, d4rurY_, 0.9988, 0.18, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
39, d4rurK_, 0.9988, 0.18, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
40, d4quyY_, 0.9988, 0.18, 0.991, 212, 212, YCP BETA5-A49S-MUTANT
41, d4quyK_, 0.9988, 0.18, 0.991, 212, 212, YCP BETA5-A49S-MUTANT
42, d5fg9Y_, 0.9987, 0.19, 0.995, 212, 212, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
43, d5fg7Y_, 0.9987, 0.19, 0.995, 212, 212, YEAST 20S PROTEASOME BETA2-T1A MUTANT
44, d5fg7K_, 0.9987, 0.19, 0.995, 212, 212, YEAST 20S PROTEASOME BETA2-T1A MUTANT
45, d4z1lY_, 0.9987, 0.19, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
46, d4z1lK_, 0.9987, 0.19, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
47, d4qv9Y_, 0.9987, 0.19, 0.991, 212, 212, YCP BETA5-C63F MUTANT
48, d4qv9K_, 0.9987, 0.19, 0.991, 212, 212, YCP BETA5-C63F MUTANT
49, d5cz7Y_, 0.9986, 0.20, 0.986, 217, 212, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
50, d5cz7K_, 0.9986, 0.20, 0.986, 217, 212, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
51, d5cgfY_, 0.9986, 0.20, 0.991, 212, 212, YEAST 20S PROTEASOME BETA5-G48C MUTANT
52, d5cgfK_, 0.9986, 0.20, 0.991, 212, 212, YEAST 20S PROTEASOME BETA5-G48C MUTANT
53, d4ya4Y_, 0.9986, 0.20, 0.995, 212, 212, YEAST 20S PROTEASOME BETA2-H114D MUTANT
54, d4ya4K_, 0.9986, 0.20, 0.995, 212, 212, YEAST 20S PROTEASOME BETA2-H114D MUTANT
55, d4ya1Y_, 0.9986, 0.20, 0.995, 212, 212, YEAST 20S PROTEASOME BETA2-H116N MUTANT
56, d4ya1K_, 0.9986, 0.20, 0.995, 212, 212, YEAST 20S PROTEASOME BETA2-H116N MUTANT
57, d4y8mY_, 0.9986, 0.20, 0.995, 212, 212, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
58, d4y8mK_, 0.9986, 0.20, 0.995, 212, 212, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
59, d5fgfY_, 0.9985, 0.20, 0.986, 214, 212, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
60, d5fgfK_, 0.9985, 0.20, 0.986, 214, 212, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
61, d5fgeY_, 0.9985, 0.21, 0.991, 218, 212, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
62, d5fgeK_, 0.9985, 0.21, 0.991, 218, 212, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
63, d5fgdY_, 0.9985, 0.21, 0.991, 216, 212, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
64, d5fgdK_, 0.9985, 0.21, 0.991, 215, 212, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
65, d5cz4K_, 0.9985, 0.21, 0.995, 212, 212, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
66, d5bouY_, 0.9985, 0.20, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
67, d5bouK_, 0.9985, 0.20, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
68, d4y8rY_, 0.9985, 0.21, 0.995, 212, 212, YEAST 20S PROTEASOME BETA2-H116D MUTANT
69, d4y8rK_, 0.9985, 0.20, 0.995, 212, 212, YEAST 20S PROTEASOME BETA2-H116D MUTANT
70, d5lajY_, 0.9984, 0.21, 0.995, 212, 212, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
71, d5lajK_, 0.9984, 0.21, 0.995, 212, 212, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
72, d5cz4Y_, 0.9984, 0.21, 0.995, 212, 212, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
73, d4qw0Y_, 0.9984, 0.21, 0.986, 212, 212, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
74, d4qw0K_, 0.9984, 0.21, 0.986, 212, 212, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
75, d2gplY_, 0.9984, 0.21, 0.995, 212, 212, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
76, d2gplK_, 0.9984, 0.21, 0.995, 212, 212, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
77, d5fhsY_, 0.9983, 0.22, 0.991, 212, 212, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
78, d4qvyY_, 0.9983, 0.22, 0.991, 212, 212, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
79, d4qvyK_, 0.9983, 0.22, 0.991, 212, 212, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
80, d3gpwY_, 0.9982, 0.22, 0.995, 212, 212, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
81, d3gpwK_, 0.9982, 0.22, 0.995, 212, 212, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
82, d3gptY_, 0.9982, 0.22, 0.995, 212, 212, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
83, d3gptK_, 0.9982, 0.22, 0.995, 212, 212, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
84, d5fhsK_, 0.9981, 0.23, 0.991, 212, 212, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
85, d4lqiY_, 0.9981, 0.23, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
86, d4lqiK_, 0.9981, 0.23, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
87, d4j70Y_, 0.9981, 0.23, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
88, d4j70K_, 0.9981, 0.23, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
89, d3un8K_, 0.9981, 0.23, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
90, d3hyeY_, 0.9981, 0.23, 0.995, 212, 212, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
91, d3hyeK_, 0.9981, 0.23, 0.995, 212, 212, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
92, d1rypL_, 0.9981, 0.24, 0.991, 212, 212, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
93, d3un8Y_, 0.9980, 0.24, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
94, d3tddY_, 0.9980, 0.24, 0.995, 212, 212, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
95, d3tddK_, 0.9980, 0.24, 0.995, 212, 212, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
96, d1rypZ_, 0.9980, 0.24, 0.991, 212, 212, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
97, d2fakY_, 0.9979, 0.25, 0.995, 212, 212, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
98, d2fakK_, 0.9979, 0.25, 0.995, 212, 212, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
99, d4qv0K_, 0.9978, 0.27, 0.986, 212, 212, YCP BETA5-A49T-A50V-DOUBLE MUTANT
100, d4q1sK_, 0.9977, 0.26, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
101, d3dy3K_, 0.9977, 0.26, 0.995, 212, 212, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
102, d4eu2Z_, 0.9976, 0.26, 0.991, 212, 212, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
103, d3dy3Y_, 0.9976, 0.26, 0.995, 212, 212, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
104, d4qvvK_, 0.9975, 0.27, 0.991, 212, 212, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
105, d4qv0Y_, 0.9975, 0.29, 0.986, 212, 212, YCP BETA5-A49T-A50V-DOUBLE MUTANT
106, d4eu2L_, 0.9975, 0.27, 0.991, 212, 212, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
107, d3e47Y_, 0.9975, 0.27, 0.995, 212, 212, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
108, d3e47K_, 0.9975, 0.27, 0.995, 212, 212, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
109, d2fnyY_, 0.9975, 0.27, 0.995, 212, 212,  
110, d2fnyK_, 0.9975, 0.27, 0.995, 212, 212,  
111, d4qvvY_, 0.9974, 0.27, 0.991, 212, 212, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
112, d1g0uY_, 0.9974, 0.27, 0.995, 212, 212, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
113, d1g0uK_, 0.9974, 0.27, 0.995, 212, 212, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
114, d4fzgY_, 0.9973, 0.28, 0.995, 212, 212, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
115, d4fzgK_, 0.9973, 0.28, 0.995, 212, 212, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
116, d3shjY_, 0.9973, 0.28, 0.995, 212, 212, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
117, d3shjK_, 0.9973, 0.28, 0.995, 212, 212, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
118, d4qvwY_, 0.9972, 0.28, 0.991, 212, 212, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
119, d4qvwK_, 0.9972, 0.28, 0.991, 212, 212, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
120, d3dy4Y_, 0.9972, 0.29, 0.995, 212, 212, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
121, d3dy4K_, 0.9972, 0.29, 0.995, 212, 212, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
122, d4fzcY_, 0.9971, 0.29, 0.995, 212, 212, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
123, d4fzcK_, 0.9970, 0.29, 0.995, 212, 212, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
124, d4qw1Y_, 0.9966, 0.32, 0.991, 212, 212, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
125, d4qw1K_, 0.9966, 0.32, 0.991, 212, 212, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
126, d3wxrL_, 0.9965, 0.32, 0.995, 212, 212, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
127, d3wxrZ_, 0.9963, 0.33, 0.995, 212, 212, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
128, d4qvlY_, 0.9962, 0.34, 0.995, 212, 212, YCP IN COMPLEX WITH BORTEZOMIB
129, d4qvlK_, 0.9962, 0.34, 0.995, 212, 212, YCP IN COMPLEX WITH BORTEZOMIB
130, d5d0xY_, 0.9959, 0.35, 0.991, 212, 212, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
131, d5d0xK_, 0.9959, 0.35, 0.991, 212, 212, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
132, d4qw3Y_, 0.9956, 0.36, 0.991, 212, 212, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
133, d4qw3K_, 0.9956, 0.36, 0.991, 212, 212, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
134, d4qvmY_, 0.9955, 0.37, 0.991, 212, 212, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
135, d4qvmK_, 0.9955, 0.37, 0.991, 212, 212, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
136, d5bxnY_, 0.9953, 0.37, 0.995, 212, 212, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
137, d5bxnK_, 0.9953, 0.37, 0.995, 212, 212, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
138, d4r02Y_, 0.9952, 0.38, 0.995, 212, 212, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
139, d4qvpY_, 0.9952, 0.38, 0.991, 212, 212, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
140, d4qvpK_, 0.9952, 0.38, 0.991, 212, 212, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
141, d4jt0Y_, 0.9952, 0.38, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
142, d4jt0K_, 0.9952, 0.38, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
143, d3l5qP_, 0.9952, 0.37, 0.991, 212, 212,  
144, d3l5q2_, 0.9952, 0.37, 0.991, 212, 212,  
145, d1vsyZ_, 0.9952, 0.38, 0.991, 212, 212,  
146, d1vsyL_, 0.9952, 0.38, 0.991, 212, 212,  
147, d5jhrY_, 0.9946, 0.40, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
148, d5jhrK_, 0.9946, 0.40, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
149, d4qvnY_, 0.9946, 0.40, 0.991, 212, 212, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
150, d4qvnK_, 0.9946, 0.40, 0.991, 212, 212, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
151, d4r02K_, 0.9941, 0.42, 0.995, 212, 212, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
152, d4qvqY_, 0.9940, 0.42, 0.991, 212, 212, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
153, d3nzjY_, 0.9940, 0.42, 0.995, 212, 212, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
154, d4qvqK_, 0.9939, 0.42, 0.991, 212, 212, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
155, d3nzjK_, 0.9939, 0.42, 0.995, 212, 212, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
156, d4r18Y_, 0.9938, 0.21, 0.995, 211, 211, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
157, d4r18K_, 0.9938, 0.21, 0.995, 211, 211, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
158, d3mg4Y_, 0.9938, 0.43, 0.995, 212, 212, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
159, d5laiY_, 0.9937, 0.21, 0.995, 211, 211, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
160, d5laiK_, 0.9937, 0.21, 0.995, 211, 211, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
161, d1jd2R_, 0.9937, 0.43, 0.995, 212, 212, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
162, d4r17K_, 0.9936, 0.22, 0.995, 211, 211, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
163, d3bdmY_, 0.9936, 0.43, 0.995, 212, 212, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
164, d4r17Y_, 0.9935, 0.22, 0.995, 211, 211, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
165, d3bdmK_, 0.9935, 0.44, 0.995, 212, 212, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
166, d1jd2K_, 0.9935, 0.44, 0.995, 212, 212, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
167, d5dkiY_, 0.9934, 0.44, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
168, d5dkiK_, 0.9934, 0.44, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
169, d4inuY_, 0.9933, 0.45, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
170, d4inrY_, 0.9933, 0.44, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
171, d4inrK_, 0.9932, 0.45, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
172, d3mg0K_, 0.9930, 0.46, 0.995, 212, 212, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
173, d5dkjY_, 0.9929, 0.46, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
174, d5dkjK_, 0.9929, 0.46, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
175, d4q1sY_, 0.9928, 0.27, 0.995, 211, 211, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
176, d4inuK_, 0.9928, 0.46, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
177, d4jsqY_, 0.9927, 0.46, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
178, d4jsqK_, 0.9927, 0.47, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
179, d3mg4K_, 0.9927, 0.47, 0.995, 212, 212, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
180, d4no1Y_, 0.9925, 0.47, 0.995, 212, 212, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
181, d4no1K_, 0.9925, 0.47, 0.995, 212, 212, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
182, d3mg0Y_, 0.9925, 0.47, 0.995, 212, 212, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
183, d4intY_, 0.9924, 0.47, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
184, d4intK_, 0.9923, 0.48, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
185, d3gpjY_, 0.9923, 0.48, 0.995, 212, 212, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
186, d2f16Y_, 0.9923, 0.48, 0.995, 212, 212, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
187, d2f16K_, 0.9923, 0.48, 0.995, 212, 212, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
188, d3gpjK_, 0.9922, 0.48, 0.995, 212, 212, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
189, d4jsuY_, 0.9921, 0.48, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
190, d4jsuK_, 0.9921, 0.48, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
191, p3un4Y_, 0.9919, 0.49, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
192, p3un4K_, 0.9919, 0.49, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
193, d3oevY_, 0.9913, 0.52, 0.995, 212, 212, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
194, d5d0tY_, 0.9909, 0.52, 0.991, 212, 212, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
195, d5d0tK_, 0.9909, 0.52, 0.991, 212, 212, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
196, d5l5eY_, 0.9908, 0.37, 0.763, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
197, d5l5eK_, 0.9908, 0.37, 0.763, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
198, d5l5aK_, 0.9906, 0.37, 0.773, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
199, d5l5aY_, 0.9905, 0.38, 0.773, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
200, d5l5bY_, 0.9900, 0.40, 0.768, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
201, d5l5bK_, 0.9900, 0.40, 0.763, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
202, d4qwuK_, 0.9900, 0.62, 1.000, 212, 212, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
203, d4qwrY_, 0.9900, 0.55, 1.000, 212, 212, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
204, d4qwrK_, 0.9900, 0.55, 1.000, 212, 212, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
205, d5m2bY_, 0.9899, 0.40, 0.763, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
206, d5m2bK_, 0.9899, 0.40, 0.763, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
207, d3oevK_, 0.9899, 0.56, 0.995, 212, 212, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
208, d4qwuY_, 0.9898, 0.63, 1.000, 212, 212, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
209, d5l64Y_, 0.9897, 0.41, 0.820, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
210, d5l5zY_, 0.9897, 0.41, 0.820, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
211, d5l5zK_, 0.9897, 0.41, 0.820, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
212, d5l64K_, 0.9896, 0.41, 0.820, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
213, d5l5rY_, 0.9896, 0.41, 0.758, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
214, d5l5rK_, 0.9896, 0.41, 0.758, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
215, d5l5fY_, 0.9895, 0.42, 0.763, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
216, d5l5fK_, 0.9895, 0.42, 0.763, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
217, d2zcyY_, 0.9895, 0.56, 0.995, 212, 212, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
218, d2zcyK_, 0.9894, 0.56, 0.995, 212, 212, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
219, d5l5dY_, 0.9893, 0.43, 0.763, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
220, d5l5wY_, 0.9892, 0.43, 0.825, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
221, d5l5dK_, 0.9892, 0.43, 0.763, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
222, d4ltcY_, 0.9892, 0.57, 0.995, 212, 212, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
223, d5l5wK_, 0.9891, 0.43, 0.825, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
224, d5fggY_, 0.9891, 0.57, 0.991, 212, 212, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
225, d5fggK_, 0.9891, 0.57, 0.991, 212, 212, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
226, d4qwjY_, 0.9891, 0.57, 0.991, 212, 212, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
227, d4qwjK_, 0.9891, 0.57, 0.991, 212, 212, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
228, d5l63Y_, 0.9890, 0.43, 0.820, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
229, d5l63K_, 0.9890, 0.43, 0.820, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
230, d5l60Y_, 0.9889, 0.44, 0.820, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
231, d5l60K_, 0.9889, 0.44, 0.820, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
232, d5l62Y_, 0.9888, 0.44, 0.820, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
233, d5l62K_, 0.9888, 0.44, 0.820, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
234, d3nzxY_, 0.9888, 0.58, 0.995, 212, 212, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
235, d3nzxK_, 0.9888, 0.58, 0.995, 212, 212, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
236, d5l61Y_, 0.9887, 0.45, 0.820, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
237, d5l61K_, 0.9887, 0.45, 0.820, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
238, d5l5iK_, 0.9887, 0.45, 0.763, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
239, d5l5iY_, 0.9886, 0.45, 0.763, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
240, d4qwkY_, 0.9886, 0.59, 0.986, 212, 212, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
241, d4qwkK_, 0.9886, 0.59, 0.986, 212, 212, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
242, d4ltcK_, 0.9886, 0.59, 0.995, 212, 212, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
243, d5l6bY_, 0.9884, 0.46, 0.773, 211, 211, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
244, d5l6bK_, 0.9884, 0.45, 0.773, 211, 211, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
245, d5l5oY_, 0.9884, 0.46, 0.763, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
246, d5l6cY_, 0.9883, 0.46, 0.773, 211, 211, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
247, d5l6cK_, 0.9883, 0.46, 0.773, 211, 211, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
248, d5l5xY_, 0.9883, 0.46, 0.820, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
249, d5l5xK_, 0.9883, 0.46, 0.820, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
250, d5l5oK_, 0.9883, 0.46, 0.763, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
251, d5l5jY_, 0.9883, 0.46, 0.763, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
252, d5l5jK_, 0.9883, 0.46, 0.763, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
253, d5cz9Y_, 0.9883, 0.59, 0.991, 212, 212, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
254, d5cz9K_, 0.9883, 0.59, 0.991, 212, 212, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
255, d4qz6Y_, 0.9883, 0.59, 0.986, 212, 212, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
256, d4qz6K_, 0.9883, 0.59, 0.986, 212, 212, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
257, d5l67Y_, 0.9882, 0.46, 0.773, 211, 211, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
258, d5l67K_, 0.9882, 0.46, 0.773, 211, 211, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
259, d5l5tY_, 0.9882, 0.46, 0.758, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
260, d5l5tK_, 0.9882, 0.46, 0.758, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
261, d5l65K_, 0.9881, 0.47, 0.773, 211, 211, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
262, d5l65Y_, 0.9880, 0.47, 0.773, 211, 211, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
263, d5l5vY_, 0.9880, 0.47, 0.758, 211, 211,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
264, d5l5vK_, 0.9880, 0.47, 0.758, 211, 211,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
265, d5l5uY_, 0.9880, 0.47, 0.758, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
266, d5l5uK_, 0.9880, 0.47, 0.758, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
267, d5l5pK_, 0.9880, 0.47, 0.763, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
268, d5l68Y_, 0.9879, 0.47, 0.773, 211, 211, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
269, d5l68K_, 0.9879, 0.47, 0.773, 211, 211, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
270, d5l5pY_, 0.9879, 0.47, 0.763, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
271, d4no8Y_, 0.9879, 0.60, 0.995, 212, 212, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
272, d4no8K_, 0.9879, 0.60, 0.995, 212, 212, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
273, d5l6aY_, 0.9878, 0.48, 0.773, 211, 211, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
274, d5l5yY_, 0.9878, 0.47, 0.820, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
275, d5l5yK_, 0.9878, 0.47, 0.820, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
276, d5l6aK_, 0.9877, 0.48, 0.773, 211, 211, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
277, d5lttY_, 0.9876, 0.48, 0.768, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
278, d5l66Y_, 0.9876, 0.48, 0.773, 211, 211, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
279, d5l66K_, 0.9876, 0.48, 0.773, 211, 211, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
280, d5lttK_, 0.9874, 0.49, 0.768, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
281, d4no6Y_, 0.9874, 0.62, 0.995, 212, 212, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
282, d5l5sY_, 0.9873, 0.49, 0.758, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
283, d5l5sK_, 0.9873, 0.49, 0.758, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
284, d4no6K_, 0.9873, 0.62, 0.995, 212, 212, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
285, d5l5qY_, 0.9872, 0.49, 0.763, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
286, d5l5qK_, 0.9872, 0.49, 0.763, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
287, d5l5hY_, 0.9872, 0.49, 0.763, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
288, d5l5hK_, 0.9872, 0.49, 0.763, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
289, d4qwiY_, 0.9872, 0.62, 0.991, 212, 212, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
290, d4qwiK_, 0.9872, 0.62, 0.991, 212, 212, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
291, d4qwgK_, 0.9871, 0.62, 0.991, 212, 212, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
292, d4qwgY_, 0.9870, 0.63, 0.991, 212, 212, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
293, d4qw7Y_, 0.9870, 0.62, 0.991, 212, 212, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
294, d4qw7K_, 0.9870, 0.62, 0.991, 212, 212, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
295, d4hnpK_, 0.9870, 0.63, 0.995, 212, 212, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
296, d4qwlY_, 0.9869, 0.63, 0.991, 212, 212, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
297, d4qwlK_, 0.9868, 0.63, 0.991, 212, 212, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
298, d5cz5Y_, 0.9866, 0.64, 0.995, 212, 212, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
299, d5cz5K_, 0.9866, 0.64, 0.995, 212, 212, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
300, d4hnpY_, 0.9866, 0.64, 0.995, 212, 212, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
301, d4qw6Y_, 0.9865, 0.64, 0.991, 212, 212, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
302, d4qw6K_, 0.9865, 0.64, 0.991, 212, 212, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
303, d5l69Y_, 0.9864, 0.52, 0.773, 211, 211, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
304, d5l69K_, 0.9864, 0.52, 0.773, 211, 211, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
305, d5jhsY_, 0.9864, 0.64, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
306, d5jhsK_, 0.9864, 0.64, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
307, d5d0sY_, 0.9864, 0.64, 0.991, 212, 212, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
308, d5d0sK_, 0.9864, 0.64, 0.991, 212, 212, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
309, d4qwsY_, 0.9864, 0.64, 0.991, 212, 212, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
310, d4qwsK_, 0.9864, 0.64, 0.991, 212, 212, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
311, d5d0zY_, 0.9863, 0.64, 0.991, 212, 212, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
312, d5d0zK_, 0.9863, 0.64, 0.991, 212, 212, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
313, d4qwfY_, 0.9863, 0.64, 0.991, 212, 212, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
314, d4qwfK_, 0.9863, 0.64, 0.991, 212, 212, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
315, d4qw5Y_, 0.9863, 0.64, 0.991, 212, 212, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
316, d4qw5K_, 0.9863, 0.64, 0.991, 212, 212, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
317, d4qz5Y_, 0.9862, 0.65, 0.991, 212, 212, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
318, d4qz5K_, 0.9862, 0.65, 0.991, 212, 212, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
319, d4nnnY_, 0.9862, 0.65, 0.995, 212, 212, YCP IN COMPLEX WITH MG132
320, d4nnnK_, 0.9862, 0.65, 0.995, 212, 212, YCP IN COMPLEX WITH MG132
321, p3jcpUA_, 0.9862, 0.64, 0.995, 212, 212, 
322, p3jcpG_, 0.9862, 0.64, 0.995, 212, 212, 
323, d5fgiY_, 0.9861, 0.65, 0.995, 212, 212, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
324, d5fgiK_, 0.9861, 0.65, 0.995, 212, 212, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
325, d4hrcY_, 0.9861, 0.65, 0.995, 212, 212, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
326, d4hrcK_, 0.9860, 0.65, 0.995, 212, 212, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
327, d3nzwY_, 0.9860, 0.65, 0.995, 212, 212, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
328, d3nzwK_, 0.9860, 0.65, 0.995, 212, 212, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
329, d1g65K_, 0.9860, 0.65, 0.995, 212, 212, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
330, d4qw4Y_, 0.9859, 0.65, 0.995, 212, 212, YCP IN COMPLEX WITH CARFILZOMIB
331, d4qw4K_, 0.9859, 0.65, 0.995, 212, 212, YCP IN COMPLEX WITH CARFILZOMIB
332, d4no9Y_, 0.9859, 0.65, 0.995, 212, 212, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
333, d4no9K_, 0.9859, 0.65, 0.995, 212, 212, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
334, d5ahjY_, 0.9857, 0.66, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
335, d5ahjK_, 0.9857, 0.66, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
336, d4qz3K_, 0.9857, 0.66, 0.991, 212, 212, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
337, d1g65Y_, 0.9857, 0.66, 0.995, 212, 212, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
338, d5cz8Y_, 0.9856, 0.66, 0.991, 221, 212, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
339, d4qz3Y_, 0.9856, 0.66, 0.991, 212, 212, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
340, d3oeuY_, 0.9856, 0.67, 0.995, 212, 212, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
341, d5cz8K_, 0.9855, 0.67, 0.991, 220, 212, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
342, d4qz7Y_, 0.9854, 0.66, 0.991, 212, 212, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
343, d4qz7K_, 0.9854, 0.66, 0.991, 212, 212, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
344, d4hrdK_, 0.9854, 0.66, 0.995, 212, 212, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
345, d5l55Y_, 0.9852, 0.67, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
346, d5l55K_, 0.9852, 0.67, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
347, d5l54Y_, 0.9852, 0.67, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
348, d5l54K_, 0.9852, 0.67, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
349, d4hrdY_, 0.9852, 0.67, 0.995, 212, 212, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
350, d3okjY_, 0.9852, 0.67, 0.995, 212, 212, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
351, d3okjK_, 0.9852, 0.67, 0.995, 212, 212, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
352, d5l52Y_, 0.9850, 0.67, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
353, d5l52K_, 0.9850, 0.67, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
354, d3oeuK_, 0.9849, 0.68, 0.995, 212, 212, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
355, d4qzxY_, 0.9848, 0.68, 0.991, 212, 212, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
356, d4qzxK_, 0.9848, 0.68, 0.991, 212, 212, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
357, d4qxjK_, 0.9848, 0.68, 0.991, 212, 212, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
358, d3mg7Y_, 0.9848, 0.69, 0.995, 212, 212, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
359, d4qxjY_, 0.9847, 0.68, 0.991, 212, 212, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
360, d4qwxK_, 0.9847, 0.68, 0.995, 212, 212, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
361, d3d29Y_, 0.9847, 0.68, 0.995, 212, 212, PROTEASOME INHIBITION BY FELLUTAMIDE B
362, d3d29K_, 0.9847, 0.68, 0.995, 212, 212, PROTEASOME INHIBITION BY FELLUTAMIDE B
363, d4qltY_, 0.9846, 0.68, 0.995, 212, 212, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
364, d4qltK_, 0.9846, 0.68, 0.995, 212, 212, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
365, d3sdiK_, 0.9845, 0.69, 0.995, 212, 212, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
366, d3mg7K_, 0.9845, 0.69, 0.995, 212, 212, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
367, d4qz4Y_, 0.9844, 0.69, 0.991, 212, 212, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
368, d4qz4K_, 0.9844, 0.69, 0.991, 212, 212, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
369, d4qz1Y_, 0.9844, 0.69, 0.991, 212, 212, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
370, d4qz1K_, 0.9844, 0.69, 0.991, 212, 212, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
371, d4qz0Y_, 0.9844, 0.69, 0.991, 212, 212, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
372, d4qz0K_, 0.9844, 0.69, 0.991, 212, 212, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
373, d4qwxY_, 0.9844, 0.69, 0.995, 212, 212, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
374, d3sdiY_, 0.9844, 0.69, 0.995, 212, 212, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
375, d3mg6K_, 0.9843, 0.69, 0.995, 212, 212, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
376, d4qlvY_, 0.9842, 0.69, 0.995, 212, 212, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
377, d4qlvK_, 0.9842, 0.69, 0.995, 212, 212, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
378, d4qluY_, 0.9842, 0.69, 0.995, 212, 212, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
379, d4qluK_, 0.9842, 0.69, 0.995, 212, 212, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
380, d3mg6Y_, 0.9842, 0.70, 0.995, 212, 212, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
381, d4qlsY_, 0.9841, 0.69, 0.995, 212, 212, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
382, d4qlsK_, 0.9841, 0.69, 0.995, 212, 212, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
383, d3sdkY_, 0.9841, 0.70, 0.995, 212, 212, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
384, d3mg8Y_, 0.9841, 0.70, 0.995, 212, 212, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
385, d4qz2Y_, 0.9840, 0.70, 0.991, 212, 212, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
386, d4qz2K_, 0.9840, 0.70, 0.991, 212, 212, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
387, d4nnwY_, 0.9838, 0.70, 0.995, 212, 212, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
388, d3sdkK_, 0.9838, 0.71, 0.995, 212, 212, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
389, d4nnwK_, 0.9837, 0.70, 0.995, 212, 212, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
390, d3mg8K_, 0.9837, 0.71, 0.995, 212, 212, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
391, d4g4sL_, 0.9834, 0.71, 0.995, 212, 212, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
392, d4qlqY_, 0.9824, 0.73, 0.995, 212, 212, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
393, d4qlqK_, 0.9824, 0.73, 0.995, 212, 212, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
394, p3jcoUA_, 0.9788, 0.80, 0.995, 212, 212, 
395, p3jcoG_, 0.9787, 0.81, 0.995, 212, 212, 
396, p5mpcL_, 0.9771, 0.85, 0.995, 212, 212, 
397, p5wviSA_, 0.9479, 1.31, 0.995, 212, 212, 
398, d4r3oZ_, 0.9378, 0.57, 0.662, 201, 201, HUMAN CONSTITUTIVE 20S PROTEASOME
399, d4r3oL_, 0.9377, 0.58, 0.662, 201, 201, HUMAN CONSTITUTIVE 20S PROTEASOME
400, p3uneK_, 0.9364, 0.62, 0.662, 201, 201, MOUSE CONSTITUTIVE 20S PROTEASOME
401, p5gjrRA_, 0.9361, 0.62, 0.662, 201, 201, 
402, p5gjrDA_, 0.9360, 0.62, 0.662, 201, 201, 
403, d1iruL_, 0.9357, 0.64, 0.662, 201, 201, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
404, d1iruZ_, 0.9356, 0.64, 0.662, 201, 201, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
405, p5gjqs_, 0.9355, 0.63, 0.662, 201, 201, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
406, p3uneY_, 0.9355, 0.64, 0.662, 201, 201, MOUSE CONSTITUTIVE 20S PROTEASOME
407, p3une1_, 0.9353, 0.64, 0.662, 201, 201, MOUSE CONSTITUTIVE 20S PROTEASOME
408, d5le5K_, 0.9350, 0.66, 0.662, 201, 201, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
409, p3unem_, 0.9347, 0.66, 0.662, 201, 201, MOUSE CONSTITUTIVE 20S PROTEASOME
410, p5gjqe_, 0.9346, 0.66, 0.657, 201, 201, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
411, d4r67L_, 0.9332, 0.69, 0.662, 201, 201, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
412, d4r673_, 0.9332, 0.69, 0.662, 201, 201, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
413, d4r67Z_, 0.9331, 0.69, 0.662, 201, 201, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
414, d5lf3Y_, 0.9329, 0.70, 0.662, 201, 201, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
415, p4r67n_, 0.9329, 0.70, 0.662, 201, 201, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
416, d5lexK_, 0.9324, 0.59, 0.665, 200, 200, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
417, p5l4gZ_, 0.9323, 0.71, 0.662, 201, 201, 
418, p5l4gL_, 0.9321, 0.72, 0.662, 201, 201, 
419, d5lf1Y_, 0.9320, 0.72, 0.662, 201, 201, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
420, p5lf0Y_, 0.9319, 0.73, 0.662, 201, 201, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
421, p5vfqL_, 0.9313, 0.74, 0.657, 201, 201, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
422, d5lf7Y_, 0.9312, 0.74, 0.662, 201, 201, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
423, p5vfpL_, 0.9309, 0.74, 0.657, 201, 201, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
424, d5lf4Y_, 0.9307, 0.75, 0.662, 201, 201, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
425, p5vfuCA_, 0.9305, 0.75, 0.657, 201, 201, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
426, p5vftR_, 0.9305, 0.75, 0.657, 201, 201, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
427, p5vfoR_, 0.9303, 0.76, 0.657, 201, 201, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
428, p5vfsL_, 0.9302, 0.76, 0.657, 201, 201, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
429, p5vfqKA_, 0.9301, 0.76, 0.657, 201, 201, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
430, p5vfor_, 0.9300, 0.76, 0.662, 201, 201, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
431, p5vfpJA_, 0.9297, 0.77, 0.657, 201, 201, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
432, d5lf3K_, 0.9297, 0.66, 0.665, 200, 200, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
433, p5vfrR_, 0.9296, 0.77, 0.657, 201, 201, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
434, d3unb1_, 0.9294, 0.78, 0.662, 201, 201, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
435, p5vfsKA_, 0.9293, 0.78, 0.657, 201, 201, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
436, p5t0cJB_, 0.9290, 0.78, 0.657, 201, 201, 
437, p5t0cDA_, 0.9290, 0.78, 0.657, 201, 201, 
438, d3unbY_, 0.9290, 0.78, 0.662, 201, 201, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
439, p5vfrr_, 0.9289, 0.79, 0.662, 201, 201, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
440, p5lf6Y_, 0.9288, 0.79, 0.657, 201, 201, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
441, p5lf0K_, 0.9287, 0.69, 0.665, 200, 200, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
442, d5lf1K_, 0.9286, 0.69, 0.665, 200, 200, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
443, p3unhY_, 0.9285, 0.80, 0.617, 201, 201, MOUSE 20S IMMUNOPROTEASOME
444, p3unhK_, 0.9285, 0.80, 0.617, 201, 201, MOUSE 20S IMMUNOPROTEASOME
445, p6gopY_, 0.9281, 0.19, 0.995, 197, 197, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
446, p6gopK_, 0.9281, 0.19, 0.995, 197, 197, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
447, d5lexY_, 0.9281, 0.58, 0.668, 199, 199, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
448, p4y6vK_, 0.9280, 0.20, 0.995, 197, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
449, p4ya5Y_, 0.9279, 0.21, 0.995, 197, 197, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
450, p4ya5K_, 0.9279, 0.21, 0.995, 197, 197, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
451, p4y8nY_, 0.9279, 0.20, 0.995, 197, 197, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
452, p4y8nK_, 0.9279, 0.20, 0.995, 197, 197, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
453, p4y6vY_, 0.9279, 0.21, 0.995, 197, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
454, p4y69Y_, 0.9279, 0.21, 0.995, 197, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
455, p4y69K_, 0.9279, 0.21, 0.995, 197, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
456, p4y8uY_, 0.9278, 0.21, 0.995, 197, 197, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
457, p4y8uK_, 0.9278, 0.21, 0.995, 197, 197, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
458, d5lf7K_, 0.9277, 0.71, 0.665, 200, 200, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
459, p4ya3Y_, 0.9277, 0.22, 0.995, 197, 197, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
460, p4ya3K_, 0.9277, 0.22, 0.995, 197, 197, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
461, p4ya0Y_, 0.9277, 0.22, 0.995, 197, 197, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
462, p4ya0K_, 0.9277, 0.22, 0.995, 197, 197, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
463, p4y6aY_, 0.9277, 0.22, 0.995, 197, 197, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
464, p4y6aK_, 0.9277, 0.22, 0.995, 197, 197, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
465, d5le5Y_, 0.9276, 0.60, 0.668, 199, 199, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
466, p4y8tY_, 0.9275, 0.23, 0.995, 197, 197, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
467, p4y8tK_, 0.9275, 0.23, 0.995, 197, 197, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
468, p5nifL_, 0.9274, 0.24, 0.995, 197, 197, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
469, p5lezK_, 0.9274, 0.72, 0.665, 200, 200, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
470, p4zzgL_, 0.9274, 0.24, 0.995, 197, 197, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
471, d3unbK_, 0.9274, 0.82, 0.662, 201, 201, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
472, p3unbm_, 0.9273, 0.82, 0.662, 201, 201, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
473, p5nifZ_, 0.9271, 0.26, 0.995, 197, 197, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
474, p4zzgZ_, 0.9271, 0.26, 0.995, 197, 197, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
475, d5lf4K_, 0.9270, 0.73, 0.665, 200, 200, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
476, p4x6zZ_, 0.9270, 0.26, 0.995, 197, 197, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
477, p4x6zL_, 0.9269, 0.27, 0.995, 197, 197, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
478, p5vfuQA_, 0.9267, 0.83, 0.657, 201, 201, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
479, p5vftr_, 0.9267, 0.83, 0.657, 201, 201, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
480, p5leyK_, 0.9267, 0.73, 0.665, 200, 200, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
481, p4y7xY_, 0.9263, 0.30, 0.995, 197, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
482, p4y7xK_, 0.9262, 0.31, 0.995, 197, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
483, p5t0gR_, 0.9259, 0.85, 0.657, 201, 201, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
484, p5fghY_, 0.9257, 0.33, 0.990, 197, 197, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
485, p5fghK_, 0.9257, 0.34, 0.990, 197, 197, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
486, p5lf6K_, 0.9254, 0.76, 0.665, 200, 200, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
487, p4y8kY_, 0.9253, 0.35, 0.995, 197, 197, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
488, p4y8kK_, 0.9252, 0.36, 0.995, 197, 197, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
489, p4v7oZ_, 0.9251, 0.36, 0.990, 197, 197, 
490, p4v7oL_, 0.9251, 0.36, 0.990, 197, 197, 
491, p4v7oHB_, 0.9251, 0.36, 0.990, 197, 197, 
492, p4qbyY_, 0.9246, 0.38, 0.995, 197, 197, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
493, p4qbyK_, 0.9246, 0.38, 0.995, 197, 197, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
494, p1z7qZ_, 0.9246, 0.39, 0.990, 197, 197, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
495, p1z7qL_, 0.9246, 0.38, 0.990, 197, 197, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
496, d3unfY_, 0.9245, 0.88, 0.617, 201, 201, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
497, d3unfK_, 0.9245, 0.87, 0.617, 201, 201, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
498, p4y7yK_, 0.9242, 0.40, 0.995, 197, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
499, p4y7yY_, 0.9241, 0.40, 0.995, 197, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
500, p4gk7Y_, 0.9238, 0.41, 0.995, 197, 197, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
501, p4gk7K_, 0.9238, 0.41, 0.995, 197, 197, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
502, p5lezY_, 0.9226, 0.72, 0.663, 199, 199, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
503, p1fntL_, 0.9224, 0.47, 0.990, 197, 197, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
504, p1fntZ_, 0.9223, 0.47, 0.990, 197, 197, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
505, p6avoD_, 0.9221, 0.92, 0.597, 201, 201, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
506, p6avoC_, 0.9221, 0.92, 0.597, 201, 201, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
507, p5leyY_, 0.9220, 0.74, 0.668, 199, 199, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
508, p5m32Y_, 0.9214, 0.94, 0.657, 201, 201, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
509, p5cghY_, 0.9209, 0.52, 0.990, 197, 197, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
510, p5cghK_, 0.9209, 0.52, 0.990, 197, 197, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
511, p4v7oTA_, 0.9204, 0.36, 0.990, 196, 196, 
512, p4y8sY_, 0.9203, 0.54, 0.995, 197, 197, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
513, p4y8sK_, 0.9203, 0.54, 0.995, 197, 197, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
514, p5mp9l_, 0.9200, 0.54, 0.995, 197, 197, 26S PROTEASOME IN PRESENCE OF ATP (S1)
515, p5mp95_, 0.9193, 0.57, 0.995, 197, 197, 26S PROTEASOME IN PRESENCE OF ATP (S1)
516, p5cggY_, 0.9189, 0.58, 0.990, 197, 197, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
517, p5cggK_, 0.9188, 0.58, 0.990, 197, 197, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
518, p4ya2Y_, 0.9184, 0.59, 0.995, 197, 197, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
519, p4cr45_, 0.9184, 1.70, 0.976, 212, 209, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
520, p4ya2K_, 0.9183, 0.59, 0.995, 197, 197, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
521, p5m32K_, 0.9182, 0.91, 0.660, 200, 200, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
522, p4y78Y_, 0.9182, 0.60, 0.995, 197, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
523, p4y70Y_, 0.9182, 0.60, 0.995, 197, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
524, p4y70K_, 0.9182, 0.60, 0.995, 197, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
525, p4ya7Y_, 0.9181, 0.60, 0.995, 197, 197, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
526, p5mpal_, 0.9180, 0.60, 0.995, 197, 197, 26S PROTEASOME IN PRESENCE OF ATP (S2)
527, p4ya7K_, 0.9180, 0.60, 0.995, 197, 197, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
528, p4y9zY_, 0.9180, 0.60, 0.995, 197, 197, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
529, p4y9zK_, 0.9180, 0.60, 0.995, 197, 197, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
530, p4y8qY_, 0.9180, 0.60, 0.995, 197, 197, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
531, p4y8qK_, 0.9180, 0.60, 0.995, 197, 197, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
532, p4y8lY_, 0.9180, 0.60, 0.995, 197, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
533, p4y8lK_, 0.9180, 0.60, 0.995, 197, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
534, p4y7wY_, 0.9180, 0.60, 0.995, 197, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
535, p4y7wK_, 0.9180, 0.60, 0.995, 197, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
536, p4y78K_, 0.9180, 0.60, 0.995, 197, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
537, p4y8pY_, 0.9179, 0.60, 0.995, 197, 197, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
538, p4y8pK_, 0.9179, 0.60, 0.995, 197, 197, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
539, p4y80Y_, 0.9179, 0.61, 0.995, 197, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
540, p4y80K_, 0.9179, 0.61, 0.995, 197, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
541, p4ya9Y_, 0.9178, 0.61, 0.995, 197, 197, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
542, p4ya9K_, 0.9178, 0.61, 0.995, 197, 197, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
543, p4y8hY_, 0.9177, 0.61, 0.995, 197, 197, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
544, p4y8hK_, 0.9177, 0.61, 0.995, 197, 197, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
545, p4y6zY_, 0.9177, 0.61, 0.995, 197, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
546, p4y6zK_, 0.9177, 0.61, 0.995, 197, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
547, p4y8jY_, 0.9175, 0.62, 0.995, 197, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
548, p4y8jK_, 0.9175, 0.61, 0.995, 197, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
549, p4y82Y_, 0.9175, 0.61, 0.995, 197, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
550, p4y82K_, 0.9175, 0.61, 0.995, 197, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
551, p4y77Y_, 0.9175, 0.62, 0.995, 197, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
552, p4y77K_, 0.9175, 0.62, 0.995, 197, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
553, p4y8iY_, 0.9174, 0.62, 0.995, 197, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
554, p4y8iK_, 0.9174, 0.62, 0.995, 197, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
555, p4y8gY_, 0.9174, 0.62, 0.995, 197, 197, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
556, p4y81Y_, 0.9174, 0.62, 0.995, 197, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
557, p4y75Y_, 0.9174, 0.62, 0.995, 197, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
558, p4y75K_, 0.9174, 0.62, 0.995, 197, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
559, p4y74Y_, 0.9174, 0.62, 0.995, 197, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
560, p4y8gK_, 0.9173, 0.62, 0.995, 197, 197, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
561, p4y84Y_, 0.9173, 0.62, 0.995, 197, 197, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
562, p4y81K_, 0.9173, 0.62, 0.995, 197, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
563, p4y74K_, 0.9173, 0.62, 0.995, 197, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
564, p4y84K_, 0.9172, 0.62, 0.995, 197, 197, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
565, p4y8oY_, 0.9168, 0.63, 0.995, 197, 197, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
566, p4y8oK_, 0.9168, 0.63, 0.995, 197, 197, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
567, p5mpbL_, 0.9167, 0.93, 0.995, 200, 200, 
568, p5mpa5_, 0.9167, 0.63, 0.995, 197, 197, 26S PROTEASOME IN PRESENCE OF ATP (S2)
569, p5cgiY_, 0.9164, 0.64, 0.990, 197, 197, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
570, p5cgiK_, 0.9164, 0.64, 0.990, 197, 197, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
571, d4cr25_, 0.9127, 2.00, 0.971, 212, 210, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
572, p5a5b5_, 0.9126, 1.81, 0.976, 212, 209, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
573, p4cr35_, 0.9126, 1.81, 0.976, 212, 209, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
574, p5t0hR_, 0.9100, 1.12, 0.657, 201, 201, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
575, p5mpcZ_, 0.9075, 0.85, 0.995, 197, 197, 
576, p5mpbZ_, 0.9051, 0.90, 0.995, 197, 197, 
577, p5wvkE_, 0.9049, 0.90, 0.995, 197, 197, 
578, p5t0iR_, 0.8978, 1.37, 0.657, 201, 201, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
579, p5wvkL_, 0.8969, 1.04, 0.995, 197, 197, 
580, p5t0jR_, 0.8944, 1.38, 0.657, 201, 201, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
581, p5wviIA_, 0.8830, 1.28, 0.995, 197, 197, 
582, p5gjqo_, 0.8825, 1.73, 0.272, 202, 202, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
583, p5gjrNA_, 0.8819, 1.74, 0.272, 202, 202, 
584, p5gjrZ_, 0.8817, 1.75, 0.272, 202, 202, 
585, d4r3oV_, 0.8816, 1.75, 0.272, 202, 202, HUMAN CONSTITUTIVE 20S PROTEASOME
586, d4r3oH_, 0.8816, 1.75, 0.272, 202, 202, HUMAN CONSTITUTIVE 20S PROTEASOME
587, p3uneN_, 0.8806, 1.77, 0.267, 202, 202, MOUSE CONSTITUTIVE 20S PROTEASOME
588, p3unep_, 0.8805, 1.77, 0.267, 202, 202, MOUSE CONSTITUTIVE 20S PROTEASOME
589, p5gjqa_, 0.8804, 1.76, 0.272, 202, 202, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
590, p3uneb_, 0.8803, 1.76, 0.267, 202, 202, MOUSE CONSTITUTIVE 20S PROTEASOME
591, p3une4_, 0.8799, 1.76, 0.267, 202, 202, MOUSE CONSTITUTIVE 20S PROTEASOME
592, d5le5N_, 0.8797, 1.76, 0.272, 202, 202, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
593, p5le5b_, 0.8791, 1.77, 0.272, 203, 202, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
594, d5lf1N_, 0.8789, 1.78, 0.272, 202, 202, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
595, p5lf1b_, 0.8788, 1.78, 0.272, 203, 202, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
596, d4r67H_, 0.8786, 1.78, 0.272, 202, 202, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
597, p4r67x_, 0.8785, 1.78, 0.272, 202, 202, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
598, d4r67V_, 0.8785, 1.78, 0.272, 202, 202, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
599, p5lf0N_, 0.8784, 1.78, 0.272, 202, 202, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
600, p4r67j_, 0.8784, 1.79, 0.272, 202, 202, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
601, p5a0qZ_, 0.8783, 0.97, 0.677, 192, 192, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
602, p5a0qL_, 0.8783, 0.97, 0.677, 192, 192, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
603, p5lf0b_, 0.8779, 1.80, 0.272, 203, 202, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
604, p5leyN_, 0.8778, 1.80, 0.272, 202, 202, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
605, p5leyb_, 0.8778, 1.80, 0.272, 203, 202, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
606, p5l4gM_, 0.8778, 1.57, 0.275, 200, 200, 
607, p5lf3b_, 0.8775, 1.81, 0.272, 203, 202, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
608, d5lf7N_, 0.8771, 1.82, 0.272, 202, 202, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
609, p5lf7b_, 0.8771, 1.81, 0.272, 203, 202, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
610, d1iruV_, 0.8771, 1.82, 0.272, 202, 202, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
611, d1iruH_, 0.8771, 1.82, 0.272, 202, 202, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
612, p5lexb_, 0.8770, 1.82, 0.272, 203, 202, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
613, d5lexN_, 0.8769, 1.83, 0.272, 202, 202, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
614, p5lf6N_, 0.8766, 1.82, 0.272, 202, 202, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
615, p5lf6b_, 0.8766, 1.81, 0.272, 203, 202, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
616, p5m32b_, 0.8763, 1.82, 0.272, 203, 202, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
617, p5m32N_, 0.8761, 1.84, 0.272, 202, 202, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
618, d1pmaY_, 0.8759, 2.16, 0.259, 203, 201, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
619, d1j2qN_, 0.8759, 2.09, 0.308, 202, 201, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
620, d1j2qL_, 0.8759, 2.09, 0.308, 202, 201, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
621, d1j2qK_, 0.8759, 2.09, 0.308, 202, 201, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
622, d1j2qJ_, 0.8759, 2.09, 0.308, 202, 201, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
623, d1j2qM_, 0.8758, 2.09, 0.308, 202, 201, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
624, d1j2qI_, 0.8758, 2.09, 0.308, 202, 201, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
625, d1j2qH_, 0.8758, 2.09, 0.308, 202, 201, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
626, d1pma1_, 0.8757, 2.17, 0.259, 203, 201, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
627, d5lf4N_, 0.8756, 1.82, 0.272, 202, 202, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
628, d1pmaZ_, 0.8756, 2.18, 0.254, 203, 201, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
629, p5lf4b_, 0.8755, 1.83, 0.272, 203, 202, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
630, d3mi0R1, 0.8755, 2.57, 0.233, 234, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
631, p5vy3Z_, 0.8753, 2.19, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
632, p5vy3X_, 0.8753, 2.19, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
633, p5vy3V_, 0.8753, 2.19, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
634, p5vy3T_, 0.8753, 2.19, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
635, p5vy3R_, 0.8753, 2.19, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
636, p5vy3P_, 0.8753, 2.19, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
637, p5vy3N_, 0.8753, 2.19, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
638, p5vy3L_, 0.8753, 2.19, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
639, p5vy3J_, 0.8753, 2.19, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
640, p5vy3H_, 0.8753, 2.19, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
641, p5vy3F_, 0.8753, 2.19, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
642, p5vy3D_, 0.8753, 2.19, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
643, p5vy3B_, 0.8753, 2.19, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
644, p5vy31_, 0.8753, 2.19, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
645, d3mi0V1, 0.8753, 2.58, 0.233, 234, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
646, d1pmaW_, 0.8753, 2.18, 0.259, 203, 201, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
647, p5vy4Z_, 0.8752, 2.18, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
648, p5vy4X_, 0.8752, 2.18, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
649, p5vy4V_, 0.8752, 2.18, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
650, p5vy4T_, 0.8752, 2.18, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
651, p5vy4R_, 0.8752, 2.18, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
652, p5vy4P_, 0.8752, 2.18, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
653, p5vy4N_, 0.8752, 2.18, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
654, p5vy4L_, 0.8752, 2.18, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
655, p5vy4J_, 0.8752, 2.18, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
656, p5vy4H_, 0.8752, 2.18, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
657, p5vy4F_, 0.8752, 2.18, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
658, p5vy4D_, 0.8752, 2.18, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
659, p5vy4BA_, 0.8752, 2.18, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
660, p5vy4B_, 0.8752, 2.18, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
661, p5vy41_, 0.8752, 2.18, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
662, d3unb4_, 0.8752, 1.84, 0.267, 202, 202, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
663, d3c92Z1, 0.8752, 2.16, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
664, d3c92X1, 0.8752, 2.17, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
665, d3c92L1, 0.8752, 2.16, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
666, d3c92J1, 0.8752, 2.17, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
667, d3c91Z1, 0.8752, 2.16, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
668, d3c91X1, 0.8752, 2.17, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
669, d3c91L1, 0.8752, 2.16, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
670, d3c91J1, 0.8752, 2.17, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
671, d1pmaS_, 0.8752, 2.16, 0.259, 203, 201, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
672, d1pmaQ_, 0.8752, 2.17, 0.259, 203, 201, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
673, d1pmaB_, 0.8752, 2.18, 0.254, 203, 201, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
674, p5lezN_, 0.8751, 1.83, 0.272, 202, 202, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
675, d3unbb_, 0.8751, 1.82, 0.267, 202, 202, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
676, d3c92W1, 0.8751, 2.17, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
677, d3c92V1, 0.8751, 2.18, 0.254, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
678, d3c92I1, 0.8751, 2.17, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
679, d3c92H1, 0.8751, 2.18, 0.254, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
680, d3c91W1, 0.8751, 2.17, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
681, d3c91V1, 0.8751, 2.18, 0.254, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
682, d3c91I1, 0.8751, 2.17, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
683, d3c91H1, 0.8751, 2.18, 0.254, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
684, d1pmaP_, 0.8751, 2.17, 0.259, 203, 201, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
685, d1pma2_, 0.8751, 2.17, 0.259, 203, 201, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
686, d3unbp_, 0.8750, 1.85, 0.267, 202, 202, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
687, d3c92N1, 0.8750, 2.17, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
688, d3c9221, 0.8750, 2.17, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
689, d3c91N1, 0.8750, 2.17, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
690, d3c9121, 0.8750, 2.17, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
691, d1pmaV_, 0.8750, 2.18, 0.254, 203, 201, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
692, d1pmaU_, 0.8750, 2.17, 0.259, 203, 201, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
693, d3unbN_, 0.8749, 1.85, 0.267, 202, 202, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
694, d1ya7M_, 0.8749, 2.22, 0.259, 203, 201, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
695, p5lezb_, 0.8748, 1.84, 0.272, 203, 202, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
696, d3jseM_, 0.8748, 2.22, 0.254, 203, 201, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
697, d3jseK_, 0.8748, 2.22, 0.259, 203, 201, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
698, d3c92Y1, 0.8748, 2.18, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
699, d3c92M1, 0.8748, 2.19, 0.254, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
700, d3c92K1, 0.8748, 2.18, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
701, d3c9211, 0.8748, 2.19, 0.254, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
702, d3c91Y1, 0.8748, 2.18, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
703, d3c91M1, 0.8748, 2.19, 0.254, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
704, d3c91K1, 0.8748, 2.18, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
705, d3c9111, 0.8748, 2.19, 0.254, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
706, d1pmaT_, 0.8748, 2.19, 0.254, 203, 201, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
707, d1pmaR_, 0.8748, 2.18, 0.259, 203, 201, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
708, d3jseL_, 0.8747, 2.22, 0.259, 203, 201, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
709, d3jseJ_, 0.8747, 2.22, 0.254, 203, 201, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
710, d3jseH_, 0.8747, 2.22, 0.259, 203, 201, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
711, d3jseN_, 0.8746, 2.22, 0.254, 203, 201, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
712, d3jseI_, 0.8746, 2.22, 0.254, 203, 201, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
713, d1pmaX_, 0.8746, 2.17, 0.259, 203, 201, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
714, d1yauM_, 0.8744, 2.23, 0.259, 203, 201, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
715, d1yarM_, 0.8743, 2.22, 0.259, 203, 201, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
716, d1ya7J_, 0.8743, 2.21, 0.254, 203, 201, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
717, p6avoF_, 0.8742, 1.54, 0.296, 199, 199, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
718, d1ya7K_, 0.8742, 2.21, 0.259, 203, 201, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
719, d1ya7H_, 0.8742, 2.21, 0.259, 203, 201, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
720, p6avoA_, 0.8741, 1.54, 0.296, 199, 199, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
721, p3jtlM_, 0.8741, 2.22, 0.259, 203, 201, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
722, p3jtlL_, 0.8741, 2.22, 0.254, 203, 201, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
723, p3jtlJ_, 0.8741, 2.22, 0.254, 203, 201, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
724, p3jtlI_, 0.8741, 2.22, 0.254, 203, 201, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
725, d1yauL_, 0.8741, 2.22, 0.259, 203, 201, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
726, d1yauJ_, 0.8741, 2.22, 0.259, 203, 201, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
727, d1ya7L_, 0.8741, 2.22, 0.259, 203, 201, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
728, p3jtlN_, 0.8740, 2.22, 0.259, 203, 201, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
729, p3jtlK_, 0.8740, 2.22, 0.254, 203, 201, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
730, p3jtlH_, 0.8740, 2.22, 0.259, 203, 201, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
731, d3jrmM_, 0.8740, 2.24, 0.254, 203, 201, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
732, d3jrmL_, 0.8740, 2.24, 0.254, 203, 201, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
733, d3jrmK_, 0.8740, 2.24, 0.254, 203, 201, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
734, d3jrmH_, 0.8740, 2.24, 0.254, 203, 201, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
735, d3jrmJ_, 0.8739, 2.24, 0.254, 203, 201, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
736, d3jrmI_, 0.8739, 2.24, 0.254, 203, 201, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
737, d1yarJ_, 0.8739, 2.23, 0.254, 203, 201, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
738, d3jrmN_, 0.8738, 2.24, 0.254, 203, 201, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
739, d1yauN_, 0.8738, 2.24, 0.254, 203, 201, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
740, d1yauK_, 0.8738, 2.22, 0.254, 203, 201, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
741, d1yarK_, 0.8738, 2.22, 0.254, 203, 201, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
742, d1ya7N_, 0.8738, 2.23, 0.254, 203, 201, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
743, d1ya7I_, 0.8738, 2.23, 0.259, 203, 201, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
744, d1yauI_, 0.8737, 2.24, 0.254, 203, 201, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
745, d1yarN_, 0.8737, 2.23, 0.259, 203, 201, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
746, d1yarL_, 0.8737, 2.22, 0.254, 203, 201, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
747, d1yarI_, 0.8736, 2.23, 0.254, 203, 201, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
748, d1yauH_, 0.8735, 2.23, 0.259, 203, 201, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
749, d5lf3N1, 0.8731, 1.81, 0.269, 201, 201, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
750, d1yarH_, 0.8731, 2.23, 0.259, 203, 201, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
751, d3krdV_, 0.8730, 2.71, 0.232, 229, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
752, d3krdR_, 0.8729, 2.51, 0.225, 229, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
753, d3h4pl_, 0.8725, 2.10, 0.295, 202, 200, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
754, p3h4pf_, 0.8719, 2.12, 0.295, 202, 200, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
755, p5l4gAA_, 0.8718, 1.60, 0.276, 199, 199, 
756, p3h4pa_, 0.8716, 2.12, 0.295, 202, 200, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
757, d3h4pj_, 0.8715, 2.13, 0.295, 202, 200, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
758, d3h4ph_, 0.8715, 2.11, 0.295, 202, 200, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
759, d3h4pn_, 0.8714, 2.23, 0.289, 202, 201, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
760, d3h4pi_, 0.8714, 2.11, 0.295, 202, 200, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
761, p3h4pd_, 0.8714, 2.12, 0.295, 202, 200, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
762, d3h4pk_, 0.8712, 2.12, 0.295, 202, 200, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
763, p3j9iZ_, 0.8711, 2.29, 0.257, 203, 202, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
764, p3j9iY_, 0.8711, 2.29, 0.257, 203, 202, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
765, p3j9iX_, 0.8711, 2.29, 0.257, 203, 202, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
766, p3j9iW_, 0.8711, 2.29, 0.257, 203, 202, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
767, p3j9iV_, 0.8711, 2.29, 0.257, 203, 202, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
768, p3j9iN_, 0.8711, 2.29, 0.257, 203, 202, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
769, p3j9iM_, 0.8711, 2.29, 0.257, 203, 202, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
770, p3j9iL_, 0.8711, 2.29, 0.257, 203, 202, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
771, p3j9iK_, 0.8711, 2.29, 0.257, 203, 202, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
772, p3j9iJ_, 0.8711, 2.29, 0.257, 203, 202, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
773, p3j9iI_, 0.8711, 2.29, 0.257, 203, 202, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
774, p3j9iH_, 0.8711, 2.29, 0.257, 203, 202, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
775, p3j9i2_, 0.8711, 2.29, 0.257, 203, 202, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
776, p3j9i1_, 0.8711, 2.29, 0.257, 203, 202, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
777, p3h4pg_, 0.8711, 2.11, 0.295, 202, 200, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
778, d3h4pm_, 0.8707, 2.11, 0.295, 202, 200, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
779, p3h4pc_, 0.8706, 2.13, 0.295, 202, 200, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
780, p3h4pb_, 0.8705, 2.11, 0.295, 202, 200, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
781, d1q5qN_, 0.8705, 2.15, 0.263, 224, 205, THE RHODOCOCCUS 20S PROTEASOME
782, d1q5qJ_, 0.8705, 2.15, 0.263, 224, 205, THE RHODOCOCCUS 20S PROTEASOME
783, p3h4pe_, 0.8704, 2.13, 0.295, 202, 200, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
784, d1q5qM_, 0.8704, 2.15, 0.263, 224, 205, THE RHODOCOCCUS 20S PROTEASOME
785, d1q5qL_, 0.8704, 2.15, 0.263, 224, 205, THE RHODOCOCCUS 20S PROTEASOME
786, d1q5qK_, 0.8704, 2.15, 0.263, 224, 205, THE RHODOCOCCUS 20S PROTEASOME
787, d1q5qI_, 0.8704, 2.15, 0.263, 224, 205, THE RHODOCOCCUS 20S PROTEASOME
788, d1q5qH_, 0.8704, 2.15, 0.263, 224, 205, THE RHODOCOCCUS 20S PROTEASOME
789, d3hfaX_, 0.8697, 2.43, 0.232, 224, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
790, p6bdfZ_, 0.8695, 2.18, 0.260, 201, 200, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
791, p6bdfX_, 0.8695, 2.18, 0.260, 201, 200, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
792, p6bdfV_, 0.8695, 2.18, 0.260, 201, 200, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
793, p6bdfT_, 0.8695, 2.18, 0.260, 201, 200, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
794, p6bdfR_, 0.8695, 2.18, 0.260, 201, 200, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
795, p6bdfP_, 0.8695, 2.18, 0.260, 201, 200, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
796, p6bdfN_, 0.8695, 2.18, 0.260, 201, 200, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
797, p6bdfL_, 0.8695, 2.18, 0.260, 201, 200, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
798, p6bdfJ_, 0.8695, 2.18, 0.260, 201, 200, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
799, p6bdfH_, 0.8695, 2.18, 0.260, 201, 200, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
800, p6bdfF_, 0.8695, 2.18, 0.260, 201, 200, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
801, p6bdfD_, 0.8695, 2.18, 0.260, 201, 200, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
802, p6bdfB_, 0.8695, 2.18, 0.260, 201, 200, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
803, p6bdf1_, 0.8695, 2.18, 0.260, 201, 200, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
804, d3hfaZ_, 0.8693, 2.47, 0.232, 224, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
805, d3hfaV_, 0.8691, 2.48, 0.232, 226, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
806, p3unhN_, 0.8687, 1.62, 0.281, 199, 199, MOUSE 20S IMMUNOPROTEASOME
807, p3unhb_, 0.8687, 1.62, 0.281, 199, 199, MOUSE 20S IMMUNOPROTEASOME
808, d3hfaT_, 0.8685, 2.37, 0.233, 223, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
809, d3hfaN_, 0.8685, 2.37, 0.233, 223, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
810, p5l4gBA_, 0.8684, 1.28, 0.254, 194, 193, 
811, d3mi0L_, 0.8683, 2.38, 0.233, 223, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
812, d3mi02_, 0.8683, 2.37, 0.233, 223, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
813, d5lf1H_, 0.8682, 1.30, 0.254, 220, 193, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
814, d5le5H_, 0.8682, 1.30, 0.254, 220, 193, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
815, d3hfaE_, 0.8682, 2.38, 0.238, 223, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
816, d3mi0E_, 0.8681, 2.37, 0.233, 223, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
817, d3hfaH_, 0.8681, 2.38, 0.233, 223, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
818, d5lf1V_, 0.8680, 1.30, 0.254, 220, 193, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
819, d3mi0Z_, 0.8680, 2.37, 0.233, 223, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
820, d4r3oI_, 0.8679, 1.30, 0.254, 220, 193, HUMAN CONSTITUTIVE 20S PROTEASOME
821, d3unfN_, 0.8679, 1.62, 0.286, 199, 199, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
822, d5trgL_, 0.8678, 2.36, 0.233, 223, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
823, d3unfb_, 0.8678, 1.62, 0.286, 199, 199, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
824, d3mi0T_, 0.8678, 2.38, 0.233, 223, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
825, d4r3oW_, 0.8677, 1.30, 0.254, 220, 193, HUMAN CONSTITUTIVE 20S PROTEASOME
826, p5lzpU_, 0.8676, 2.39, 0.228, 223, 206, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
827, d5le5V_, 0.8676, 1.30, 0.254, 220, 193, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
828, d3unfH_, 0.8676, 1.27, 0.280, 219, 193, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
829, p4r67k_, 0.8675, 1.30, 0.254, 195, 193, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
830, d4q1sV_, 0.8675, 1.29, 0.280, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
831, d3unfV_, 0.8675, 1.28, 0.280, 219, 193, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
832, p3unex_, 0.8675, 1.31, 0.254, 195, 193, MOUSE CONSTITUTIVE 20S PROTEASOME
833, d3mi0X_, 0.8675, 2.39, 0.233, 223, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
834, p4r67y_, 0.8674, 1.30, 0.254, 195, 193, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
835, d4r67W_, 0.8674, 1.30, 0.254, 220, 193, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
836, d5trsL_, 0.8673, 2.37, 0.233, 223, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
837, p5lzpO_, 0.8673, 2.39, 0.228, 223, 206, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
838, p5lf0H_, 0.8673, 1.31, 0.254, 195, 193, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
839, d5l6cV_, 0.8673, 1.30, 0.280, 226, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
840, d5l6cH_, 0.8673, 1.30, 0.280, 226, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
841, d4r67I_, 0.8673, 1.30, 0.254, 220, 193, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
842, d4q1sH_, 0.8673, 1.30, 0.280, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
843, p3uneV_, 0.8673, 1.32, 0.254, 195, 193, MOUSE CONSTITUTIVE 20S PROTEASOME
844, d5trrL_, 0.8672, 2.38, 0.233, 223, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
845, d5lf3H_, 0.8672, 1.32, 0.254, 220, 193, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
846, d5lexH_, 0.8672, 1.32, 0.254, 220, 193, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
847, p5gjrOA_, 0.8672, 1.30, 0.254, 195, 193, 
848, d1iruW_, 0.8672, 1.30, 0.254, 220, 193, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
849, d1iruI_, 0.8672, 1.31, 0.254, 220, 193, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
850, p5lzpI_, 0.8671, 2.39, 0.223, 223, 206, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
851, p5lf0V_, 0.8671, 1.31, 0.254, 195, 193, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
852, d5l5tV_, 0.8671, 1.30, 0.280, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
853, d5l5tH_, 0.8671, 1.30, 0.280, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
854, p3unej_, 0.8671, 1.31, 0.254, 195, 193, MOUSE CONSTITUTIVE 20S PROTEASOME
855, p5lzpC_, 0.8670, 2.38, 0.223, 223, 206, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
856, d5lf3V_, 0.8670, 1.32, 0.254, 220, 193, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
857, d5l5pV_, 0.8670, 1.30, 0.280, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
858, d5l5pH_, 0.8670, 1.30, 0.280, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
859, d3tddH_, 0.8670, 1.31, 0.280, 222, 193, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
860, p6avoE_, 0.8669, 1.19, 0.281, 193, 192, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
861, p6avoB_, 0.8669, 1.19, 0.281, 193, 192, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
862, d5l67V_, 0.8669, 1.30, 0.280, 226, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
863, d5l67H_, 0.8669, 1.30, 0.280, 226, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
864, d5l5oV_, 0.8669, 1.31, 0.280, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
865, d5l5oH_, 0.8669, 1.31, 0.280, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
866, d3tddV_, 0.8669, 1.31, 0.280, 222, 193, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
867, d5trsY_, 0.8668, 2.37, 0.233, 223, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
868, d5trgY_, 0.8668, 2.37, 0.233, 223, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
869, d5lf7H_, 0.8668, 1.32, 0.254, 220, 193, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
870, d5lexV_, 0.8668, 1.32, 0.254, 220, 193, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
871, d5l5vV_, 0.8668, 1.30, 0.280, 226, 193,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
872, d5l5vH_, 0.8668, 1.30, 0.280, 226, 193,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
873, p5l4gN_, 0.8668, 1.32, 0.254, 195, 193, 
874, p3uneH_, 0.8668, 1.32, 0.254, 195, 193, MOUSE CONSTITUTIVE 20S PROTEASOME
875, d3l5qY_, 0.8668, 1.30, 0.280, 222, 193,  
876, d3l5qM_, 0.8668, 1.30, 0.280, 222, 193,  
877, d1vsyW_, 0.8668, 1.30, 0.280, 222, 193,  
878, d5tryL_, 0.8667, 2.39, 0.233, 223, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
879, p5lzpT_, 0.8667, 2.39, 0.223, 223, 206, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
880, d5l64V_, 0.8667, 1.31, 0.280, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
881, d5l64H_, 0.8667, 1.31, 0.280, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
882, d3mg6V_, 0.8667, 1.30, 0.280, 222, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
883, d3hfaR_, 0.8667, 2.34, 0.234, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
884, d1vsyI_, 0.8667, 1.30, 0.280, 222, 193,  
885, d5l6aV_, 0.8666, 1.31, 0.280, 226, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
886, d5l6aH_, 0.8666, 1.31, 0.280, 226, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
887, d5l62V_, 0.8666, 1.31, 0.280, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
888, d5l62H_, 0.8666, 1.31, 0.280, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
889, d5l5uV_, 0.8666, 1.31, 0.280, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
890, d5l5uH_, 0.8666, 1.31, 0.280, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
891, d5l5qV_, 0.8666, 1.31, 0.280, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
892, d5l5qH_, 0.8666, 1.31, 0.280, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
893, d4j70V_, 0.8666, 1.31, 0.280, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
894, d4j70H_, 0.8666, 1.31, 0.280, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
895, d4inuH_, 0.8666, 1.31, 0.280, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
896, d5lttH_, 0.8665, 1.31, 0.280, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
897, p5leyH_, 0.8665, 1.33, 0.254, 195, 193, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
898, d5l69V_, 0.8665, 1.31, 0.280, 226, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
899, d5l69H_, 0.8665, 1.31, 0.280, 226, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
900, d5l61H_, 0.8665, 1.31, 0.280, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
901, d5l5jV_, 0.8665, 1.31, 0.280, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
902, d5l5jH_, 0.8665, 1.31, 0.280, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
903, d5cz4H_, 0.8665, 1.31, 0.280, 226, 193, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
904, d5bouH_, 0.8665, 1.31, 0.280, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
905, d4z1lV_, 0.8665, 1.31, 0.280, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
906, d4z1lH_, 0.8665, 1.31, 0.280, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
907, d4y8mV_, 0.8665, 1.31, 0.280, 226, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
908, d4y8mH_, 0.8665, 1.31, 0.280, 226, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
909, d4qz7V_, 0.8665, 1.31, 0.280, 222, 193, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
910, d4qz7H_, 0.8665, 1.31, 0.280, 222, 193, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
911, d4qw3V_, 0.8665, 1.31, 0.280, 226, 193, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
912, d4qw3H_, 0.8665, 1.31, 0.280, 226, 193, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
913, d4inuV_, 0.8665, 1.31, 0.280, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
914, p3unbx_, 0.8665, 1.32, 0.254, 195, 193, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
915, d3hfaL_, 0.8665, 2.35, 0.234, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
916, p5lzpR_, 0.8664, 2.40, 0.223, 223, 206, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
917, d5lttV_, 0.8664, 1.31, 0.280, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
918, d5lf7V_, 0.8664, 1.32, 0.254, 220, 193, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
919, d5l68V_, 0.8664, 1.31, 0.280, 226, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
920, d5l68H_, 0.8664, 1.31, 0.280, 226, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
921, d5l61V_, 0.8664, 1.31, 0.280, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
922, d5d0xV_, 0.8664, 1.31, 0.280, 226, 193, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
923, d5d0xH_, 0.8664, 1.31, 0.280, 226, 193, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
924, d5bouV_, 0.8664, 1.31, 0.280, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
925, d3mi0N_, 0.8664, 2.36, 0.234, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
926, d3hfaP_, 0.8664, 2.35, 0.234, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
927, p5trrb_, 0.8663, 2.40, 0.233, 223, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
928, d5m2bV_, 0.8663, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
929, d5m2bH_, 0.8663, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
930, d5lf4H_, 0.8663, 1.33, 0.254, 220, 193, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
931, p5leyV_, 0.8663, 1.32, 0.254, 195, 193, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
932, d5l63V_, 0.8663, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
933, d5l60V_, 0.8663, 1.31, 0.280, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
934, d5l60H_, 0.8663, 1.31, 0.280, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
935, d4hnpV_, 0.8663, 1.32, 0.280, 222, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
936, d3hfaG_, 0.8663, 2.35, 0.234, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
937, d3hfaC_, 0.8663, 2.35, 0.234, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
938, d3hfa2_, 0.8663, 2.35, 0.234, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
939, d3e47V_, 0.8663, 1.31, 0.280, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
940, d3e47H_, 0.8663, 1.31, 0.280, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
941, d5laiV_, 0.8662, 1.31, 0.280, 226, 193, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
942, d5laiH_, 0.8662, 1.31, 0.280, 226, 193, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
943, d5l63H_, 0.8662, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
944, d5l5sH_, 0.8662, 1.31, 0.280, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
945, d5l5rV_, 0.8662, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
946, d5l5rH_, 0.8662, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
947, d5l5iV_, 0.8662, 1.31, 0.280, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
948, d5l5iH_, 0.8662, 1.31, 0.280, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
949, d5l5hV_, 0.8662, 1.31, 0.280, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
950, d5l5hH_, 0.8662, 1.31, 0.280, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
951, d5fg9V_, 0.8662, 1.31, 0.280, 230, 193, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
952, d5fg9H_, 0.8662, 1.31, 0.280, 230, 193, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
953, d4r17H_, 0.8662, 1.31, 0.280, 226, 193, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
954, d4r00H_, 0.8662, 1.31, 0.280, 226, 193, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
955, d4qvvV_, 0.8662, 1.31, 0.280, 226, 193, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
956, d4qvvH_, 0.8662, 1.31, 0.280, 226, 193, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
957, d4inrV_, 0.8662, 1.31, 0.280, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
958, d3hfaJ_, 0.8662, 2.35, 0.234, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
959, d3dy4V_, 0.8662, 1.31, 0.280, 222, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
960, d5ts0W_, 0.8661, 2.38, 0.233, 223, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
961, d5thoL_, 0.8661, 2.38, 0.233, 223, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
962, d5l5sV_, 0.8661, 1.31, 0.280, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
963, p5cghH_, 0.8661, 1.31, 0.280, 196, 193, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
964, d4rurV_, 0.8661, 1.31, 0.280, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
965, d4rurH_, 0.8661, 1.31, 0.280, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
966, d4r17V_, 0.8661, 1.32, 0.280, 226, 193, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
967, d4r00V_, 0.8661, 1.31, 0.280, 226, 193, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
968, d4qzzV_, 0.8661, 1.32, 0.280, 226, 193, YCP IN COMPLEX WITH OMURALIDE
969, d4qzzH_, 0.8661, 1.32, 0.280, 226, 193, YCP IN COMPLEX WITH OMURALIDE
970, d4qw0V_, 0.8661, 1.32, 0.280, 226, 193, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
971, d4qw0H_, 0.8661, 1.32, 0.280, 226, 193, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
972, d4qvmV_, 0.8661, 1.32, 0.280, 226, 193, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
973, d4qvmH_, 0.8661, 1.32, 0.280, 226, 193, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
974, d4hnpH_, 0.8661, 1.31, 0.280, 222, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
975, d4eu2W_, 0.8661, 1.31, 0.280, 222, 193, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
976, d3mg8V_, 0.8661, 1.31, 0.280, 222, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
977, d3mg7V_, 0.8661, 1.31, 0.280, 222, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
978, d3dy4H_, 0.8661, 1.31, 0.280, 222, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
979, d2fnyV_, 0.8661, 1.32, 0.280, 222, 193,  
980, d2fnyH_, 0.8661, 1.32, 0.280, 222, 193,  
981, d1z7qW1, 0.8661, 1.32, 0.280, 222, 193, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
982, d1z7qI1, 0.8661, 1.32, 0.280, 222, 193, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
983, d5lf4V_, 0.8660, 1.33, 0.254, 220, 193, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
984, p5lezH_, 0.8660, 1.33, 0.254, 195, 193, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
985, d5l5wV_, 0.8660, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
986, d5l5wH_, 0.8660, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
987, d5l5bV_, 0.8660, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
988, d5l5bH_, 0.8660, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
989, d5l55V_, 0.8660, 1.31, 0.280, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
990, d5l55H_, 0.8660, 1.31, 0.280, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
991, d5dkiV_, 0.8660, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
992, d5cz7V_, 0.8660, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
993, d5cz7H_, 0.8660, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
994, p5cghV_, 0.8660, 1.31, 0.280, 196, 193, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
995, d4ya1V_, 0.8660, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME BETA2-H116N MUTANT
996, d4ya1H_, 0.8660, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME BETA2-H116N MUTANT
997, p4y6vV_, 0.8660, 1.32, 0.280, 196, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
998, p4y6vH_, 0.8660, 1.32, 0.280, 196, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
999, d4qzxV_, 0.8660, 1.31, 0.280, 222, 193, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1000, d4qzxH_, 0.8660, 1.31, 0.280, 222, 193, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1001, d4quxV_, 0.8660, 1.32, 0.280, 226, 193, YCP BETA5-A49T-MUTANT
1002, d4quxH_, 0.8660, 1.32, 0.280, 226, 193, YCP BETA5-A49T-MUTANT
1003, d4inrH_, 0.8660, 1.31, 0.280, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
1004, p5tryb_, 0.8659, 2.40, 0.233, 223, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
1005, d5l6bV_, 0.8659, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1006, d5l6bH_, 0.8659, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1007, d5l66V_, 0.8659, 1.33, 0.280, 226, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1008, d5l66H_, 0.8659, 1.33, 0.280, 226, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1009, d5l5zV_, 0.8659, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1010, d5l5zH_, 0.8659, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1011, d5l5fV_, 0.8659, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1012, d5l5fH_, 0.8659, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1013, d5dkjV_, 0.8659, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1014, d5dkjH_, 0.8659, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1015, d5dkiH_, 0.8659, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1016, d5d0tV_, 0.8659, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
1017, d5d0tH_, 0.8659, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
1018, p4y8nV_, 0.8659, 1.32, 0.280, 196, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
1019, p4y8nH_, 0.8659, 1.32, 0.280, 196, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
1020, p4y7xV_, 0.8659, 1.31, 0.280, 196, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
1021, p4y7xH_, 0.8659, 1.31, 0.280, 196, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
1022, d4qvqV_, 0.8659, 1.32, 0.280, 226, 193, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
1023, d4qvqH_, 0.8659, 1.32, 0.280, 226, 193, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
1024, d4intV_, 0.8659, 1.32, 0.280, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1025, p3unhV_, 0.8659, 1.22, 0.276, 193, 192, MOUSE 20S IMMUNOPROTEASOME
1026, p3unhH_, 0.8659, 1.22, 0.276, 193, 192, MOUSE 20S IMMUNOPROTEASOME
1027, d5ts0L_, 0.8658, 2.39, 0.233, 223, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
1028, d5trgW_, 0.8658, 2.38, 0.233, 223, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
1029, d5lajV_, 0.8658, 1.31, 0.280, 226, 193, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1030, d5lajH_, 0.8658, 1.31, 0.280, 226, 193, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1031, d5l5dV_, 0.8658, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1032, d5l5dH_, 0.8658, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1033, d5l5aV_, 0.8658, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
1034, p5fghV_, 0.8658, 1.32, 0.280, 196, 193, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
1035, p5fghH_, 0.8658, 1.32, 0.280, 196, 193, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
1036, d5cz6V_, 0.8658, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
1037, d5cz6H_, 0.8658, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
1038, d5cz4V_, 0.8658, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
1039, d5cgfV_, 0.8658, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME BETA5-G48C MUTANT
1040, d5cgfH_, 0.8658, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME BETA5-G48C MUTANT
1041, d4qwjV_, 0.8658, 1.32, 0.280, 222, 193, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1042, d4qwjH_, 0.8658, 1.32, 0.280, 222, 193, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1043, d4qvyV_, 0.8658, 1.32, 0.280, 226, 193, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1044, d4intH_, 0.8658, 1.32, 0.280, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1045, d3sdiH_, 0.8658, 1.31, 0.280, 222, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
1046, p3ipmM_, 0.8658, 2.32, 0.259, 203, 201, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
1047, p3ipmK_, 0.8658, 2.32, 0.259, 203, 201, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
1048, d5trrW_, 0.8657, 2.40, 0.233, 223, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
1049, p5trra_, 0.8657, 2.41, 0.233, 223, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
1050, d5trgI_, 0.8657, 2.35, 0.234, 222, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
1051, p5trgb_, 0.8657, 2.39, 0.233, 223, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
1052, p5trga_, 0.8657, 2.39, 0.233, 223, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
1053, p5lf6H_, 0.8657, 1.34, 0.254, 195, 193, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
1054, d5l5aH_, 0.8657, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
1055, d5l52V_, 0.8657, 1.32, 0.280, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1056, d5l52H_, 0.8657, 1.32, 0.280, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1057, d5jhsV_, 0.8657, 1.32, 0.280, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
1058, d5jhsH_, 0.8657, 1.32, 0.280, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
1059, p4x6zW_, 0.8657, 1.32, 0.280, 196, 193, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1060, d4r02H_, 0.8657, 1.32, 0.280, 226, 193, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
1061, d4qxjV_, 0.8657, 1.32, 0.280, 222, 193, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1062, d4qxjH_, 0.8657, 1.32, 0.280, 222, 193, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1063, d4qvyH_, 0.8657, 1.32, 0.280, 226, 193, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1064, d4jsqV_, 0.8657, 1.32, 0.280, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1065, d4jsqH_, 0.8657, 1.32, 0.280, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1066, d3un8V_, 0.8657, 1.32, 0.280, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1067, d3sdiV_, 0.8657, 1.32, 0.280, 222, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
1068, d3mi0J_, 0.8657, 2.36, 0.234, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
1069, p3ipmN_, 0.8657, 2.32, 0.259, 203, 201, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
1070, p3ipmL_, 0.8657, 2.32, 0.259, 203, 201, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
1071, p3ipmJ_, 0.8657, 2.32, 0.259, 203, 201, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
1072, p3ipmI_, 0.8657, 2.32, 0.259, 203, 201, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
1073, p3ipmH_, 0.8657, 2.32, 0.259, 203, 201, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
1074, p5lezV_, 0.8656, 1.34, 0.254, 195, 193, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
1075, p4y8kV_, 0.8656, 1.32, 0.280, 196, 193, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
1076, p4y8kH_, 0.8656, 1.32, 0.280, 196, 193, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
1077, d4qvwV_, 0.8656, 1.33, 0.280, 226, 193, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1078, d4qvwH_, 0.8656, 1.33, 0.280, 226, 193, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1079, d3oevV_, 0.8656, 1.31, 0.280, 222, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
1080, d3mi0G_, 0.8656, 2.36, 0.234, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
1081, d3mi0C_, 0.8656, 2.36, 0.234, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
1082, p1fntW_, 0.8656, 1.32, 0.280, 195, 193, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1083, p5lf6V_, 0.8655, 1.34, 0.254, 195, 193, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
1084, d5l5xV_, 0.8655, 1.33, 0.280, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1085, d5l5xH_, 0.8655, 1.33, 0.280, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1086, d5l5eV_, 0.8655, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1087, d5l5eH_, 0.8655, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1088, d4r02V_, 0.8655, 1.32, 0.280, 226, 193, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
1089, d4qz2V_, 0.8655, 1.32, 0.280, 222, 193, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1090, d4qz2H_, 0.8655, 1.32, 0.280, 222, 193, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1091, d4qvpV_, 0.8655, 1.33, 0.280, 226, 193, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
1092, d4qvpH_, 0.8655, 1.33, 0.280, 226, 193, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
1093, d4qv7V_, 0.8655, 1.32, 0.280, 226, 193, YCP BETA5-A50V MUTANT
1094, d4qv7H_, 0.8655, 1.32, 0.280, 226, 193, YCP BETA5-A50V MUTANT
1095, d3oeuV_, 0.8655, 1.31, 0.280, 222, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
1096, d3mg7H_, 0.8655, 1.32, 0.280, 222, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
1097, d3mg6H_, 0.8655, 1.32, 0.280, 222, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
1098, d3mg0H_, 0.8655, 1.33, 0.280, 222, 193, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1099, p1fntI_, 0.8655, 1.33, 0.280, 195, 193, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1100, p5trya_, 0.8654, 2.41, 0.233, 223, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
1101, d5trgK_, 0.8654, 2.41, 0.233, 223, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
1102, d5d0wV_, 0.8654, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME BETA5-T1S MUTANT
1103, d5d0wH_, 0.8654, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME BETA5-T1S MUTANT
1104, d5czaH_, 0.8654, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME BETA5-D166N MUTANT
1105, d4y9yV_, 0.8654, 1.33, 0.280, 226, 193, YEAST 20S PROTEASOME BETA2-H116E MUTANT
1106, p4x6zI_, 0.8654, 1.32, 0.280, 196, 193, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1107, d4qz0V_, 0.8654, 1.32, 0.280, 222, 193, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1108, d4qz0H_, 0.8654, 1.32, 0.280, 222, 193, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1109, d4qwgV_, 0.8654, 1.32, 0.280, 222, 193, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
1110, d4qwgH_, 0.8654, 1.32, 0.280, 222, 193, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
1111, d4qv3V_, 0.8654, 1.32, 0.280, 226, 193, YCP BETA5-M45V MUTANT
1112, d4qv3H_, 0.8654, 1.32, 0.280, 226, 193, YCP BETA5-M45V MUTANT
1113, d4qlvV_, 0.8654, 1.31, 0.280, 222, 193, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
1114, d4qlvH_, 0.8654, 1.31, 0.280, 222, 193, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
1115, d3wxrI_, 0.8654, 1.33, 0.280, 222, 193, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
1116, d3unbH_, 0.8654, 1.34, 0.254, 220, 193, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1117, d3un8H_, 0.8654, 1.32, 0.280, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1118, d3mg8H_, 0.8654, 1.32, 0.280, 222, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
1119, d3d29H_, 0.8654, 1.33, 0.280, 222, 193, PROTEASOME INHIBITION BY FELLUTAMIDE B
1120, p5lzpG_, 0.8653, 2.37, 0.229, 222, 205, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
1121, d5l5yV_, 0.8653, 1.33, 0.280, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1122, d5l5yH_, 0.8653, 1.33, 0.280, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1123, d5fgaV_, 0.8653, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
1124, d5fgaH_, 0.8653, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
1125, d5czaV_, 0.8653, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME BETA5-D166N MUTANT
1126, p5cggV_, 0.8653, 1.33, 0.280, 196, 193, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
1127, p5cggH_, 0.8653, 1.33, 0.280, 196, 193, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
1128, d4y9yH_, 0.8653, 1.33, 0.280, 226, 193, YEAST 20S PROTEASOME BETA2-H116E MUTANT
1129, p4y8hV_, 0.8653, 1.32, 0.280, 196, 193, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
1130, p4y8hH_, 0.8653, 1.33, 0.280, 196, 193, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
1131, d4qzwH_, 0.8653, 1.33, 0.280, 222, 193, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1132, d4qwkV_, 0.8653, 1.32, 0.280, 222, 193, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1133, d4qwkH_, 0.8653, 1.32, 0.280, 222, 193, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1134, d4qvlV_, 0.8653, 1.33, 0.280, 226, 193, YCP IN COMPLEX WITH BORTEZOMIB
1135, d4qvlH_, 0.8653, 1.33, 0.280, 226, 193, YCP IN COMPLEX WITH BORTEZOMIB
1136, d4eu2I_, 0.8653, 1.32, 0.280, 222, 193, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1137, d3mg0V_, 0.8653, 1.33, 0.280, 222, 193, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1138, d3hyeV_, 0.8653, 1.33, 0.280, 222, 193, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
1139, d3hyeH_, 0.8653, 1.33, 0.280, 222, 193, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
1140, d3gptV_, 0.8653, 1.33, 0.280, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
1141, d3gptH_, 0.8653, 1.33, 0.280, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
1142, d3d29V_, 0.8653, 1.33, 0.280, 222, 193, PROTEASOME INHIBITION BY FELLUTAMIDE B
1143, p5trsb_, 0.8652, 2.40, 0.233, 223, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
1144, d5trgV_, 0.8652, 2.40, 0.233, 223, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
1145, p5thob_, 0.8652, 2.40, 0.233, 223, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
1146, d5l65V_, 0.8652, 1.33, 0.280, 226, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1147, d5l65H_, 0.8652, 1.33, 0.280, 226, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1148, d5jhrH_, 0.8652, 1.33, 0.280, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
1149, d4y8rV_, 0.8652, 1.33, 0.285, 226, 193, YEAST 20S PROTEASOME BETA2-H116D MUTANT
1150, d4y8rH_, 0.8652, 1.33, 0.285, 226, 193, YEAST 20S PROTEASOME BETA2-H116D MUTANT
1151, d4qzwV_, 0.8652, 1.33, 0.280, 222, 193, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1152, d4qz1V_, 0.8652, 1.33, 0.280, 222, 193, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1153, d4qz1H_, 0.8652, 1.33, 0.280, 222, 193, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1154, d4qw1V_, 0.8652, 1.33, 0.280, 226, 193, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
1155, d4qw1H_, 0.8652, 1.33, 0.280, 226, 193, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
1156, d4qv4V_, 0.8652, 1.32, 0.280, 226, 193, YCP BETA5-M45T MUTANT
1157, d4qv4H_, 0.8652, 1.32, 0.280, 226, 193, YCP BETA5-M45T MUTANT
1158, d3sdkV_, 0.8652, 1.32, 0.280, 222, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
1159, d3oevH_, 0.8652, 1.32, 0.280, 222, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
1160, d3nzwV_, 0.8652, 1.32, 0.280, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1161, d3nzwH_, 0.8652, 1.32, 0.280, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1162, d3mi0H_, 0.8652, 2.37, 0.234, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
1163, p5vfuNA_, 0.8651, 1.25, 0.255, 193, 192, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1164, p5vfto_, 0.8651, 1.25, 0.255, 193, 192, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1165, d5tryI_, 0.8651, 2.36, 0.234, 222, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
1166, d5trrV_, 0.8651, 2.41, 0.233, 223, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
1167, d5jhrV_, 0.8651, 1.33, 0.280, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
1168, p5gjrAA_, 0.8651, 1.24, 0.255, 193, 192, 
1169, d4ya4V_, 0.8651, 1.33, 0.285, 226, 193, YEAST 20S PROTEASOME BETA2-H114D MUTANT
1170, d4ya4H_, 0.8651, 1.33, 0.285, 226, 193, YEAST 20S PROTEASOME BETA2-H114D MUTANT
1171, p4y8qV_, 0.8651, 1.32, 0.280, 196, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
1172, p4y8qH_, 0.8651, 1.32, 0.280, 196, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
1173, p4y8gV_, 0.8651, 1.33, 0.280, 196, 193, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
1174, p4y8gH_, 0.8651, 1.33, 0.280, 196, 193, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
1175, p4y82V_, 0.8651, 1.33, 0.280, 196, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
1176, p4y82H_, 0.8651, 1.33, 0.280, 196, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
1177, d4qv1V_, 0.8651, 1.33, 0.280, 226, 193, YCP BETA5-M45A MUTANT
1178, d4qv1H_, 0.8651, 1.33, 0.280, 226, 193, YCP BETA5-M45A MUTANT
1179, d3sdkH_, 0.8651, 1.32, 0.280, 222, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
1180, p5trsa_, 0.8650, 2.42, 0.233, 223, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
1181, d5trrI_, 0.8650, 2.35, 0.234, 222, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
1182, p5thoa_, 0.8650, 2.41, 0.233, 223, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
1183, d5fhsV_, 0.8650, 1.33, 0.280, 222, 193, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
1184, d5fhsH_, 0.8650, 1.33, 0.280, 222, 193, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
1185, d5fgiV_, 0.8650, 1.32, 0.275, 234, 193, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1186, p4y8lH_, 0.8650, 1.33, 0.280, 196, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
1187, d4qz3V_, 0.8650, 1.33, 0.280, 222, 193, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1188, d4qz3H_, 0.8650, 1.33, 0.280, 222, 193, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1189, d4qvnH_, 0.8650, 1.34, 0.280, 226, 193, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
1190, d4qv8V_, 0.8650, 1.32, 0.280, 226, 193, YCP BETA5-C52F MUTANT
1191, d4qv8H_, 0.8650, 1.32, 0.280, 226, 193, YCP BETA5-C52F MUTANT
1192, d4qv5V_, 0.8650, 1.33, 0.280, 226, 193, YCP BETA5-M45I MUTANT
1193, d4qv5H_, 0.8650, 1.33, 0.280, 226, 193, YCP BETA5-M45I MUTANT
1194, d4qv0V_, 0.8650, 1.33, 0.280, 226, 193, YCP BETA5-A49T-A50V-DOUBLE MUTANT
1195, d4qv0H_, 0.8650, 1.33, 0.280, 226, 193, YCP BETA5-A49T-A50V-DOUBLE MUTANT
1196, d4quyV_, 0.8650, 1.33, 0.280, 226, 193, YCP BETA5-A49S-MUTANT
1197, d4quyH_, 0.8650, 1.33, 0.280, 226, 193, YCP BETA5-A49S-MUTANT
1198, d4no9V_, 0.8650, 1.33, 0.280, 222, 193, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
1199, d4no9H_, 0.8650, 1.33, 0.280, 222, 193, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
1200, d3wxrW_, 0.8650, 1.32, 0.280, 222, 193, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
1201, d3oeuH_, 0.8650, 1.32, 0.280, 222, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
1202, d3mi0P_, 0.8650, 2.37, 0.234, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
1203, p6gopV_, 0.8649, 1.33, 0.280, 196, 193, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
1204, p6gopH_, 0.8649, 1.33, 0.280, 196, 193, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
1205, d5trrY_, 0.8649, 2.39, 0.233, 223, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
1206, d5thoW_, 0.8649, 2.39, 0.233, 223, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
1207, p5lzpA_, 0.8649, 2.38, 0.229, 222, 205, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
1208, d5fgdV_, 0.8649, 1.33, 0.280, 222, 193, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1209, d5fgdH_, 0.8649, 1.33, 0.280, 222, 193, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1210, d5cz9V_, 0.8649, 1.33, 0.280, 222, 193, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
1211, d5cz9H_, 0.8649, 1.33, 0.280, 222, 193, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
1212, p4y81V_, 0.8649, 1.33, 0.280, 196, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
1213, p4y81H_, 0.8649, 1.33, 0.280, 196, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
1214, d4qwxV_, 0.8649, 1.33, 0.280, 222, 193, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1215, d4qwxH_, 0.8649, 1.33, 0.280, 222, 193, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1216, d4qvnV_, 0.8649, 1.34, 0.280, 226, 193, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
1217, d5trsW_, 0.8648, 2.40, 0.233, 223, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
1218, p5lzpF_, 0.8648, 2.38, 0.229, 222, 205, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
1219, d5fgeV_, 0.8648, 1.33, 0.280, 222, 193, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1220, d5fgeH_, 0.8648, 1.33, 0.280, 222, 193, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1221, d5cz5V_, 0.8648, 1.33, 0.280, 222, 193, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
1222, d5cz5H_, 0.8648, 1.33, 0.280, 222, 193, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
1223, p4zzgI_, 0.8648, 1.24, 0.281, 194, 192, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1224, p4y8iV_, 0.8648, 1.33, 0.280, 196, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
1225, d4qwsV_, 0.8648, 1.33, 0.280, 222, 193, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
1226, d4qwsH_, 0.8648, 1.33, 0.280, 222, 193, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
1227, d4qwiV_, 0.8648, 1.33, 0.280, 222, 193, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
1228, d4qwiH_, 0.8648, 1.33, 0.280, 222, 193, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
1229, d4qlsV_, 0.8648, 1.32, 0.280, 222, 193, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
1230, d4qlsH_, 0.8648, 1.33, 0.280, 222, 193, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
1231, d4qlqV_, 0.8648, 1.33, 0.280, 222, 193, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
1232, d4qlqH_, 0.8648, 1.33, 0.280, 222, 193, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
1233, d3bdmV_, 0.8648, 1.34, 0.280, 222, 193, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
1234, d3bdmH_, 0.8648, 1.34, 0.280, 222, 193, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
1235, d2f16V_, 0.8648, 1.34, 0.280, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
1236, d2f16H_, 0.8648, 1.34, 0.280, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
1237, p5ts0a_, 0.8647, 2.43, 0.238, 223, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
1238, d5fg7V_, 0.8647, 1.33, 0.275, 228, 193, YEAST 20S PROTEASOME BETA2-T1A MUTANT
1239, d5fg7H_, 0.8647, 1.33, 0.275, 228, 193, YEAST 20S PROTEASOME BETA2-T1A MUTANT
1240, p4y8iH_, 0.8647, 1.33, 0.280, 196, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
1241, d4qv9V_, 0.8647, 1.33, 0.280, 226, 193, YCP BETA5-C63F MUTANT
1242, d4qv9H_, 0.8647, 1.33, 0.280, 226, 193, YCP BETA5-C63F MUTANT
1243, d3nzjV_, 0.8647, 1.33, 0.280, 222, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
1244, d3nzjH_, 0.8647, 1.32, 0.280, 222, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
1245, d2fakV_, 0.8647, 1.33, 0.280, 222, 193, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
1246, d2fakH_, 0.8647, 1.33, 0.280, 222, 193, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
1247, p6bgoZ_, 0.8646, 2.38, 0.234, 222, 205, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
1248, p6bgoY_, 0.8646, 2.38, 0.234, 222, 205, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
1249, p6bgoX_, 0.8646, 2.38, 0.234, 222, 205, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
1250, p6bgoW_, 0.8646, 2.38, 0.234, 222, 205, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
1251, p6bgoV_, 0.8646, 2.38, 0.234, 222, 205, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
1252, p6bgoU_, 0.8646, 2.38, 0.234, 222, 205, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
1253, p6bgoT_, 0.8646, 2.38, 0.234, 222, 205, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
1254, p6bgoS_, 0.8646, 2.38, 0.234, 222, 205, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
1255, p6bgoR_, 0.8646, 2.38, 0.234, 222, 205, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
1256, p6bgoQ_, 0.8646, 2.38, 0.234, 222, 205, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
1257, p6bgoP_, 0.8646, 2.38, 0.234, 222, 205, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
1258, p6bgoc_, 0.8646, 2.38, 0.234, 222, 205, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
1259, p6bgob_, 0.8646, 2.38, 0.234, 222, 205, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
1260, p6bgoa_, 0.8646, 2.38, 0.234, 222, 205, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
1261, p6bglZ_, 0.8646, 2.38, 0.234, 222, 205, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
1262, p6bglY_, 0.8646, 2.38, 0.234, 222, 205, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
1263, p6bglX_, 0.8646, 2.38, 0.234, 222, 205, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
1264, p6bglW_, 0.8646, 2.38, 0.234, 222, 205, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
1265, p6bglV_, 0.8646, 2.38, 0.234, 222, 205, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
1266, p6bglU_, 0.8646, 2.38, 0.234, 222, 205, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
1267, p6bglT_, 0.8646, 2.38, 0.234, 222, 205, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
1268, p6bglS_, 0.8646, 2.38, 0.234, 222, 205, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
1269, p6bglR_, 0.8646, 2.38, 0.234, 222, 205, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
1270, p6bglQ_, 0.8646, 2.38, 0.234, 222, 205, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
1271, p6bglP_, 0.8646, 2.38, 0.234, 222, 205, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
1272, p6bglc_, 0.8646, 2.38, 0.234, 222, 205, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
1273, p6bglb_, 0.8646, 2.38, 0.234, 222, 205, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
1274, p6bgla_, 0.8646, 2.38, 0.234, 222, 205, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
1275, d5tryW_, 0.8646, 2.40, 0.233, 223, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
1276, d5trsI_, 0.8646, 2.37, 0.234, 222, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
1277, d5thoM_, 0.8646, 2.40, 0.233, 223, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
1278, d5cz5N_, 0.8646, 1.51, 0.260, 206, 196, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
1279, p4y77V_, 0.8646, 1.34, 0.280, 196, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
1280, p4y77H_, 0.8646, 1.34, 0.280, 196, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
1281, d4ltcV_, 0.8646, 1.33, 0.280, 222, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
1282, d3nzxV_, 0.8646, 1.33, 0.280, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
1283, d3nzxH_, 0.8646, 1.33, 0.280, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
1284, d2gplV_, 0.8646, 1.34, 0.280, 222, 193, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
1285, d2gplH_, 0.8646, 1.34, 0.280, 222, 193, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
1286, p5ts0b_, 0.8645, 2.40, 0.233, 223, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
1287, d5tryY_, 0.8645, 2.40, 0.233, 223, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
1288, d5thoV_, 0.8645, 2.41, 0.233, 223, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
1289, p5nifI_, 0.8645, 1.24, 0.281, 194, 192, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1290, p5lzpL_, 0.8645, 2.38, 0.229, 222, 205, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
1291, p5lzpE_, 0.8645, 2.38, 0.224, 222, 205, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
1292, d5l54V_, 0.8645, 1.33, 0.280, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1293, d5l54H_, 0.8645, 1.33, 0.280, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1294, d5fgiH_, 0.8645, 1.33, 0.275, 234, 193, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1295, d4qz6V_, 0.8645, 1.34, 0.280, 222, 193, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1296, d4qz6H_, 0.8645, 1.34, 0.280, 222, 193, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1297, d4qwuV_, 0.8645, 1.34, 0.280, 226, 193, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
1298, d4qwuH_, 0.8645, 1.34, 0.280, 226, 193, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
1299, d4qluV_, 0.8645, 1.33, 0.280, 222, 193, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
1300, d4qluH_, 0.8645, 1.33, 0.280, 222, 193, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
1301, d4jt0V_, 0.8645, 1.34, 0.280, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1302, d4jt0H_, 0.8645, 1.34, 0.280, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1303, d1g0uH_, 0.8645, 1.34, 0.280, 222, 193, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
1304, d5trsN_, 0.8644, 2.39, 0.233, 223, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
1305, d5trgM_, 0.8644, 2.36, 0.234, 222, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
1306, p5lzpK_, 0.8644, 2.38, 0.224, 222, 205, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
1307, d5d0sV_, 0.8644, 1.34, 0.280, 222, 193, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
1308, d5d0sH_, 0.8644, 1.34, 0.280, 222, 193, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
1309, p4v7oW_, 0.8644, 1.25, 0.281, 194, 192, 
1310, p4v7oI_, 0.8644, 1.25, 0.281, 194, 192, 
1311, p4v7oEB_, 0.8644, 1.25, 0.281, 194, 192, 
1312, d4qv6V_, 0.8644, 1.34, 0.280, 226, 193, YCP BETA5-A49V MUTANT
1313, d4qv6H_, 0.8644, 1.34, 0.280, 226, 193, YCP BETA5-A49V MUTANT
1314, d4fzcV_, 0.8644, 1.34, 0.280, 222, 193, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
1315, d4fzcH_, 0.8644, 1.34, 0.280, 222, 193, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
1316, d3mg4V_, 0.8644, 1.32, 0.280, 222, 193, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
1317, d1g0uV_, 0.8644, 1.34, 0.280, 222, 193, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
1318, p4v7oQA_, 0.8643, 1.25, 0.281, 194, 192, 
1319, d4r18V_, 0.8643, 1.33, 0.280, 226, 193, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1320, d4r18H_, 0.8643, 1.33, 0.280, 226, 193, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1321, d4qz4V_, 0.8643, 1.34, 0.280, 222, 193, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1322, d4qz4H_, 0.8643, 1.34, 0.280, 222, 193, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1323, d4qwrV_, 0.8643, 1.34, 0.280, 222, 193, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
1324, d4qwrH_, 0.8643, 1.34, 0.280, 222, 193, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
1325, d4no1V_, 0.8643, 1.34, 0.280, 222, 193, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
1326, d4no1H_, 0.8643, 1.34, 0.280, 222, 193, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
1327, p3unbj_, 0.8643, 1.35, 0.254, 195, 193, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1328, d3gpwV_, 0.8643, 1.34, 0.280, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
1329, d3gpwH_, 0.8643, 1.34, 0.280, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
1330, d5trgX_, 0.8642, 2.36, 0.234, 222, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
1331, p5nifW_, 0.8642, 1.25, 0.281, 194, 192, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1332, d5d0zV_, 0.8642, 1.34, 0.280, 222, 193, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
1333, d5d0zH_, 0.8642, 1.34, 0.280, 222, 193, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
1334, d4y8mN_, 0.8642, 1.52, 0.260, 196, 196, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
1335, p4y8mb_, 0.8642, 1.52, 0.260, 196, 196, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
1336, d4qz5V_, 0.8642, 1.34, 0.280, 222, 193, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
1337, d4qz5H_, 0.8642, 1.34, 0.280, 222, 193, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
1338, d4ltcH_, 0.8642, 1.33, 0.280, 222, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
1339, d4hrcH_, 0.8642, 1.34, 0.280, 222, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
1340, p4hnpb_, 0.8642, 1.52, 0.260, 196, 196, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
1341, d3unbV_, 0.8642, 1.35, 0.254, 220, 193, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1342, d3gpjV_, 0.8642, 1.35, 0.280, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
1343, d5fgfV_, 0.8641, 1.34, 0.280, 222, 193, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
1344, d5fgfH_, 0.8641, 1.34, 0.280, 222, 193, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
1345, d5czaN_, 0.8641, 1.52, 0.260, 196, 196, YEAST 20S PROTEASOME BETA5-D166N MUTANT
1346, p5czab_, 0.8641, 1.52, 0.260, 196, 196, YEAST 20S PROTEASOME BETA5-D166N MUTANT
1347, d5bouN_, 0.8641, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
1348, p4zzgW_, 0.8641, 1.25, 0.281, 194, 192, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1349, p4y8oH_, 0.8641, 1.34, 0.280, 196, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
1350, d4lqiV_, 0.8641, 1.34, 0.280, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1351, d4lqiH_, 0.8641, 1.34, 0.280, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1352, d4jsuV_, 0.8641, 1.34, 0.280, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1353, d3mg4H_, 0.8641, 1.33, 0.280, 222, 193, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
1354, d3gpjH_, 0.8641, 1.35, 0.280, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
1355, p5vfuZ_, 0.8640, 1.27, 0.255, 193, 192, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1356, p5vftO_, 0.8640, 1.27, 0.255, 193, 192, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1357, p5mp92_, 0.8640, 1.33, 0.280, 196, 193, 26S PROTEASOME IN PRESENCE OF ATP (S1)
1358, d5l5bN_, 0.8640, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1359, p5l5bb_, 0.8640, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1360, p5boub_, 0.8640, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
1361, d4ya1N_, 0.8640, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME BETA2-H116N MUTANT
1362, p4ya1b_, 0.8640, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME BETA2-H116N MUTANT
1363, p4y8oV_, 0.8640, 1.34, 0.280, 196, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
1364, p4y6aN_, 0.8640, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
1365, d4qw4V_, 0.8640, 1.34, 0.280, 222, 193, YCP IN COMPLEX WITH CARFILZOMIB
1366, d4qw4H_, 0.8640, 1.34, 0.280, 222, 193, YCP IN COMPLEX WITH CARFILZOMIB
1367, d4q1sb_, 0.8640, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
1368, d4jsuH_, 0.8640, 1.34, 0.280, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1369, d4hrdN_, 0.8640, 1.52, 0.265, 196, 196, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
1370, d4hrdH_, 0.8640, 1.35, 0.280, 222, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
1371, d4g4sI_, 0.8640, 1.34, 0.280, 220, 193, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
1372, d3sdkN_, 0.8640, 1.52, 0.260, 196, 196, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
1373, d3dy3V_, 0.8640, 1.34, 0.280, 222, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
1374, d3dy3H_, 0.8640, 1.34, 0.280, 222, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
1375, p5mpai_, 0.8639, 1.32, 0.280, 196, 193, 26S PROTEASOME IN PRESENCE OF ATP (S2)
1376, d5l5aN_, 0.8639, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
1377, p5l5ab_, 0.8639, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
1378, d5fggV_, 0.8639, 1.35, 0.280, 222, 193, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1379, d5fggH_, 0.8639, 1.35, 0.280, 222, 193, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1380, p5fgab_, 0.8639, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
1381, d5cz6N_, 0.8639, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
1382, p5cz6b_, 0.8639, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
1383, d5cgfN_, 0.8639, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME BETA5-G48C MUTANT
1384, p5cgfb_, 0.8639, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME BETA5-G48C MUTANT
1385, d5bxnH_, 0.8639, 1.74, 0.272, 222, 195, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
1386, d4z1lN_, 0.8639, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
1387, p4z1lb_, 0.8639, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
1388, p4y6ab_, 0.8639, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
1389, d4qwlV_, 0.8639, 1.35, 0.280, 222, 193, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
1390, d4qwlH_, 0.8639, 1.35, 0.280, 222, 193, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
1391, d4qw7V_, 0.8639, 1.35, 0.280, 222, 193, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
1392, d4no6V_, 0.8639, 1.35, 0.280, 222, 193, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
1393, d4no6H_, 0.8639, 1.35, 0.280, 222, 193, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
1394, d3oeuN_, 0.8639, 1.52, 0.260, 196, 196, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
1395, d5trsV_, 0.8638, 2.42, 0.233, 223, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
1396, d5trrM_, 0.8638, 2.37, 0.234, 222, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
1397, d5trgN_, 0.8638, 2.41, 0.233, 223, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
1398, d5fgaN_, 0.8638, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
1399, d5fg9N_, 0.8638, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
1400, d5bxlN_, 0.8638, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME BETA2-G170A MUTANT
1401, p5bxlb_, 0.8638, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME BETA2-G170A MUTANT
1402, d4ya4N_, 0.8638, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME BETA2-H114D MUTANT
1403, p4ya4b_, 0.8638, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME BETA2-H114D MUTANT
1404, d4y9yN_, 0.8638, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME BETA2-H116E MUTANT
1405, p4y9yb_, 0.8638, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME BETA2-H116E MUTANT
1406, p4y8pV_, 0.8638, 1.35, 0.280, 196, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
1407, p4y8pH_, 0.8638, 1.35, 0.280, 196, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
1408, p4qzzb_, 0.8638, 1.53, 0.260, 196, 196, YCP IN COMPLEX WITH OMURALIDE
1409, d4qw7H_, 0.8638, 1.35, 0.280, 222, 193, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
1410, d4qw6V_, 0.8638, 1.35, 0.280, 222, 193, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
1411, d4qw6H_, 0.8638, 1.35, 0.280, 222, 193, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
1412, d4quxN_, 0.8638, 1.53, 0.260, 196, 196, YCP BETA5-A49T-MUTANT
1413, p4quxb_, 0.8638, 1.53, 0.260, 196, 196, YCP BETA5-A49T-MUTANT
1414, d4qltV_, 0.8638, 1.34, 0.280, 222, 193, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
1415, d5thoY_, 0.8637, 2.40, 0.233, 223, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
1416, d5lajN_, 0.8637, 1.53, 0.260, 196, 196, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1417, p5lajb_, 0.8637, 1.53, 0.260, 196, 196, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1418, p5l5rb_, 0.8637, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
1419, d5jhrN_, 0.8637, 1.53, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
1420, p5jhrb_, 0.8637, 1.53, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
1421, p5fg9b_, 0.8637, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
1422, d5d0wN_, 0.8637, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME BETA5-T1S MUTANT
1423, p5d0wb_, 0.8637, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME BETA5-T1S MUTANT
1424, p4ya3H_, 0.8637, 1.25, 0.281, 194, 192, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
1425, p4y8uN_, 0.8637, 1.53, 0.265, 196, 196, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
1426, p4y8ub_, 0.8637, 1.53, 0.265, 196, 196, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
1427, p4y6vN_, 0.8637, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
1428, d4rurN_, 0.8637, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
1429, p4rurb_, 0.8637, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
1430, d4qzzN_, 0.8637, 1.53, 0.260, 196, 196, YCP IN COMPLEX WITH OMURALIDE
1431, d4qw5V_, 0.8637, 1.35, 0.280, 222, 193, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
1432, d4qw5H_, 0.8637, 1.35, 0.280, 222, 193, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
1433, d4qw0N_, 0.8637, 1.53, 0.265, 196, 196, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1434, p4qw0b_, 0.8637, 1.53, 0.265, 196, 196, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1435, d4qv7N_, 0.8637, 1.53, 0.265, 196, 196, YCP BETA5-A50V MUTANT
1436, p4qv7b_, 0.8637, 1.53, 0.265, 196, 196, YCP BETA5-A50V MUTANT
1437, d4qltH_, 0.8637, 1.34, 0.280, 222, 193, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
1438, d4hrdV_, 0.8637, 1.35, 0.280, 222, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
1439, d3sdk2_, 0.8637, 1.53, 0.260, 196, 196, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
1440, d3mg62_, 0.8637, 1.53, 0.260, 196, 196, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
1441, d5laiN_, 0.8636, 1.53, 0.260, 196, 196, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1442, p5laib_, 0.8636, 1.53, 0.260, 196, 196, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1443, d5l5rN_, 0.8636, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
1444, d5l5eN_, 0.8636, 1.53, 0.265, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1445, p5l5eb_, 0.8636, 1.53, 0.265, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1446, d5fgeN_, 0.8636, 1.53, 0.265, 196, 196, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1447, p5fgeb_, 0.8636, 1.53, 0.265, 196, 196, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1448, d5fg7N_, 0.8636, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME BETA2-T1A MUTANT
1449, p5fg7b_, 0.8636, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME BETA2-T1A MUTANT
1450, d5cz8V_, 0.8636, 1.35, 0.280, 222, 193, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
1451, d5cz8H_, 0.8636, 1.35, 0.280, 222, 193, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
1452, d5cz4N_, 0.8636, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
1453, p5cz4b_, 0.8636, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
1454, p5cghN_, 0.8636, 1.53, 0.265, 196, 196, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
1455, p5cghb_, 0.8636, 1.53, 0.265, 196, 196, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
1456, d5ahjV_, 0.8636, 1.35, 0.280, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
1457, d5ahjH_, 0.8636, 1.35, 0.280, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
1458, p4ya5V_, 0.8636, 1.26, 0.286, 194, 192, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
1459, p4ya5H_, 0.8636, 1.26, 0.286, 194, 192, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
1460, p4ya3V_, 0.8636, 1.26, 0.281, 194, 192, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
1461, p4y69b_, 0.8636, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
1462, d4r17N_, 0.8636, 1.53, 0.260, 196, 196, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1463, p4r17b_, 0.8636, 1.53, 0.260, 196, 196, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1464, d4r00N_, 0.8636, 1.53, 0.265, 196, 196, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
1465, p4r00b_, 0.8636, 1.53, 0.265, 196, 196, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
1466, d4qvyN_, 0.8636, 1.53, 0.260, 196, 196, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1467, p4qvyb_, 0.8636, 1.53, 0.260, 196, 196, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1468, d4qv4N_, 0.8636, 1.53, 0.260, 196, 196, YCP BETA5-M45T MUTANT
1469, p4qv4b_, 0.8636, 1.53, 0.260, 196, 196, YCP BETA5-M45T MUTANT
1470, d4qv3N_, 0.8636, 1.53, 0.265, 196, 196, YCP BETA5-M45V MUTANT
1471, p4qv3b_, 0.8636, 1.53, 0.265, 196, 196, YCP BETA5-M45V MUTANT
1472, d4no8V_, 0.8636, 1.34, 0.280, 222, 193, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
1473, d4no8H_, 0.8636, 1.34, 0.280, 222, 193, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
1474, p4hrdb_, 0.8636, 1.53, 0.260, 196, 196, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
1475, d4hrcV_, 0.8636, 1.36, 0.280, 222, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
1476, d4hnpN_, 0.8636, 1.53, 0.260, 196, 196, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
1477, p3un4V_, 0.8636, 1.35, 0.280, 196, 193, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
1478, p3un4H_, 0.8636, 1.35, 0.280, 196, 193, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
1479, d2zcyV_, 0.8636, 1.36, 0.280, 222, 193, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
1480, d2gplN_, 0.8636, 1.53, 0.260, 196, 196, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
1481, d2gpl2_, 0.8636, 1.53, 0.260, 196, 196, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
1482, d1rypI_, 0.8636, 1.35, 0.280, 222, 193, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1483, d1g65V_, 0.8636, 1.36, 0.280, 222, 193, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
1484, d5ts0V_, 0.8635, 2.41, 0.233, 223, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
1485, d5ts0I_, 0.8635, 2.37, 0.234, 222, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
1486, d5trsK_, 0.8635, 2.44, 0.233, 223, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
1487, d5m2bN_, 0.8635, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
1488, p5m2bb_, 0.8635, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
1489, d5l5oN_, 0.8635, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1490, p5l5ob_, 0.8635, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1491, d5cz9N_, 0.8635, 1.53, 0.265, 196, 196, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
1492, p4ya5N_, 0.8635, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
1493, p4ya5b_, 0.8635, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
1494, d4y8rN_, 0.8635, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME BETA2-H116D MUTANT
1495, p4y8rb_, 0.8635, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME BETA2-H116D MUTANT
1496, p4y75V_, 0.8635, 1.35, 0.280, 196, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
1497, p4y6vb_, 0.8635, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
1498, p4y69V_, 0.8635, 1.26, 0.281, 194, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
1499, d4qvvN_, 0.8635, 1.53, 0.265, 196, 196, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1500, p4qvvb_, 0.8635, 1.53, 0.265, 196, 196, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1501, d4qv8N_, 0.8635, 1.53, 0.265, 196, 196, YCP BETA5-C52F MUTANT
1502, p4qv8b_, 0.8635, 1.53, 0.265, 196, 196, YCP BETA5-C52F MUTANT
1503, p4qv5b_, 0.8635, 1.53, 0.265, 196, 196, YCP BETA5-M45I MUTANT
1504, d4qv1N_, 0.8635, 1.54, 0.260, 196, 196, YCP BETA5-M45A MUTANT
1505, p4qv1b_, 0.8635, 1.54, 0.260, 196, 196, YCP BETA5-M45A MUTANT
1506, d2zcyH_, 0.8635, 1.36, 0.280, 222, 193, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
1507, d5trsZ_, 0.8634, 2.36, 0.234, 222, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
1508, d5trrZ_, 0.8634, 2.36, 0.234, 222, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
1509, d5trgH_, 0.8634, 2.37, 0.234, 222, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
1510, p5lttb_, 0.8634, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
1511, d5fgfN_, 0.8634, 1.53, 0.265, 196, 196, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
1512, d5fgdN_, 0.8634, 1.53, 0.265, 196, 196, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1513, p5cz9b_, 0.8634, 1.53, 0.265, 196, 196, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
1514, p5cggN_, 0.8634, 1.53, 0.265, 196, 196, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
1515, p5cggb_, 0.8634, 1.53, 0.265, 196, 196, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
1516, p4y75H_, 0.8634, 1.35, 0.280, 196, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
1517, p4y69N_, 0.8634, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
1518, d4qwfV_, 0.8634, 1.35, 0.280, 222, 193, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
1519, d4qwfH_, 0.8634, 1.35, 0.280, 222, 193, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
1520, d4qw3N_, 0.8634, 1.53, 0.265, 196, 196, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
1521, p4qw3b_, 0.8634, 1.53, 0.265, 196, 196, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
1522, d4qv5N_, 0.8634, 1.53, 0.265, 196, 196, YCP BETA5-M45I MUTANT
1523, d4quyN_, 0.8634, 1.53, 0.260, 196, 196, YCP BETA5-A49S-MUTANT
1524, p4quyb_, 0.8634, 1.53, 0.260, 196, 196, YCP BETA5-A49S-MUTANT
1525, d4no9N_, 0.8634, 1.53, 0.265, 196, 196, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
1526, p4no9b_, 0.8634, 1.53, 0.265, 196, 196, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
1527, d4nnnH_, 0.8634, 1.35, 0.280, 222, 193, YCP IN COMPLEX WITH MG132
1528, d4eu2V_, 0.8634, 1.53, 0.265, 196, 196, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1529, d3shjV_, 0.8634, 1.35, 0.280, 222, 193, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1530, d3oevN_, 0.8634, 1.53, 0.260, 196, 196, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
1531, d3mg72_, 0.8634, 1.53, 0.260, 196, 196, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
1532, d1g65H_, 0.8634, 1.36, 0.280, 222, 193, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
1533, d5ts0H_, 0.8633, 2.37, 0.234, 222, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
1534, d5thoI_, 0.8633, 2.38, 0.234, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
1535, d5lttN_, 0.8633, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
1536, d5l6cN_, 0.8633, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1537, p5l6cb_, 0.8633, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1538, d5l6aN_, 0.8633, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1539, p5l6ab_, 0.8633, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1540, p5l67b_, 0.8633, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1541, d5l65N_, 0.8633, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1542, d5l64N_, 0.8633, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1543, p5l64b_, 0.8633, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1544, d5l5pN_, 0.8633, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1545, p5l5pb_, 0.8633, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1546, d5l55N_, 0.8633, 1.53, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1547, p5l55b_, 0.8633, 1.53, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1548, d5jhsN_, 0.8633, 1.53, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
1549, p5jhsb_, 0.8633, 1.53, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
1550, d5fhsN_, 0.8633, 1.53, 0.265, 196, 196, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
1551, p5fhsb_, 0.8633, 1.53, 0.265, 196, 196, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
1552, p5fgfb_, 0.8633, 1.53, 0.265, 196, 196, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
1553, p5fgdb_, 0.8633, 1.53, 0.265, 196, 196, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1554, d5cz7N_, 0.8633, 1.53, 0.265, 196, 196, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
1555, p5cz7b_, 0.8633, 1.53, 0.265, 196, 196, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
1556, d5bxnV_, 0.8633, 1.53, 0.273, 222, 194, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
1557, p4y8nN_, 0.8633, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
1558, p4y84V_, 0.8633, 1.26, 0.281, 194, 192, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
1559, p4y7xN_, 0.8633, 1.53, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
1560, p4y7xb_, 0.8633, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
1561, p4y6aV_, 0.8633, 1.26, 0.286, 194, 192, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
1562, p4y6aH_, 0.8633, 1.26, 0.286, 194, 192, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
1563, d4r18N_, 0.8633, 1.54, 0.260, 196, 196, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1564, d4r18b_, 0.8633, 1.54, 0.260, 196, 196, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1565, d4qwsN_, 0.8633, 1.53, 0.265, 196, 196, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
1566, p4qwsb_, 0.8633, 1.53, 0.265, 196, 196, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
1567, d4qvmN_, 0.8633, 1.53, 0.265, 196, 196, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
1568, d4qv9N_, 0.8633, 1.54, 0.260, 196, 196, YCP BETA5-C63F MUTANT
1569, p4qv9b_, 0.8633, 1.54, 0.260, 196, 196, YCP BETA5-C63F MUTANT
1570, d4nnnV_, 0.8633, 1.36, 0.280, 222, 193, YCP IN COMPLEX WITH MG132
1571, d3shjH_, 0.8633, 1.35, 0.280, 222, 193, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1572, d3oev2_, 0.8633, 1.53, 0.260, 196, 196, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
1573, d5trsH_, 0.8632, 2.38, 0.234, 222, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
1574, p5t0cGB_, 0.8632, 1.27, 0.255, 193, 192, 
1575, p5t0cAA_, 0.8632, 1.27, 0.255, 193, 192, 
1576, d5l67N_, 0.8632, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1577, p5l65b_, 0.8632, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1578, d5l63N_, 0.8632, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1579, p5l63b_, 0.8632, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1580, d5l5vN_, 0.8632, 1.54, 0.260, 196, 196,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1581, p5l5vb_, 0.8632, 1.54, 0.260, 196, 196,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1582, d5l5tN_, 0.8632, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1583, p5l5tb_, 0.8632, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1584, d5l5fN_, 0.8632, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1585, p5l5fb_, 0.8632, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1586, d5l5dN_, 0.8632, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1587, p5l5db_, 0.8632, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1588, p5fghN_, 0.8632, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
1589, p5fghb_, 0.8632, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
1590, p5d0zb_, 0.8632, 1.53, 0.265, 196, 196, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
1591, p5cgiV_, 0.8632, 1.27, 0.281, 194, 192, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
1592, p5cgiH_, 0.8632, 1.27, 0.281, 194, 192, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
1593, p4ya3b_, 0.8632, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
1594, p4y8kb_, 0.8632, 1.53, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
1595, p4y84H_, 0.8632, 1.26, 0.281, 194, 192, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
1596, p4y69H_, 0.8632, 1.26, 0.281, 194, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
1597, d4qvwN_, 0.8632, 1.53, 0.265, 196, 196, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1598, p4qvwb_, 0.8632, 1.53, 0.265, 196, 196, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1599, d4qvpN_, 0.8632, 1.53, 0.265, 196, 196, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
1600, p4qvpb_, 0.8632, 1.53, 0.265, 196, 196, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
1601, p4qvmb_, 0.8632, 1.53, 0.265, 196, 196, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
1602, d4qv0N_, 0.8632, 1.53, 0.265, 196, 196, YCP BETA5-A49T-A50V-DOUBLE MUTANT
1603, p4qv0b_, 0.8632, 1.53, 0.265, 196, 196, YCP BETA5-A49T-A50V-DOUBLE MUTANT
1604, d4no1N_, 0.8632, 1.54, 0.265, 196, 196, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
1605, p4no1b_, 0.8632, 1.54, 0.265, 196, 196, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
1606, p4ltcb_, 0.8632, 1.54, 0.260, 196, 196, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
1607, d4fzgV_, 0.8632, 1.36, 0.280, 222, 193, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1608, d4fzgH_, 0.8632, 1.36, 0.280, 222, 193, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1609, d3sdi2_, 0.8632, 1.54, 0.260, 196, 196, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
1610, d3okjV_, 0.8632, 1.35, 0.280, 222, 193, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
1611, d3okjH_, 0.8632, 1.36, 0.280, 222, 193, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
1612, d3krdT_, 0.8632, 2.37, 0.229, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
1613, d1rypW_, 0.8632, 1.36, 0.280, 222, 193, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1614, d5l62N_, 0.8631, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1615, p5l62b_, 0.8631, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1616, d5l5wN_, 0.8631, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1617, p5l5wb_, 0.8631, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1618, d5l5iN_, 0.8631, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
1619, p5l5ib_, 0.8631, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
1620, d5l5hN_, 0.8631, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1621, p5l5hb_, 0.8631, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1622, d5d0zN_, 0.8631, 1.53, 0.265, 196, 196, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
1623, d5d0xN_, 0.8631, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
1624, p5d0xb_, 0.8631, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
1625, d5d0vV_, 0.8631, 1.36, 0.280, 222, 193, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
1626, d5d0vH_, 0.8631, 1.36, 0.280, 222, 193, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
1627, d5d0tN_, 0.8631, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
1628, p5d0tb_, 0.8631, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
1629, p4ya3N_, 0.8631, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
1630, p4ya0V_, 0.8631, 1.27, 0.281, 194, 192, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
1631, p4y8uV_, 0.8631, 1.26, 0.286, 194, 192, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
1632, p4y8uH_, 0.8631, 1.26, 0.286, 194, 192, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
1633, p4y8nb_, 0.8631, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
1634, p4qwjb_, 0.8631, 1.53, 0.265, 196, 196, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1635, d4q1sN_, 0.8631, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
1636, d3mg82_, 0.8631, 1.53, 0.260, 196, 196, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
1637, d3krdL_, 0.8631, 2.37, 0.234, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
1638, d3krdE_, 0.8631, 2.36, 0.234, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
1639, d5trrN_, 0.8630, 2.41, 0.233, 223, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
1640, d5l60N_, 0.8630, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1641, p5l60b_, 0.8630, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1642, d5l5uN_, 0.8630, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1643, d5l5qN_, 0.8630, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
1644, p5l5qb_, 0.8630, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
1645, d5fggN_, 0.8630, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1646, p5fggb_, 0.8630, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1647, p5cz5b_, 0.8630, 1.53, 0.260, 206, 196, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
1648, p4ya0H_, 0.8630, 1.27, 0.281, 194, 192, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
1649, p4y8tV_, 0.8630, 1.36, 0.285, 196, 193, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
1650, p4y8tH_, 0.8630, 1.36, 0.285, 196, 193, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
1651, p4y80V_, 0.8630, 1.27, 0.281, 194, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
1652, p4y80N_, 0.8630, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
1653, p4y80H_, 0.8630, 1.27, 0.281, 194, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
1654, p4y80b_, 0.8630, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
1655, p4y70N_, 0.8630, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
1656, p4y70b_, 0.8630, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
1657, p4x6zH_, 0.8630, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1658, d4qwkN_, 0.8630, 1.54, 0.265, 196, 196, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1659, p4qwkb_, 0.8630, 1.54, 0.265, 196, 196, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1660, d4qwjN_, 0.8630, 1.53, 0.265, 196, 196, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1661, d4qwiN_, 0.8630, 1.54, 0.265, 196, 196, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
1662, d4qw7N_, 0.8630, 1.54, 0.265, 196, 196, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
1663, p4qw7b_, 0.8630, 1.54, 0.265, 196, 196, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
1664, d4lqiN_, 0.8630, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1665, d3sdiN_, 0.8630, 1.54, 0.260, 196, 196, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
1666, d5trrK_, 0.8629, 2.44, 0.233, 223, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
1667, d5thoK_, 0.8629, 2.43, 0.233, 223, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
1668, p5mp9i_, 0.8629, 1.25, 0.281, 194, 192, 26S PROTEASOME IN PRESENCE OF ATP (S1)
1669, d5l6bN_, 0.8629, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1670, p5l6bb_, 0.8629, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1671, d5l68N_, 0.8629, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1672, p5l68b_, 0.8629, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1673, d5l66N_, 0.8629, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1674, p5l66b_, 0.8629, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1675, d5l5zN_, 0.8629, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1676, p5l5zb_, 0.8629, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1677, d5l5yN_, 0.8629, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1678, p5l5yb_, 0.8629, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1679, p5l5ub_, 0.8629, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1680, d5l5sN_, 0.8629, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
1681, p5l5sb_, 0.8629, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
1682, d5l5jN_, 0.8629, 1.55, 0.260, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1683, p5l5jb_, 0.8629, 1.55, 0.260, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1684, p5gjqb_, 0.8629, 1.28, 0.255, 193, 192, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
1685, d5dkjN_, 0.8629, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1686, p5dkjb_, 0.8629, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1687, d5d0sN_, 0.8629, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
1688, p5d0sb_, 0.8629, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
1689, p4y8kN_, 0.8629, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
1690, p4y7yN_, 0.8629, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1691, p4y7yb_, 0.8629, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1692, p4qwib_, 0.8629, 1.54, 0.265, 196, 196, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
1693, d4qwgN_, 0.8629, 1.54, 0.265, 196, 196, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
1694, p4qwgb_, 0.8629, 1.54, 0.265, 196, 196, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
1695, d4qw6N_, 0.8629, 1.54, 0.265, 196, 196, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
1696, p4qw6b_, 0.8629, 1.54, 0.265, 196, 196, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
1697, d4qvqN_, 0.8629, 1.54, 0.265, 196, 196, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
1698, p4qvqb_, 0.8629, 1.54, 0.265, 196, 196, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
1699, d4qvnN_, 0.8629, 1.54, 0.265, 196, 196, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
1700, p4qvnb_, 0.8629, 1.54, 0.265, 196, 196, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
1701, d4qvlN_, 0.8629, 1.54, 0.265, 196, 196, YCP IN COMPLEX WITH BORTEZOMIB
1702, p4qvlb_, 0.8629, 1.54, 0.265, 196, 196, YCP IN COMPLEX WITH BORTEZOMIB
1703, d4qlsb_, 0.8629, 1.54, 0.265, 196, 196, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
1704, p4j70b_, 0.8629, 1.55, 0.260, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1705, d3mg8N_, 0.8629, 1.54, 0.260, 196, 196, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
1706, d3mg7N_, 0.8629, 1.54, 0.260, 196, 196, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
1707, d3mg6N_, 0.8629, 1.54, 0.260, 196, 196, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
1708, p5vfsI_, 0.8628, 1.39, 0.259, 193, 193, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1709, d5bxnN_, 0.8628, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
1710, p5bxnb_, 0.8628, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
1711, d5ahjN_, 0.8628, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
1712, p5ahjb_, 0.8628, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
1713, p4y78b_, 0.8628, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
1714, p4y74N_, 0.8628, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
1715, p4y6zH_, 0.8628, 1.27, 0.281, 194, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
1716, p4y6zb_, 0.8628, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
1717, p4x6zV_, 0.8628, 1.55, 0.260, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1718, d4qwrN_, 0.8628, 1.54, 0.265, 196, 196, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
1719, p4qwrb_, 0.8628, 1.54, 0.265, 196, 196, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
1720, d4qw1N_, 0.8628, 1.54, 0.265, 196, 196, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
1721, p4qw1b_, 0.8628, 1.54, 0.265, 196, 196, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
1722, d4qlsN_, 0.8628, 1.54, 0.265, 196, 196, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
1723, d4ltcN_, 0.8628, 1.54, 0.260, 196, 196, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
1724, d3krdN_, 0.8628, 2.38, 0.234, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
1725, d3krdJ_, 0.8628, 2.38, 0.234, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
1726, p6gopN_, 0.8627, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
1727, d5thoZ_, 0.8627, 2.37, 0.234, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
1728, d5l69N_, 0.8627, 1.55, 0.260, 196, 196, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1729, p5l69b_, 0.8627, 1.55, 0.260, 196, 196, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1730, d5l61N_, 0.8627, 1.55, 0.260, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1731, p5l61b_, 0.8627, 1.55, 0.260, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1732, d5l54N_, 0.8627, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1733, d5d0vN_, 0.8627, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
1734, p5d0vb_, 0.8627, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
1735, p4y7wN_, 0.8627, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
1736, p4y7wb_, 0.8627, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
1737, p4y74b_, 0.8627, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
1738, p4y6zV_, 0.8627, 1.27, 0.281, 194, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
1739, d4qwfN_, 0.8627, 1.54, 0.265, 196, 196, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
1740, p4qwfb_, 0.8627, 1.54, 0.265, 196, 196, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
1741, d4qw5N_, 0.8627, 1.54, 0.265, 196, 196, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
1742, p4qw5b_, 0.8627, 1.54, 0.265, 196, 196, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
1743, d4qlvN_, 0.8627, 1.54, 0.265, 196, 196, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
1744, d4qlvb_, 0.8627, 1.54, 0.265, 196, 196, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
1745, d4nnnN_, 0.8627, 1.54, 0.265, 196, 196, YCP IN COMPLEX WITH MG132
1746, p4nnnb_, 0.8627, 1.54, 0.265, 196, 196, YCP IN COMPLEX WITH MG132
1747, d3krd2_, 0.8627, 2.37, 0.234, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
1748, p6gopb_, 0.8626, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
1749, d5ts0N_, 0.8626, 2.41, 0.233, 223, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
1750, d5ts0K_, 0.8626, 2.44, 0.233, 223, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
1751, d5tryV_, 0.8626, 2.43, 0.233, 223, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
1752, d5trsM_, 0.8626, 2.39, 0.234, 222, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
1753, d5l5xN_, 0.8626, 1.55, 0.260, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1754, p5l5xb_, 0.8626, 1.55, 0.260, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1755, p5l54b_, 0.8626, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1756, p4ya9N_, 0.8626, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
1757, p4ya9b_, 0.8626, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
1758, p4ya0N_, 0.8626, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
1759, p4y7yH_, 0.8626, 1.28, 0.281, 194, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1760, p4y78N_, 0.8626, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
1761, d4r02N_, 0.8626, 1.55, 0.265, 196, 196, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
1762, d4qwlN_, 0.8626, 1.54, 0.265, 196, 196, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
1763, p4qwlb_, 0.8626, 1.54, 0.265, 196, 196, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
1764, d4qw4N_, 0.8626, 1.54, 0.265, 196, 196, YCP IN COMPLEX WITH CARFILZOMIB
1765, p4qw4b_, 0.8626, 1.54, 0.265, 196, 196, YCP IN COMPLEX WITH CARFILZOMIB
1766, d4qv6N_, 0.8626, 1.55, 0.260, 196, 196, YCP BETA5-A49V MUTANT
1767, p4qv6b_, 0.8626, 1.55, 0.260, 196, 196, YCP BETA5-A49V MUTANT
1768, d4hrcN_, 0.8626, 1.55, 0.260, 196, 196, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
1769, d4fzgN_, 0.8626, 1.55, 0.260, 196, 196, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1770, d4eu2H_, 0.8626, 1.53, 0.265, 196, 196, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1771, d3tddN_, 0.8626, 1.54, 0.265, 196, 196, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
1772, d3tdd2_, 0.8626, 1.54, 0.265, 196, 196, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
1773, d3oeu2_, 0.8626, 1.54, 0.260, 196, 196, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
1774, d3nzx2_, 0.8626, 1.55, 0.260, 196, 196, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
1775, d5trrX_, 0.8625, 2.38, 0.234, 222, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
1776, d5trrH_, 0.8625, 2.38, 0.234, 222, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
1777, d5cz8N_, 0.8625, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
1778, p5cz8b_, 0.8625, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
1779, p4ya7N_, 0.8625, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
1780, p4ya7b_, 0.8625, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
1781, p4ya0b_, 0.8625, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
1782, p4y8lV_, 0.8625, 1.28, 0.281, 194, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
1783, p4y8jN_, 0.8625, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
1784, p4y7yV_, 0.8625, 1.28, 0.281, 194, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1785, p4y77N_, 0.8625, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
1786, p4y6zN_, 0.8625, 1.55, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
1787, p4r02b_, 0.8625, 1.55, 0.265, 196, 196, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
1788, d4qluN_, 0.8625, 1.55, 0.265, 196, 196, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
1789, d4qlub_, 0.8625, 1.55, 0.265, 196, 196, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
1790, p4qbyV_, 0.8625, 1.27, 0.281, 194, 192, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
1791, p4qbyH_, 0.8625, 1.27, 0.281, 194, 192, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
1792, d4j70N_, 0.8625, 1.55, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1793, p4fzgb_, 0.8625, 1.55, 0.260, 196, 196, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1794, p3un8b_, 0.8625, 1.55, 0.260, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1795, d3nzxN_, 0.8625, 1.55, 0.260, 196, 196, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
1796, d3nzwN_, 0.8625, 1.54, 0.265, 196, 196, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1797, d3nzw2_, 0.8625, 1.54, 0.265, 196, 196, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1798, d3mkaV_, 0.8625, 2.42, 0.228, 249, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
1799, d5tryK_, 0.8624, 2.45, 0.233, 223, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
1800, d5trrJ_, 0.8624, 2.39, 0.234, 222, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
1801, p5dkib_, 0.8624, 1.55, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1802, p5cgib_, 0.8624, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
1803, p4y8tN_, 0.8624, 1.55, 0.265, 196, 196, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
1804, p4y8tb_, 0.8624, 1.55, 0.265, 196, 196, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
1805, p4y8sN_, 0.8624, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
1806, p4y8sb_, 0.8624, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
1807, p4y75b_, 0.8624, 1.55, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
1808, d4qzxN_, 0.8624, 1.54, 0.265, 196, 196, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1809, p4qzxb_, 0.8624, 1.54, 0.265, 196, 196, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1810, d4qltN_, 0.8624, 1.55, 0.265, 196, 196, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
1811, d4qltb_, 0.8624, 1.55, 0.265, 196, 196, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
1812, d4qlqN_, 0.8624, 1.55, 0.265, 196, 196, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
1813, d4qlqb_, 0.8624, 1.55, 0.265, 196, 196, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
1814, p4no8b_, 0.8624, 1.55, 0.265, 196, 196, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
1815, d3un8N_, 0.8624, 1.56, 0.260, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1816, d3nzjN_, 0.8624, 1.55, 0.260, 196, 196, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
1817, d3nzj2_, 0.8624, 1.55, 0.260, 196, 196, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
1818, d5ts0Y_, 0.8623, 2.41, 0.233, 223, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
1819, d5tryN_, 0.8623, 2.42, 0.233, 223, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
1820, d5trgZ_, 0.8623, 2.39, 0.234, 222, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
1821, d5thoH_, 0.8623, 2.39, 0.234, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
1822, p5lzpP_, 0.8623, 2.36, 0.230, 221, 204, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
1823, p5gjqp_, 0.8623, 1.28, 0.255, 193, 192, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
1824, d5fgiN_, 0.8623, 1.54, 0.260, 213, 196, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1825, p5fgib_, 0.8623, 1.54, 0.260, 213, 196, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1826, p5cgiN_, 0.8623, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
1827, p4y9zb_, 0.8623, 1.55, 0.265, 196, 196, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
1828, p4y8lb_, 0.8623, 1.55, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
1829, d4qzwN_, 0.8623, 1.55, 0.265, 196, 196, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1830, p4qzwb_, 0.8623, 1.55, 0.265, 196, 196, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1831, d4qz6N_, 0.8623, 1.54, 0.265, 196, 196, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1832, p4qz6b_, 0.8623, 1.54, 0.265, 196, 196, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1833, d4qz0N_, 0.8623, 1.54, 0.265, 196, 196, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1834, p4qz0b_, 0.8623, 1.54, 0.265, 196, 196, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1835, d4qwuN_, 0.8623, 1.54, 0.265, 196, 196, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
1836, p4qwub_, 0.8623, 1.55, 0.265, 196, 196, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
1837, d4no8N_, 0.8623, 1.55, 0.265, 196, 196, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
1838, d4jt0N_, 0.8623, 1.55, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1839, p4jt0b_, 0.8623, 1.55, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1840, d3krdC_, 0.8623, 2.39, 0.234, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
1841, d3e47N_, 0.8623, 1.54, 0.265, 196, 196, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
1842, d3e472_, 0.8623, 1.54, 0.265, 196, 196, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
1843, d5tryZ_, 0.8622, 2.38, 0.234, 222, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
1844, d5trgJ_, 0.8622, 2.39, 0.234, 222, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
1845, d5l52N_, 0.8622, 1.55, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1846, p5l52b_, 0.8622, 1.55, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1847, d5dkiN_, 0.8622, 1.55, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1848, p4y9zN_, 0.8622, 1.55, 0.265, 196, 196, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
1849, p4y8jb_, 0.8622, 1.55, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
1850, p4y84N_, 0.8622, 1.55, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
1851, p4y84b_, 0.8622, 1.55, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
1852, p4y82N_, 0.8622, 1.55, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
1853, p4y82b_, 0.8622, 1.55, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
1854, p4y77b_, 0.8622, 1.55, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
1855, p4y70V_, 0.8622, 1.28, 0.281, 194, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
1856, p4y70H_, 0.8622, 1.28, 0.281, 194, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
1857, d4qz2N_, 0.8622, 1.54, 0.265, 196, 196, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1858, p4qz2b_, 0.8622, 1.54, 0.265, 196, 196, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1859, d4qwxN_, 0.8622, 1.55, 0.265, 196, 196, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1860, p4qwxb_, 0.8622, 1.55, 0.265, 196, 196, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1861, d4no6N_, 0.8622, 1.55, 0.265, 196, 196, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
1862, p4no6b_, 0.8622, 1.55, 0.265, 196, 196, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
1863, d3hyeN_, 0.8622, 1.55, 0.265, 196, 196, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
1864, d3hye2_, 0.8622, 1.55, 0.265, 196, 196, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
1865, d3gptN_, 0.8622, 1.55, 0.265, 196, 196, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
1866, d3gpt2_, 0.8622, 1.55, 0.265, 196, 196, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
1867, d2fnyN_, 0.8622, 1.55, 0.265, 196, 196,  
1868, d2fny2_, 0.8622, 1.55, 0.265, 196, 196,  
1869, p4y8lN_, 0.8621, 1.55, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
1870, p4y8ib_, 0.8621, 1.55, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
1871, p4y78V_, 0.8621, 1.28, 0.281, 194, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
1872, p4y78H_, 0.8621, 1.28, 0.281, 194, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
1873, d4qz1N_, 0.8621, 1.55, 0.265, 196, 196, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1874, p4qz1b_, 0.8621, 1.55, 0.265, 196, 196, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1875, d4qxjN_, 0.8621, 1.55, 0.265, 196, 196, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1876, p4qxjb_, 0.8621, 1.55, 0.265, 196, 196, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1877, p4jsub_, 0.8621, 1.56, 0.260, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1878, p4hrcb_, 0.8621, 1.55, 0.260, 196, 196, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
1879, p4fzcb_, 0.8621, 1.56, 0.260, 196, 196, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
1880, d3mkaL_, 0.8621, 2.51, 0.227, 251, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
1881, d3krdG_, 0.8621, 2.39, 0.234, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
1882, p5vfsHA_, 0.8620, 1.40, 0.259, 193, 193, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1883, d5tryH_, 0.8620, 2.39, 0.234, 222, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
1884, d5thoJ_, 0.8620, 2.40, 0.234, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
1885, p4y8jV_, 0.8620, 1.28, 0.281, 194, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
1886, p4y8jH_, 0.8620, 1.28, 0.281, 194, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
1887, p4y7wV_, 0.8620, 1.28, 0.281, 194, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
1888, p4y7wH_, 0.8620, 1.28, 0.281, 194, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
1889, d4qz3N_, 0.8620, 1.55, 0.265, 196, 196, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1890, p4qz3b_, 0.8620, 1.55, 0.265, 196, 196, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1891, d4jsuN_, 0.8620, 1.55, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1892, d4inrN_, 0.8620, 1.55, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
1893, p4inrb_, 0.8620, 1.56, 0.260, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
1894, d4fzcN_, 0.8620, 1.56, 0.260, 196, 196, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
1895, d3mg4N_, 0.8620, 1.55, 0.265, 196, 196, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
1896, d3mg0N_, 0.8620, 1.55, 0.265, 196, 196, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1897, d2f162_, 0.8620, 1.55, 0.265, 196, 196, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
1898, d1jd2O_, 0.8620, 1.38, 0.280, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
1899, p4y8hN_, 0.8619, 1.55, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
1900, p4y74V_, 0.8619, 1.29, 0.281, 194, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
1901, p4y74H_, 0.8619, 1.29, 0.281, 194, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
1902, d4qz7N_, 0.8619, 1.55, 0.265, 196, 196, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1903, p4qz7b_, 0.8619, 1.55, 0.265, 196, 196, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1904, d3mg02_, 0.8619, 1.56, 0.265, 196, 196, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1905, d2f16N_, 0.8619, 1.55, 0.265, 196, 196, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
1906, d1jd2H_, 0.8619, 1.38, 0.280, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
1907, d1g0uN_, 0.8619, 1.56, 0.260, 196, 196, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
1908, d5ts0M_, 0.8618, 2.40, 0.234, 222, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
1909, d5tryM_, 0.8618, 2.39, 0.234, 222, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
1910, d5trsX_, 0.8618, 2.40, 0.234, 222, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
1911, p4y8qN_, 0.8618, 1.55, 0.265, 196, 196, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
1912, p4y8pN_, 0.8618, 1.55, 0.265, 196, 196, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
1913, p4y8pb_, 0.8618, 1.55, 0.265, 196, 196, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
1914, p4y8iN_, 0.8618, 1.55, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
1915, p4y8gN_, 0.8618, 1.55, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
1916, d4nnwV_, 0.8618, 1.38, 0.280, 222, 193, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
1917, d4nnwH_, 0.8618, 1.38, 0.280, 222, 193, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
1918, d3krdZ_, 0.8618, 2.38, 0.234, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
1919, d5thoN_, 0.8617, 2.38, 0.234, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
1920, p4y8qb_, 0.8617, 1.55, 0.265, 196, 196, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
1921, p4y8hb_, 0.8617, 1.55, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
1922, p4y8gb_, 0.8617, 1.55, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
1923, p4y75N_, 0.8617, 1.56, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
1924, d4qz5N_, 0.8617, 1.55, 0.265, 196, 196, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
1925, d4qz4N_, 0.8617, 1.55, 0.265, 196, 196, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1926, p4qz4b_, 0.8617, 1.55, 0.265, 196, 196, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1927, d3krdX_, 0.8617, 2.40, 0.234, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
1928, d1g0u2_, 0.8617, 1.56, 0.260, 196, 196, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
1929, d5ts0Z_, 0.8616, 2.38, 0.234, 222, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
1930, d5ts0J_, 0.8616, 2.39, 0.229, 222, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
1931, d5tryX_, 0.8616, 2.39, 0.234, 222, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
1932, d5trsJ_, 0.8616, 2.40, 0.234, 222, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
1933, p4ya2N_, 0.8616, 1.55, 0.265, 196, 196, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
1934, p4ya2b_, 0.8616, 1.55, 0.265, 196, 196, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
1935, p4y81N_, 0.8616, 1.56, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
1936, p4y81b_, 0.8616, 1.56, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
1937, p4qz5b_, 0.8616, 1.55, 0.265, 196, 196, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
1938, d4intN_, 0.8616, 1.57, 0.260, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1939, d3shj2_, 0.8616, 1.57, 0.260, 196, 196, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1940, d3gpwN_, 0.8616, 1.56, 0.265, 196, 196, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
1941, d3gpw2_, 0.8616, 1.56, 0.265, 196, 196, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
1942, d5ts0X_, 0.8615, 2.40, 0.234, 222, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
1943, d5thoX_, 0.8615, 2.39, 0.234, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
1944, d4jsqN_, 0.8615, 1.57, 0.260, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1945, p4jsqb_, 0.8615, 1.57, 0.260, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1946, p4gk7N_, 0.8615, 1.56, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
1947, d3shjN_, 0.8615, 1.57, 0.260, 196, 196, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1948, d3mg42_, 0.8615, 1.56, 0.265, 196, 196, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
1949, d1rypH_, 0.8615, 1.56, 0.255, 205, 196, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1950, p5lzpN_, 0.8614, 2.37, 0.225, 221, 204, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
1951, p4y8ob_, 0.8614, 1.56, 0.265, 196, 196, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
1952, p4intb_, 0.8614, 1.57, 0.260, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1953, p4gk7b_, 0.8614, 1.56, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
1954, p4zzgH_, 0.8613, 1.56, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1955, p4y8oN_, 0.8613, 1.56, 0.265, 196, 196, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
1956, p4qbyN_, 0.8613, 1.56, 0.265, 196, 196, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
1957, p4qbyb_, 0.8613, 1.56, 0.265, 196, 196, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
1958, d4nnwN_, 0.8613, 1.56, 0.265, 196, 196, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
1959, p4nnwb_, 0.8613, 1.56, 0.265, 196, 196, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
1960, p4y9zV_, 0.8612, 1.30, 0.281, 194, 192, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
1961, p4y9zH_, 0.8612, 1.30, 0.281, 194, 192, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
1962, p4inub_, 0.8612, 1.57, 0.260, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
1963, d3krdH_, 0.8612, 2.40, 0.234, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
1964, p4ya2V_, 0.8611, 1.30, 0.281, 194, 192, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
1965, p4ya2H_, 0.8611, 1.30, 0.281, 194, 192, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
1966, d4inuN_, 0.8611, 1.57, 0.260, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
1967, p4ya7V_, 0.8610, 1.30, 0.286, 194, 192, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
1968, p4ya7H_, 0.8610, 1.30, 0.286, 194, 192, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
1969, d3wxrV_, 0.8610, 1.57, 0.260, 199, 196, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
1970, d3mkaP_, 0.8610, 2.39, 0.229, 250, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
1971, d2fakN_, 0.8610, 1.57, 0.260, 196, 196, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
1972, d2fak2_, 0.8610, 1.57, 0.260, 196, 196, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
1973, p5nifH_, 0.8609, 1.57, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1974, p4y8sH_, 0.8609, 1.30, 0.286, 194, 192, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
1975, d3mkaE_, 0.8609, 2.42, 0.228, 248, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
1976, d3krdP_, 0.8609, 2.40, 0.229, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
1977, d1jd2N_, 0.8609, 1.57, 0.260, 196, 196, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
1978, p4y8sV_, 0.8608, 1.30, 0.286, 194, 192, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
1979, d3wxrH_, 0.8608, 1.57, 0.265, 196, 196, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
1980, d1jd2U_, 0.8608, 1.58, 0.260, 196, 196, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
1981, p3un4N_, 0.8607, 1.57, 0.260, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
1982, p3un4b_, 0.8607, 1.57, 0.260, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
1983, d2fhhH_, 0.8607, 2.40, 0.234, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
1984, d1rypV_, 0.8607, 1.57, 0.260, 205, 196, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1985, d3mkaR_, 0.8606, 2.40, 0.229, 246, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
1986, d2fhhZ_, 0.8606, 2.40, 0.229, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
1987, d2fhhX_, 0.8606, 2.40, 0.229, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
1988, d2fhhG_, 0.8606, 2.40, 0.229, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
1989, d2fhhR_, 0.8605, 2.40, 0.229, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
1990, d2fhhC_, 0.8605, 2.40, 0.229, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
1991, d1g65N_, 0.8605, 1.57, 0.265, 196, 196, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
1992, p4zzgV_, 0.8604, 1.57, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1993, p4ya9V_, 0.8604, 1.31, 0.286, 194, 192, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
1994, p4ya9H_, 0.8604, 1.31, 0.286, 194, 192, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
1995, d2fhhP_, 0.8604, 2.40, 0.229, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
1996, d2fhhN_, 0.8604, 2.40, 0.229, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
1997, d3dy4N_, 0.8603, 1.59, 0.260, 196, 196, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
1998, d3dy42_, 0.8603, 1.59, 0.260, 196, 196, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
1999, d3dy3N_, 0.8603, 1.58, 0.265, 196, 196, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
2000, d3dy32_, 0.8603, 1.58, 0.265, 196, 196, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
2001, d2fhhE_, 0.8603, 2.41, 0.229, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
2002, d1g652_, 0.8603, 1.57, 0.265, 196, 196, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
2003, p5nifV_, 0.8602, 1.58, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2004, d2fhhT_, 0.8602, 2.41, 0.234, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
2005, d2fhhL_, 0.8602, 2.41, 0.229, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
2006, d5tryJ_, 0.8601, 2.41, 0.234, 222, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
2007, p5t0gO_, 0.8601, 1.32, 0.255, 193, 192, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2008, d3mkaH_, 0.8601, 2.39, 0.229, 249, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
2009, d2fhhJ_, 0.8601, 2.41, 0.229, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
2010, d2fhh2_, 0.8601, 2.41, 0.229, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
2011, p2fhgZ_, 0.8601, 2.42, 0.229, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
2012, p2fhgX_, 0.8601, 2.42, 0.229, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
2013, d3mkaG_, 0.8600, 2.40, 0.229, 251, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
2014, d2fhhV_, 0.8600, 2.41, 0.229, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
2015, p2fhgP_, 0.8600, 2.42, 0.229, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
2016, d4g4sH_, 0.8599, 1.59, 0.260, 196, 196, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
2017, d3okjN_, 0.8599, 1.58, 0.265, 196, 196, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
2018, d3bdm1_, 0.8599, 1.59, 0.260, 196, 196, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
2019, p2fhgV_, 0.8599, 2.42, 0.229, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
2020, p2fhgN_, 0.8599, 2.42, 0.229, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
2021, p2fhgH_, 0.8599, 2.42, 0.229, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
2022, p2fhgG_, 0.8599, 2.42, 0.229, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
2023, p2fhgC_, 0.8599, 2.42, 0.229, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
2024, p2fhg2_, 0.8599, 2.42, 0.229, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
2025, p4gk7H_, 0.8598, 1.32, 0.281, 194, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
2026, d3mka2_, 0.8598, 2.41, 0.229, 246, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
2027, d3bdmN_, 0.8598, 1.59, 0.260, 196, 196, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
2028, p2fhgL_, 0.8598, 2.42, 0.229, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
2029, p2fhgJ_, 0.8598, 2.42, 0.229, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
2030, d5bxlV_, 0.8597, 1.57, 0.273, 222, 194, YEAST 20S PROTEASOME BETA2-G170A MUTANT
2031, d5bxlH_, 0.8597, 1.57, 0.273, 222, 194, YEAST 20S PROTEASOME BETA2-G170A MUTANT
2032, p4gk7V_, 0.8597, 1.32, 0.281, 194, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
2033, d3mkaT_, 0.8597, 2.41, 0.229, 250, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
2034, d3gpj2_, 0.8597, 1.58, 0.265, 196, 196, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
2035, p2fhgR_, 0.8597, 2.42, 0.229, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
2036, p2fhgE_, 0.8597, 2.42, 0.229, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
2037, d3mkaN_, 0.8596, 2.47, 0.228, 252, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
2038, d3mfeP_, 0.8596, 2.40, 0.230, 221, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
2039, d3gpjN_, 0.8596, 1.59, 0.265, 196, 196, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
2040, p2fhgT_, 0.8596, 2.42, 0.229, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
2041, p5mpa2_, 0.8594, 1.39, 0.280, 196, 193, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2042, p4v7oV_, 0.8594, 1.59, 0.255, 196, 196, 
2043, p5mp9h_, 0.8593, 1.58, 0.260, 196, 196, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2044, p4v7oPA_, 0.8592, 1.59, 0.255, 196, 196, 
2045, p5m32V_, 0.8591, 1.33, 0.255, 193, 192, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2046, p5m32H_, 0.8591, 1.33, 0.255, 193, 192, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2047, p4v7oH_, 0.8591, 1.59, 0.255, 196, 196, 
2048, d2zcy1_, 0.8589, 1.60, 0.265, 196, 196, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
2049, d2zcyN_, 0.8588, 1.60, 0.265, 196, 196, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
2050, p3jcpRA_, 0.8587, 1.41, 0.280, 196, 193, 
2051, p3jcpD_, 0.8587, 1.41, 0.280, 196, 193, 
2052, d3d292_, 0.8587, 1.60, 0.265, 196, 196, PROTEASOME INHIBITION BY FELLUTAMIDE B
2053, d3d29N_, 0.8586, 1.60, 0.265, 196, 196, PROTEASOME INHIBITION BY FELLUTAMIDE B
2054, p5mp91_, 0.8585, 1.60, 0.260, 196, 196, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2055, d3mkaJ_, 0.8584, 2.42, 0.229, 252, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
2056, d3mkaC_, 0.8583, 2.42, 0.229, 250, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
2057, d1z7qV1, 0.8582, 1.54, 0.256, 195, 195, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2058, d1z7qH1, 0.8582, 1.54, 0.256, 195, 195, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2059, p1fntV_, 0.8580, 1.61, 0.260, 196, 196, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2060, d3mfeH_, 0.8579, 2.39, 0.230, 221, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
2061, p1fntH_, 0.8579, 1.61, 0.260, 196, 196, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2062, d3mfeC_, 0.8577, 2.41, 0.230, 221, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
2063, p5vfoo_, 0.8568, 1.42, 0.255, 193, 192, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2064, p5vfpGA_, 0.8566, 1.42, 0.255, 193, 192, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2065, p5vfoO_, 0.8566, 1.41, 0.260, 193, 192, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2066, d3mfeG_, 0.8565, 2.44, 0.234, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
2067, p3jcpC_, 0.8565, 1.61, 0.265, 205, 196, 
2068, p3jcpQA_, 0.8563, 1.61, 0.265, 205, 196, 
2069, p5a5b2_, 0.8562, 1.51, 0.280, 197, 193, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
2070, p4cr32_, 0.8562, 1.51, 0.280, 197, 193, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2071, p5vfqHA_, 0.8558, 1.43, 0.255, 193, 192, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2072, p5mpah_, 0.8558, 1.63, 0.260, 196, 196, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2073, p5vfqI_, 0.8557, 1.42, 0.260, 193, 192, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2074, p5mpcI_, 0.8557, 1.46, 0.280, 194, 193, 
2075, p5mpbH_, 0.8557, 1.62, 0.265, 196, 196, 
2076, d3mfeV_, 0.8557, 2.55, 0.232, 224, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
2077, p5vfpI_, 0.8556, 1.42, 0.260, 193, 192, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2078, p5ln35_, 0.8554, 1.70, 0.660, 195, 194, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
2079, d3okj2_, 0.8552, 1.58, 0.267, 195, 195, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
2080, p5vfro_, 0.8550, 1.45, 0.255, 193, 192, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2081, d3l5qD1, 0.8550, 1.59, 0.256, 195, 195,  
2082, p5mpa1_, 0.8548, 1.65, 0.260, 196, 196, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2083, d1vsyV1, 0.8548, 1.60, 0.256, 195, 195,  
2084, d1vsyH1, 0.8548, 1.60, 0.256, 195, 195,  
2085, d3l5qB1, 0.8547, 1.60, 0.256, 195, 195,  
2086, p5vfrO_, 0.8541, 1.45, 0.260, 193, 192, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2087, p5mpbV_, 0.8534, 1.64, 0.265, 196, 196, 
2088, d2h6jK1, 0.8531, 2.10, 0.255, 225, 200, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
2089, d2h6jM1, 0.8530, 2.10, 0.255, 225, 200, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
2090, d2h6jJ1, 0.8528, 2.10, 0.255, 225, 200, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
2091, p3jcoC_, 0.8526, 1.66, 0.265, 205, 196, 
2092, p5t0jO_, 0.8525, 1.70, 0.258, 195, 194, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2093, p3jcoQA_, 0.8524, 1.66, 0.265, 205, 196, 
2094, d2h6jH1, 0.8523, 2.21, 0.264, 225, 201, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
2095, d2h6jL1, 0.8522, 2.22, 0.264, 225, 201, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
2096, d2h6jI1, 0.8522, 2.22, 0.264, 225, 201, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
2097, p5mpcV_, 0.8521, 1.69, 0.265, 196, 196, 
2098, d3mfeT_, 0.8521, 2.43, 0.225, 221, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
2099, d2h6jN1, 0.8519, 2.22, 0.264, 225, 201, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
2100, p4cr42_, 0.8518, 1.53, 0.280, 197, 193, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2101, p3jcoRA_, 0.8516, 1.52, 0.280, 196, 193, 
2102, p3jcoD_, 0.8516, 1.52, 0.280, 196, 193, 
2103, d3mkaZ_, 0.8510, 2.48, 0.224, 245, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
2104, d3mfe2_, 0.8508, 2.46, 0.230, 221, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
2105, d3mkaX_, 0.8503, 2.49, 0.224, 249, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
2106, d3mfeR_, 0.8501, 2.46, 0.230, 221, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
2107, d3mfeZ_, 0.8500, 2.47, 0.230, 221, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
2108, d3mfeJ_, 0.8500, 2.47, 0.230, 221, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
2109, d1q5rM_, 0.8500, 2.34, 0.262, 251, 202, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
2110, d1q5rI_, 0.8500, 2.34, 0.262, 251, 202, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
2111, d1q5rH_, 0.8500, 2.34, 0.262, 251, 202, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
2112, d1q5rN_, 0.8499, 2.34, 0.262, 251, 202, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
2113, d1q5rL_, 0.8499, 2.34, 0.262, 251, 202, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
2114, d1q5rK_, 0.8499, 2.34, 0.262, 251, 202, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
2115, d1q5rJ_, 0.8499, 2.34, 0.262, 251, 202, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
2116, d3mfeN_, 0.8497, 2.46, 0.230, 221, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
2117, p5fmgZ_, 0.8496, 1.28, 0.471, 189, 189, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
2118, p5fmgL_, 0.8496, 1.28, 0.471, 189, 189, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
2119, d4cr22_, 0.8496, 1.61, 0.280, 223, 193, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2120, d3mfeX_, 0.8495, 2.47, 0.230, 221, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
2121, d3mfeE_, 0.8495, 2.47, 0.230, 221, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
2122, p5mpcW_, 0.8494, 1.55, 0.280, 196, 193, 
2123, p5vfon_, 0.8489, 1.40, 0.277, 191, 191, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2124, p5mpcH_, 0.8487, 1.74, 0.265, 196, 196, 
2125, d3mfeL_, 0.8487, 2.47, 0.230, 221, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
2126, p5wvkA_, 0.8482, 1.73, 0.260, 196, 196, 
2127, p5vfoN_, 0.8477, 1.42, 0.277, 191, 191, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2128, p5vfpFA_, 0.8476, 1.42, 0.277, 191, 191, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2129, p5a0qW_, 0.8474, 1.53, 0.260, 198, 192, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
2130, p5a0qI_, 0.8474, 1.53, 0.260, 198, 192, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
2131, p5wvkH_, 0.8472, 1.77, 0.260, 196, 196, 
2132, p5vfqGA_, 0.8471, 1.43, 0.277, 191, 191, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2133, p5vfqH_, 0.8468, 1.44, 0.277, 191, 191, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2134, d3unfM_, 0.8466, 2.13, 0.239, 216, 201, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2135, p5vfpH_, 0.8461, 1.45, 0.277, 191, 191, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2136, d4g4sN_, 0.8461, 2.27, 0.182, 233, 203, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
2137, p5vfuY_, 0.8458, 1.45, 0.277, 191, 191, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2138, p5vftN_, 0.8458, 1.45, 0.277, 191, 191, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2139, d3sdkM_, 0.8458, 2.29, 0.182, 233, 203, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2140, d5le5M_, 0.8457, 2.14, 0.239, 216, 201, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
2141, p5vfsH_, 0.8456, 1.45, 0.277, 191, 191, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2142, p5t0hO_, 0.8455, 1.79, 0.258, 195, 194, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2143, d4r3oN_, 0.8454, 2.15, 0.239, 217, 201, HUMAN CONSTITUTIVE 20S PROTEASOME
2144, d4r3o2_, 0.8454, 2.15, 0.239, 217, 201, HUMAN CONSTITUTIVE 20S PROTEASOME
2145, d3sdk1_, 0.8453, 2.29, 0.182, 233, 203, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2146, d3mg41_, 0.8453, 2.28, 0.182, 233, 203, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2147, p5vfrn_, 0.8452, 1.46, 0.277, 191, 191, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2148, p5wviFA_, 0.8451, 1.58, 0.280, 196, 193, 
2149, d5lf7M_, 0.8451, 2.15, 0.239, 216, 201, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
2150, d5lf4M_, 0.8450, 2.15, 0.239, 216, 201, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
2151, d5fggM_, 0.8450, 2.28, 0.182, 233, 203, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2152, d4r67N_, 0.8450, 2.15, 0.239, 217, 201, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2153, d4r672_, 0.8450, 2.15, 0.239, 217, 201, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2154, d1ryp2_, 0.8449, 2.28, 0.182, 233, 203, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
2155, p5vfrN_, 0.8448, 1.47, 0.277, 191, 191, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2156, d5l5uM_, 0.8448, 2.29, 0.182, 233, 203, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2157, d5l5rM_, 0.8448, 2.29, 0.182, 233, 203, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2158, d4eu22_, 0.8448, 2.28, 0.182, 233, 203, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
2159, d3unb3_, 0.8448, 2.15, 0.239, 216, 201, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2160, d3mg61_, 0.8448, 2.30, 0.182, 233, 203, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
2161, d4qvnM_, 0.8447, 2.29, 0.182, 233, 203, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
2162, d2fakM_, 0.8447, 2.29, 0.182, 233, 203, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
2163, d2fak1_, 0.8447, 2.29, 0.182, 233, 203, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
2164, d1rypN_, 0.8447, 2.28, 0.182, 233, 203, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
2165, p5vfuMA_, 0.8446, 1.46, 0.277, 191, 191, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2166, p5vftn_, 0.8446, 1.46, 0.277, 191, 191, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2167, d5lf3M_, 0.8446, 2.15, 0.239, 216, 201, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
2168, d5bxnM_, 0.8446, 2.29, 0.182, 233, 203, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
2169, d4qwuM_, 0.8446, 2.28, 0.182, 233, 203, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
2170, d3mg71_, 0.8446, 2.31, 0.182, 233, 203, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2171, d5l5bM_, 0.8445, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2172, d5ahjM_, 0.8445, 2.29, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
2173, d5lf1M_, 0.8444, 2.16, 0.239, 216, 201, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
2174, d5l5yM_, 0.8444, 2.29, 0.182, 233, 203, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2175, p5mpbW_, 0.8443, 1.60, 0.280, 196, 193, 
2176, d5l66M_, 0.8443, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2177, d5l61M_, 0.8443, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2178, d4ya4M_, 0.8443, 2.30, 0.182, 229, 203, YEAST 20S PROTEASOME BETA2-H114D MUTANT
2179, d4r18M_, 0.8443, 2.30, 0.182, 233, 203, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2180, d4qltM_, 0.8443, 2.28, 0.182, 233, 203, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
2181, d3dy31_, 0.8443, 2.29, 0.182, 233, 203, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
2182, d2zcyM_, 0.8443, 2.29, 0.182, 233, 203, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
2183, d2zcy0_, 0.8443, 2.28, 0.182, 233, 203, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
2184, d5l6aM_, 0.8442, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2185, d5l65M_, 0.8442, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2186, d5l63M_, 0.8442, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2187, d5l5tM_, 0.8442, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2188, d5l5sM_, 0.8442, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
2189, d5bxlM_, 0.8442, 2.30, 0.182, 229, 203, YEAST 20S PROTEASOME BETA2-G170A MUTANT
2190, d4qz7M_, 0.8442, 2.30, 0.182, 232, 203, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2191, d4qz0M_, 0.8442, 2.29, 0.182, 233, 203, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2192, d3mg81_, 0.8442, 2.31, 0.182, 233, 203, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
2193, d3gpjM_, 0.8442, 2.29, 0.182, 233, 203, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
2194, d3gpj1_, 0.8442, 2.29, 0.182, 233, 203, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
2195, d3dy3M_, 0.8442, 2.29, 0.182, 233, 203, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
2196, d5m2bM_, 0.8441, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
2197, d5l62M_, 0.8441, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2198, d5l5zM_, 0.8441, 2.29, 0.182, 233, 203, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2199, d5l5wM_, 0.8441, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2200, d5l54M_, 0.8441, 2.29, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2201, d5jhsM_, 0.8441, 2.29, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
2202, d5d0sM_, 0.8441, 2.29, 0.182, 233, 203, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
2203, d4qwfM_, 0.8441, 2.29, 0.182, 233, 203, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
2204, d4qw6M_, 0.8441, 2.29, 0.182, 233, 203, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
2205, d3mg7M_, 0.8441, 2.32, 0.182, 233, 203, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2206, d1jd2T_, 0.8441, 2.29, 0.182, 233, 203, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2207, d1g0u1_, 0.8441, 2.30, 0.182, 233, 203, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2208, d5lexM_, 0.8440, 2.16, 0.239, 216, 201, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
2209, d5lajM_, 0.8440, 2.30, 0.182, 228, 203, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2210, d5l6cM_, 0.8440, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2211, d5l6bM_, 0.8440, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2212, d5l5pM_, 0.8440, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2213, d5l5dM_, 0.8440, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2214, d5l52M_, 0.8440, 2.29, 0.182, 225, 203, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2215, d5d0wM_, 0.8440, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME BETA5-T1S MUTANT
2216, d4r17M_, 0.8440, 2.30, 0.182, 233, 203, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2217, d4qwlM_, 0.8440, 2.29, 0.182, 233, 203, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
2218, d4qv5M_, 0.8440, 2.30, 0.182, 233, 203, YCP BETA5-M45I MUTANT
2219, d3oev1_, 0.8440, 2.31, 0.182, 233, 203, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
2220, d3gpwM_, 0.8440, 2.29, 0.182, 233, 203, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
2221, d3gpw1_, 0.8440, 2.29, 0.182, 233, 203, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
2222, d5l64M_, 0.8439, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2223, d5l5oM_, 0.8439, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2224, d5l5jM_, 0.8439, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2225, d5l5hM_, 0.8439, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2226, d5l55M_, 0.8439, 2.30, 0.182, 228, 203, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2227, d5czaM_, 0.8439, 2.31, 0.182, 229, 203, YEAST 20S PROTEASOME BETA5-D166N MUTANT
2228, d4qv0M_, 0.8439, 2.30, 0.182, 233, 203, YCP BETA5-A49T-A50V-DOUBLE MUTANT
2229, d4quyM_, 0.8439, 2.30, 0.182, 233, 203, YCP BETA5-A49S-MUTANT
2230, d4no8M_, 0.8439, 2.29, 0.182, 233, 203, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
2231, d4fzgM_, 0.8439, 2.30, 0.182, 233, 203, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
2232, d3sdi1_, 0.8439, 2.31, 0.182, 233, 203, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2233, d5l67M_, 0.8438, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2234, d5fhsM_, 0.8438, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
2235, d5fgiM_, 0.8438, 2.30, 0.182, 232, 203, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2236, d5fgfM_, 0.8438, 2.29, 0.182, 233, 203, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
2237, d5fgeM_, 0.8438, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2238, d5cz9M_, 0.8438, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
2239, p5a5b1_, 0.8438, 1.78, 0.265, 205, 196, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
2240, d4qw5M_, 0.8438, 2.29, 0.182, 233, 203, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
2241, d4qw1M_, 0.8438, 2.29, 0.182, 233, 203, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
2242, d4qvqM_, 0.8438, 2.30, 0.182, 233, 203, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
2243, d4qvpM_, 0.8438, 2.30, 0.182, 233, 203, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
2244, d4qvlM_, 0.8438, 2.30, 0.182, 233, 203, YCP IN COMPLEX WITH BORTEZOMIB
2245, d4qv9M_, 0.8438, 2.30, 0.182, 233, 203, YCP BETA5-C63F MUTANT
2246, p4cr31_, 0.8438, 1.78, 0.265, 205, 196, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2247, d3hye1_, 0.8438, 2.30, 0.182, 233, 203, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
2248, d1jd2M_, 0.8438, 2.30, 0.182, 233, 203, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2249, p5vfsGA_, 0.8437, 1.48, 0.277, 191, 191, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2250, d5l69M_, 0.8437, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2251, d5l60M_, 0.8437, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2252, d5l5vM_, 0.8437, 2.31, 0.182, 233, 203,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2253, d5l5qM_, 0.8437, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
2254, d5fgdM_, 0.8437, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2255, d5fgaM_, 0.8437, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
2256, d5dkjM_, 0.8437, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
2257, d5d0tM_, 0.8437, 2.30, 0.182, 231, 203, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
2258, d4r02M_, 0.8437, 2.31, 0.182, 233, 203, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
2259, d4qz1M_, 0.8437, 2.29, 0.182, 231, 203, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2260, d4qw7M_, 0.8437, 2.29, 0.182, 233, 203, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
2261, d4qv6M_, 0.8437, 2.30, 0.182, 233, 203, YCP BETA5-A49V MUTANT
2262, d4qv3M_, 0.8437, 2.30, 0.182, 233, 203, YCP BETA5-M45V MUTANT
2263, d3wxr2_, 0.8437, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
2264, d3mg8M_, 0.8437, 2.32, 0.182, 233, 203, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
2265, d3mg4M_, 0.8437, 2.30, 0.182, 233, 203, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2266, d3hyeM_, 0.8437, 2.30, 0.182, 233, 203, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
2267, d5l68M_, 0.8436, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2268, d5jhrM_, 0.8436, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
2269, d5d0zM_, 0.8436, 2.29, 0.182, 233, 203, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
2270, d5d0vM_, 0.8436, 2.29, 0.182, 233, 203, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
2271, d4y8rM_, 0.8436, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME BETA2-H116D MUTANT
2272, d4qv7M_, 0.8436, 2.30, 0.182, 233, 203, YCP BETA5-A50V MUTANT
2273, d4qv4M_, 0.8436, 2.30, 0.182, 233, 203, YCP BETA5-M45T MUTANT
2274, d4qv1M_, 0.8436, 2.30, 0.182, 233, 203, YCP BETA5-M45A MUTANT
2275, d4qluM_, 0.8436, 2.29, 0.182, 233, 203, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
2276, d4qlsM_, 0.8436, 2.30, 0.182, 233, 203, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
2277, d4eu2N_, 0.8436, 2.30, 0.182, 233, 203, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
2278, d3nzjM_, 0.8436, 2.31, 0.182, 233, 203, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
2279, d3nzj1_, 0.8436, 2.32, 0.182, 233, 203, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
2280, d3bdm0_, 0.8436, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
2281, d1g0uM_, 0.8436, 2.30, 0.182, 233, 203, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2282, d5laiM_, 0.8435, 2.31, 0.182, 233, 203, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2283, d5l5xM_, 0.8435, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2284, d5l5iM_, 0.8435, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
2285, d5l5fM_, 0.8435, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2286, d5fg7M_, 0.8435, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME BETA2-T1A MUTANT
2287, d5cgfM_, 0.8435, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME BETA5-G48C MUTANT
2288, d4qz4M_, 0.8435, 2.29, 0.182, 225, 203, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2289, d4qw4M_, 0.8435, 2.29, 0.182, 233, 203, YCP IN COMPLEX WITH CARFILZOMIB
2290, d4ltcM_, 0.8435, 2.30, 0.182, 233, 203, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
2291, d4intM_, 0.8435, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
2292, d3oeu1_, 0.8435, 2.32, 0.182, 233, 203, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
2293, d3bdmM_, 0.8435, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
2294, d2fny1_, 0.8435, 2.31, 0.182, 233, 203,  
2295, d5cz7M_, 0.8434, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
2296, d4qzzM_, 0.8434, 2.31, 0.182, 233, 203, YCP IN COMPLEX WITH OMURALIDE
2297, d4qvwM_, 0.8434, 2.31, 0.182, 233, 203, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
2298, d4qvmM_, 0.8434, 2.30, 0.182, 233, 203, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
2299, d4q1sM_, 0.8434, 2.32, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
2300, d4no6M_, 0.8434, 2.29, 0.182, 233, 203, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
2301, d3unbM_, 0.8434, 2.17, 0.239, 216, 201, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2302, d3shjM_, 0.8434, 2.30, 0.182, 233, 203, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
2303, d3shj1_, 0.8434, 2.30, 0.182, 233, 203, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
2304, d3nzwM_, 0.8434, 2.31, 0.182, 233, 203, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
2305, d3nzw1_, 0.8434, 2.31, 0.182, 233, 203, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
2306, d3mg01_, 0.8434, 2.30, 0.182, 233, 203, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
2307, d3e47M_, 0.8434, 2.31, 0.182, 233, 203, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
2308, d3e471_, 0.8434, 2.31, 0.182, 233, 203, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
2309, d3d29M_, 0.8434, 2.29, 0.182, 233, 203, PROTEASOME INHIBITION BY FELLUTAMIDE B
2310, d2fnyM_, 0.8434, 2.31, 0.182, 233, 203,  
2311, d5lttM_, 0.8433, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
2312, d4ya1M_, 0.8433, 2.32, 0.182, 233, 203, YEAST 20S PROTEASOME BETA2-H116N MUTANT
2313, d4y9yM_, 0.8433, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME BETA2-H116E MUTANT
2314, d4qz6M_, 0.8433, 2.30, 0.182, 233, 203, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2315, d4qv8M_, 0.8433, 2.31, 0.182, 233, 203, YCP BETA5-C52F MUTANT
2316, d4qlvM_, 0.8433, 2.30, 0.182, 233, 203, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
2317, d4lqiM_, 0.8433, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
2318, d4inrM_, 0.8433, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
2319, d3okjM_, 0.8433, 2.30, 0.182, 233, 203, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
2320, d3d291_, 0.8433, 2.29, 0.182, 233, 203, PROTEASOME INHIBITION BY FELLUTAMIDE B
2321, d5cz8M_, 0.8432, 2.29, 0.182, 233, 203, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
2322, d5bouM_, 0.8432, 2.32, 0.182, 229, 203, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
2323, d4qz2M_, 0.8432, 2.30, 0.182, 233, 203, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2324, d4qwrM_, 0.8432, 2.30, 0.182, 233, 203, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
2325, d4qlqM_, 0.8432, 2.31, 0.182, 233, 203, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
2326, d4nnwM_, 0.8432, 2.30, 0.182, 233, 203, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
2327, d3sdiM_, 0.8432, 2.32, 0.182, 233, 203, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2328, d3oevM_, 0.8432, 2.33, 0.182, 233, 203, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
2329, d3gptM_, 0.8432, 2.30, 0.182, 233, 203, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
2330, d3gpt1_, 0.8432, 2.30, 0.182, 233, 203, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
2331, d2f16M_, 0.8432, 2.30, 0.182, 233, 203, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
2332, d2f161_, 0.8432, 2.30, 0.182, 233, 203, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
2333, d5l5eM_, 0.8431, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2334, d5l5aM_, 0.8431, 2.32, 0.182, 233, 203, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
2335, d5cz6M_, 0.8431, 2.32, 0.182, 233, 203, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
2336, d4qvyM_, 0.8431, 2.31, 0.182, 233, 203, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
2337, d3wxrN_, 0.8431, 2.32, 0.182, 233, 203, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
2338, d3oeuM_, 0.8431, 2.32, 0.182, 233, 203, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
2339, d3mg6M_, 0.8431, 2.33, 0.182, 233, 203, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
2340, d4qz3M_, 0.8430, 2.30, 0.182, 233, 203, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2341, d4qwxM_, 0.8430, 2.30, 0.182, 233, 203, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2342, d4quxM_, 0.8430, 2.32, 0.182, 233, 203, YCP BETA5-A49T-MUTANT
2343, d4nnnM_, 0.8430, 2.30, 0.182, 233, 203, YCP IN COMPLEX WITH MG132
2344, p4cr41_, 0.8430, 1.78, 0.260, 205, 196, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2345, d3un8M_, 0.8430, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
2346, d3tddM_, 0.8430, 2.32, 0.182, 233, 203, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
2347, d3tdd1_, 0.8430, 2.32, 0.182, 233, 203, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
2348, d3nzxM_, 0.8430, 2.31, 0.182, 233, 203, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
2349, d3nzx1_, 0.8430, 2.31, 0.182, 233, 203, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
2350, p5mpbI_, 0.8429, 1.82, 0.278, 196, 194, 
2351, d4r00M_, 0.8429, 2.31, 0.182, 233, 203, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
2352, d4j70M_, 0.8429, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
2353, d3mg0M_, 0.8429, 2.31, 0.182, 233, 203, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
2354, d3h6fR_, 0.8429, 2.85, 0.222, 222, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
2355, d1g65M_, 0.8429, 2.32, 0.182, 233, 203, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
2356, d5fg9M_, 0.8428, 2.32, 0.182, 233, 203, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
2357, d5cz5M_, 0.8428, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
2358, d4z1lM_, 0.8428, 2.32, 0.182, 229, 203, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
2359, d4qz5M_, 0.8428, 2.30, 0.182, 225, 203, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
2360, d4qwkM_, 0.8428, 2.31, 0.182, 230, 203, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2361, d4qw3M_, 0.8428, 2.31, 0.182, 233, 203, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
2362, d4no1M_, 0.8428, 2.31, 0.182, 233, 203, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
2363, d4jsqM_, 0.8428, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
2364, p5wvkI_, 0.8427, 1.55, 0.281, 194, 192, 
2365, d4rurM_, 0.8427, 2.32, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
2366, d4qwiM_, 0.8427, 2.30, 0.182, 233, 203, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
2367, d4no9M_, 0.8427, 2.31, 0.182, 233, 203, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
2368, d4inuM_, 0.8427, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
2369, d1g651_, 0.8427, 2.31, 0.182, 233, 203, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
2370, d5dkiM_, 0.8426, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
2371, d4qzwM_, 0.8426, 2.31, 0.182, 233, 203, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2372, d4hrdM_, 0.8426, 2.30, 0.182, 233, 203, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
2373, d3dy4M_, 0.8426, 2.31, 0.182, 233, 203, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
2374, d3dy41_, 0.8426, 2.31, 0.182, 233, 203, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
2375, d1iruN_, 0.8426, 2.17, 0.239, 217, 201, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2376, d1iru2_, 0.8426, 2.17, 0.239, 217, 201, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2377, p4y77a_, 0.8425, 2.22, 0.178, 223, 202, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
2378, d4fzcM_, 0.8425, 2.32, 0.182, 233, 203, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
2379, d5d0xM_, 0.8424, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
2380, d4qwsM_, 0.8424, 2.31, 0.182, 233, 203, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
2381, d4qw0M_, 0.8424, 2.32, 0.182, 233, 203, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
2382, d3h6iR_, 0.8423, 2.85, 0.222, 222, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
2383, d4jsuM_, 0.8422, 2.32, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
2384, d4hnpM_, 0.8422, 2.32, 0.182, 233, 203, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
2385, d4qzxM_, 0.8421, 2.32, 0.182, 231, 203, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2386, d4qxjM_, 0.8421, 2.31, 0.182, 228, 203, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2387, d4qwjM_, 0.8420, 2.31, 0.182, 230, 203, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
2388, d4qwgM_, 0.8420, 2.32, 0.182, 233, 203, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
2389, d4jt0M_, 0.8420, 2.32, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
2390, d2gpl1_, 0.8420, 2.33, 0.182, 233, 203, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
2391, d2gplM_, 0.8419, 2.33, 0.182, 233, 203, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
2392, d5cz4M_, 0.8416, 2.33, 0.182, 229, 203, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
2393, d4qvvM_, 0.8415, 2.33, 0.182, 233, 203, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
2394, d4y8mM_, 0.8414, 2.07, 0.180, 222, 200, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
2395, p4y8na_, 0.8413, 2.28, 0.178, 223, 202, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
2396, d4cr21_, 0.8413, 1.84, 0.265, 205, 196, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2397, p5wviC_, 0.8412, 1.55, 0.281, 194, 192, 
2398, p4y8ma_, 0.8411, 2.15, 0.179, 222, 201, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
2399, d4hrcM_, 0.8410, 2.32, 0.182, 233, 203, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
2400, p4y8oM_, 0.8405, 2.07, 0.180, 222, 200, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
2401, d1z7qN1, 0.8405, 2.36, 0.182, 233, 203, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2402, p4y8qM_, 0.8404, 2.16, 0.179, 222, 201, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
2403, p4y8qa_, 0.8404, 2.16, 0.179, 222, 201, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
2404, p4y8oa_, 0.8401, 2.16, 0.179, 222, 201, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
2405, d3l5qR_, 0.8399, 2.33, 0.182, 233, 203,  
2406, d3l5q4_, 0.8399, 2.33, 0.182, 233, 203,  
2407, d1vsy2_, 0.8398, 2.33, 0.182, 233, 203,  
2408, d1vsyN_, 0.8396, 2.34, 0.182, 233, 203,  
2409, p5wvkM_, 0.8395, 1.81, 0.196, 222, 194, 
2410, p4v7oAA_, 0.8387, 2.01, 0.195, 222, 195, 
2411, d3l5q3_, 0.8387, 2.01, 0.195, 222, 195,  
2412, p4v7oM_, 0.8385, 2.01, 0.195, 222, 195, 
2413, p4v7oIB_, 0.8385, 2.01, 0.195, 222, 195, 
2414, d3l5qQ_, 0.8385, 2.01, 0.195, 222, 195,  
2415, d1vsyM_, 0.8385, 2.01, 0.195, 222, 195,  
2416, d1vsy1_, 0.8385, 2.01, 0.195, 222, 195,  
2417, p5t0cZ_, 0.8383, 1.56, 0.277, 191, 191, 
2418, p5t0cFB_, 0.8383, 1.56, 0.277, 191, 191, 
2419, p5mpbN_, 0.8382, 2.15, 0.179, 222, 201, 
2420, d5l5wZ_, 0.8382, 2.01, 0.190, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2421, d5l5wL_, 0.8382, 2.01, 0.190, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2422, p4y8uZ_, 0.8382, 2.01, 0.195, 222, 195, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
2423, p4y8uL_, 0.8382, 2.01, 0.195, 222, 195, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
2424, d3h6fV_, 0.8382, 2.85, 0.218, 221, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
2425, p4y8tZ_, 0.8380, 2.02, 0.195, 222, 195, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
2426, p4y8tL_, 0.8380, 2.02, 0.195, 222, 195, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
2427, d3h6iV_, 0.8380, 2.86, 0.223, 220, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
2428, d5lajZ_, 0.8379, 2.02, 0.195, 222, 195, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2429, d5lajL_, 0.8379, 2.02, 0.195, 222, 195, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2430, p5wvkF_, 0.8378, 1.99, 0.195, 222, 195, 
2431, d5fgfZ_, 0.8378, 2.01, 0.195, 222, 195, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
2432, d5fgfL_, 0.8378, 2.01, 0.195, 222, 195, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
2433, d5fgdZ_, 0.8377, 2.01, 0.195, 222, 195, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2434, d5fgdL_, 0.8377, 2.01, 0.195, 222, 195, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2435, d4z1lZ_, 0.8377, 2.02, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
2436, d4z1lL_, 0.8377, 2.02, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
2437, p4y6aZ_, 0.8377, 2.02, 0.195, 222, 195, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
2438, p4y6aL_, 0.8377, 2.02, 0.195, 222, 195, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
2439, p4y69Z_, 0.8377, 2.02, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
2440, p4y69L_, 0.8377, 2.02, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
2441, d5l5bZ_, 0.8376, 2.02, 0.190, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2442, d5l5bL_, 0.8376, 2.02, 0.190, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2443, p4ya3Z_, 0.8376, 2.02, 0.195, 222, 195, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
2444, d5l5aZ_, 0.8375, 2.02, 0.195, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
2445, d5l5aL_, 0.8375, 2.02, 0.195, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
2446, d5cgfZ_, 0.8375, 2.02, 0.195, 222, 195, YEAST 20S PROTEASOME BETA5-G48C MUTANT
2447, d5bouZ_, 0.8375, 2.02, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
2448, d5bouL_, 0.8375, 2.02, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
2449, p4ya3L_, 0.8375, 2.02, 0.195, 222, 195, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
2450, p4ya0Z_, 0.8375, 2.02, 0.195, 222, 195, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
2451, p4ya0L_, 0.8375, 2.02, 0.195, 222, 195, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
2452, p3hf9e_, 0.8375, 2.53, 0.228, 216, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2453, d5m2bZ_, 0.8374, 2.02, 0.190, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
2454, d5l5eZ_, 0.8374, 2.02, 0.190, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2455, d5l5eL_, 0.8374, 2.02, 0.190, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2456, d5cz7L_, 0.8374, 2.02, 0.195, 222, 195, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
2457, d5cgfL_, 0.8374, 2.02, 0.195, 222, 195, YEAST 20S PROTEASOME BETA5-G48C MUTANT
2458, p4ya5Z_, 0.8374, 2.02, 0.195, 222, 195, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
2459, p4ya5L_, 0.8374, 2.02, 0.195, 222, 195, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
2460, d5m2bL_, 0.8373, 2.02, 0.190, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
2461, d5l5rZ_, 0.8373, 2.02, 0.190, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2462, d5l5rL_, 0.8373, 2.02, 0.190, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2463, d5cz7Z_, 0.8373, 2.02, 0.195, 222, 195, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
2464, p3hf9r_, 0.8373, 2.55, 0.228, 216, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2465, p5wviEA_, 0.8372, 1.87, 0.260, 205, 196, 
2466, d5l6cZ_, 0.8371, 2.03, 0.190, 222, 195, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2467, d5l6cL_, 0.8371, 2.03, 0.190, 222, 195, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2468, d5l6bZ_, 0.8371, 2.02, 0.190, 222, 195, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2469, d5l6bL_, 0.8371, 2.02, 0.190, 222, 195, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2470, d4y8rZ_, 0.8371, 2.02, 0.195, 222, 195, YEAST 20S PROTEASOME BETA2-H116D MUTANT
2471, d4y8rL_, 0.8371, 2.02, 0.195, 222, 195, YEAST 20S PROTEASOME BETA2-H116D MUTANT
2472, p4y8nZ_, 0.8371, 2.03, 0.195, 222, 195, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
2473, p4y8nL_, 0.8371, 2.03, 0.195, 222, 195, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
2474, d3hf9P_, 0.8371, 2.55, 0.228, 216, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2475, d5l67Z_, 0.8370, 2.03, 0.190, 222, 195, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2476, d5fgaZ_, 0.8370, 2.02, 0.195, 222, 195, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
2477, d5fgaL_, 0.8370, 2.02, 0.195, 222, 195, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
2478, d5fg9Z_, 0.8370, 2.03, 0.195, 222, 195, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
2479, d5fg9L_, 0.8370, 2.03, 0.195, 222, 195, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
2480, d5cz4Z_, 0.8370, 2.03, 0.195, 222, 195, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
2481, p4zzg1_, 0.8370, 2.01, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2482, d4ya1Z_, 0.8370, 2.02, 0.195, 222, 195, YEAST 20S PROTEASOME BETA2-H116N MUTANT
2483, d4ya1L_, 0.8370, 2.02, 0.195, 222, 195, YEAST 20S PROTEASOME BETA2-H116N MUTANT
2484, d4qv9Z_, 0.8370, 2.02, 0.195, 222, 195, YCP BETA5-C63F MUTANT
2485, d4qv9L_, 0.8370, 2.02, 0.195, 222, 195, YCP BETA5-C63F MUTANT
2486, d4qv7Z_, 0.8370, 2.03, 0.195, 222, 195, YCP BETA5-A50V MUTANT
2487, d3hf9X_, 0.8370, 2.54, 0.228, 216, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2488, p3hf9n_, 0.8370, 2.54, 0.228, 216, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2489, p3hf9l_, 0.8370, 2.54, 0.228, 216, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2490, d5l67L_, 0.8369, 2.03, 0.190, 222, 195, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2491, d5fg7Z_, 0.8369, 2.02, 0.195, 222, 195, YEAST 20S PROTEASOME BETA2-T1A MUTANT
2492, d5fg7L_, 0.8369, 2.02, 0.195, 222, 195, YEAST 20S PROTEASOME BETA2-T1A MUTANT
2493, d5cz4L_, 0.8369, 2.03, 0.195, 222, 195, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
2494, p4y6vL_, 0.8369, 2.03, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
2495, d4qv7L_, 0.8369, 2.03, 0.195, 222, 195, YCP BETA5-A50V MUTANT
2496, d3hf9H_, 0.8369, 2.54, 0.228, 216, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2497, d1z7qM1, 0.8369, 2.01, 0.195, 222, 195, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2498, p5wviQA_, 0.8368, 1.87, 0.260, 205, 196, 
2499, p5nif1_, 0.8368, 2.02, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2500, d5laiZ_, 0.8368, 2.03, 0.195, 222, 195, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2501, d5laiL_, 0.8368, 2.03, 0.195, 222, 195, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2502, d5l5fZ_, 0.8368, 2.03, 0.190, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2503, d5l5fL_, 0.8368, 2.03, 0.190, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2504, d4y8mZ_, 0.8368, 2.03, 0.195, 222, 195, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
2505, d4y8mL_, 0.8368, 2.03, 0.195, 222, 195, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
2506, p4y6vZ_, 0.8368, 2.03, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
2507, p3hf9z_, 0.8368, 2.54, 0.228, 216, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2508, p3hf9v_, 0.8368, 2.67, 0.225, 218, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2509, d3hf9G_, 0.8368, 2.54, 0.228, 216, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2510, d3hf94_, 0.8368, 2.56, 0.228, 216, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2511, p1z7qa_, 0.8368, 2.02, 0.195, 222, 195, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2512, d1rypM_, 0.8368, 2.03, 0.195, 222, 195, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
2513, d5l65Z_, 0.8367, 1.86, 0.191, 222, 194, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2514, d5l65L_, 0.8367, 1.87, 0.191, 222, 194, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2515, d5czaZ_, 0.8367, 2.03, 0.195, 222, 195, YEAST 20S PROTEASOME BETA5-D166N MUTANT
2516, d5czaL_, 0.8367, 2.03, 0.195, 222, 195, YEAST 20S PROTEASOME BETA5-D166N MUTANT
2517, d4r00Z_, 0.8367, 2.03, 0.195, 222, 195, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
2518, d4r00L_, 0.8367, 2.03, 0.195, 222, 195, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
2519, d4quyZ_, 0.8367, 2.03, 0.195, 222, 195, YCP BETA5-A49S-MUTANT
2520, d4quyL_, 0.8367, 2.03, 0.195, 222, 195, YCP BETA5-A49S-MUTANT
2521, d4quxZ_, 0.8367, 2.03, 0.195, 222, 195, YCP BETA5-A49T-MUTANT
2522, d4quxL_, 0.8367, 2.03, 0.195, 222, 195, YCP BETA5-A49T-MUTANT
2523, d3hf9Z_, 0.8367, 2.55, 0.228, 216, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2524, p3hf9x_, 0.8367, 2.55, 0.228, 216, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2525, p3hf9t_, 0.8367, 2.55, 0.228, 216, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2526, d5l5zZ_, 0.8366, 2.03, 0.190, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2527, d5l5zL_, 0.8366, 2.03, 0.190, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2528, d5fgeZ_, 0.8366, 2.02, 0.195, 222, 195, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2529, d5fgeL_, 0.8366, 2.02, 0.195, 222, 195, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2530, d4y9yZ_, 0.8366, 2.03, 0.195, 222, 195, YEAST 20S PROTEASOME BETA2-H116E MUTANT
2531, d4y9yL_, 0.8366, 2.03, 0.195, 222, 195, YEAST 20S PROTEASOME BETA2-H116E MUTANT
2532, d4j70Z_, 0.8366, 1.88, 0.196, 222, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
2533, d3wxrM_, 0.8366, 2.04, 0.195, 222, 195, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
2534, d3hf9J_, 0.8366, 2.54, 0.228, 216, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2535, d1ryp1_, 0.8366, 2.03, 0.195, 222, 195, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
2536, p4zzgM_, 0.8365, 2.02, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2537, d4ya4Z_, 0.8365, 2.03, 0.195, 222, 195, YEAST 20S PROTEASOME BETA2-H114D MUTANT
2538, d4ya4L_, 0.8365, 2.03, 0.195, 222, 195, YEAST 20S PROTEASOME BETA2-H114D MUTANT
2539, d4qv3Z_, 0.8365, 2.03, 0.195, 222, 195, YCP BETA5-M45V MUTANT
2540, d4qv3L_, 0.8365, 2.03, 0.195, 222, 195, YCP BETA5-M45V MUTANT
2541, p3hf9p_, 0.8365, 2.55, 0.228, 216, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2542, d5l6aZ_, 0.8364, 2.03, 0.190, 222, 195, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2543, d5l66Z_, 0.8364, 1.87, 0.191, 222, 194, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2544, d5l66L_, 0.8364, 1.87, 0.191, 222, 194, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2545, d4qw0Z_, 0.8364, 2.04, 0.195, 222, 195, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
2546, d4qv4Z_, 0.8364, 2.03, 0.195, 222, 195, YCP BETA5-M45T MUTANT
2547, d4qv4L_, 0.8364, 2.03, 0.195, 222, 195, YCP BETA5-M45T MUTANT
2548, d4j70L_, 0.8364, 1.88, 0.196, 222, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
2549, d5l6aL_, 0.8363, 2.03, 0.190, 222, 195, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2550, d5d0wZ_, 0.8363, 2.03, 0.195, 222, 195, YEAST 20S PROTEASOME BETA5-T1S MUTANT
2551, d5d0wL_, 0.8363, 2.03, 0.195, 222, 195, YEAST 20S PROTEASOME BETA5-T1S MUTANT
2552, d4rurZ_, 0.8363, 2.04, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
2553, d4qzzZ_, 0.8363, 2.03, 0.195, 222, 195, YCP IN COMPLEX WITH OMURALIDE
2554, d4qzzL_, 0.8363, 2.03, 0.195, 222, 195, YCP IN COMPLEX WITH OMURALIDE
2555, d4qwuZ_, 0.8363, 2.03, 0.195, 222, 195, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
2556, d4qw0L_, 0.8363, 2.04, 0.195, 222, 195, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
2557, d5l5uL_, 0.8362, 2.04, 0.190, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2558, d4rurL_, 0.8362, 2.04, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
2559, d4r18Z_, 0.8362, 1.87, 0.196, 222, 194, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2560, d4r18L_, 0.8362, 1.87, 0.196, 222, 194, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2561, d4r17Z_, 0.8362, 2.03, 0.195, 222, 195, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2562, d4r17L_, 0.8362, 2.03, 0.195, 222, 195, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2563, d4qwuL_, 0.8362, 2.03, 0.195, 222, 195, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
2564, d4qv8Z_, 0.8362, 2.03, 0.195, 222, 195, YCP BETA5-C52F MUTANT
2565, d4qv8L_, 0.8362, 2.03, 0.195, 222, 195, YCP BETA5-C52F MUTANT
2566, d4qv5Z_, 0.8362, 2.03, 0.195, 222, 195, YCP BETA5-M45I MUTANT
2567, d4qv5L_, 0.8362, 2.03, 0.195, 222, 195, YCP BETA5-M45I MUTANT
2568, d4qv1Z_, 0.8362, 2.03, 0.195, 222, 195, YCP BETA5-M45A MUTANT
2569, d4qv1L_, 0.8362, 2.03, 0.195, 222, 195, YCP BETA5-M45A MUTANT
2570, d3hf9R_, 0.8362, 2.55, 0.228, 216, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2571, d3hf9N_, 0.8362, 2.55, 0.228, 216, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2572, d3hf9L_, 0.8362, 2.55, 0.228, 216, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2573, p3hf9j_, 0.8362, 2.55, 0.228, 216, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2574, p3hf9g_, 0.8362, 2.55, 0.228, 216, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2575, d3hf92_, 0.8362, 2.55, 0.228, 216, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2576, d5l5uZ_, 0.8361, 2.03, 0.190, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2577, d5l5dL_, 0.8361, 2.04, 0.190, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2578, d5bxlZ_, 0.8361, 2.03, 0.195, 222, 195, YEAST 20S PROTEASOME BETA2-G170A MUTANT
2579, d5bxlL_, 0.8361, 2.03, 0.195, 222, 195, YEAST 20S PROTEASOME BETA2-G170A MUTANT
2580, d4qvyZ_, 0.8361, 2.04, 0.195, 222, 195, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
2581, d4qvyL_, 0.8361, 2.04, 0.195, 222, 195, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
2582, d3hf9C_, 0.8361, 2.56, 0.228, 216, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2583, d5l64Z_, 0.8360, 2.04, 0.190, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2584, d5l64L_, 0.8360, 2.04, 0.190, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2585, p5fghZ_, 0.8359, 2.04, 0.195, 222, 195, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
2586, p5fghL_, 0.8359, 2.04, 0.195, 222, 195, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
2587, d5cz6Z_, 0.8359, 2.04, 0.195, 222, 195, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
2588, d5cz6L_, 0.8359, 2.04, 0.195, 222, 195, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
2589, d4qv0Z_, 0.8359, 2.04, 0.195, 222, 195, YCP BETA5-A49T-A50V-DOUBLE MUTANT
2590, d4qv0L_, 0.8359, 2.04, 0.195, 222, 195, YCP BETA5-A49T-A50V-DOUBLE MUTANT
2591, d4lqiL_, 0.8359, 2.04, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
2592, d3wxr1_, 0.8359, 1.87, 0.196, 222, 194, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
2593, p1fntM_, 0.8359, 2.00, 0.195, 222, 195, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2594, d5d0xZ_, 0.8358, 2.04, 0.195, 222, 195, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
2595, d5d0xL_, 0.8358, 2.04, 0.195, 222, 195, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
2596, d4qvvZ_, 0.8358, 2.04, 0.195, 222, 195, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
2597, d4qvvL_, 0.8358, 2.04, 0.195, 222, 195, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
2598, d3dy4L_, 0.8358, 2.04, 0.195, 222, 195, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
2599, p1fnta_, 0.8358, 2.00, 0.195, 222, 195, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2600, p6gopZ_, 0.8357, 2.04, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
2601, d5fhsZ_, 0.8357, 2.03, 0.195, 222, 195, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
2602, d4qvwZ_, 0.8357, 2.04, 0.195, 222, 195, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
2603, d4qvwL_, 0.8357, 2.04, 0.195, 222, 195, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
2604, d4q1sZ_, 0.8357, 2.04, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
2605, d3hf9T_, 0.8357, 2.55, 0.228, 216, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2606, p6gopL_, 0.8356, 2.04, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
2607, d5l5iL_, 0.8356, 2.04, 0.190, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
2608, d5fhsL_, 0.8356, 2.03, 0.195, 222, 195, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
2609, d4q1sL_, 0.8356, 2.04, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
2610, d5l68Z_, 0.8355, 1.88, 0.191, 222, 194, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2611, d5l68L_, 0.8355, 1.88, 0.191, 222, 194, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2612, d5l5vZ_, 0.8355, 2.04, 0.190, 222, 195,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2613, d5l5vL_, 0.8355, 2.04, 0.190, 222, 195,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2614, d5l5pZ_, 0.8355, 1.88, 0.191, 222, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2615, d5l5pL_, 0.8355, 1.88, 0.191, 222, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2616, d4qvlL_, 0.8355, 2.04, 0.195, 222, 195, YCP IN COMPLEX WITH BORTEZOMIB
2617, p5nifM_, 0.8354, 1.87, 0.196, 222, 194, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2618, d4qw3Z_, 0.8354, 2.05, 0.195, 222, 195, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
2619, d5lttZ_, 0.8353, 2.05, 0.195, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
2620, d5lttL_, 0.8353, 2.05, 0.195, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
2621, d5l5xL_, 0.8353, 2.04, 0.190, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2622, d5l5oZ_, 0.8353, 1.88, 0.191, 222, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2623, d5l5oL_, 0.8353, 1.88, 0.191, 222, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2624, d5l5dZ_, 0.8353, 1.88, 0.191, 222, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2625, d4qw3L_, 0.8353, 2.05, 0.195, 222, 195, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
2626, p5mp96_, 0.8352, 2.01, 0.195, 222, 195, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2627, d5l5jZ_, 0.8352, 1.87, 0.191, 222, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2628, d5l5jL_, 0.8352, 1.87, 0.191, 222, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2629, p5fmgV_, 0.8352, 1.49, 0.206, 191, 189, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
2630, p5fmgH_, 0.8352, 1.49, 0.206, 191, 189, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
2631, p4x6zM_, 0.8352, 1.88, 0.196, 222, 194, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
2632, p4x6z1_, 0.8352, 1.88, 0.196, 222, 194, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
2633, d4qvmZ_, 0.8352, 2.05, 0.195, 222, 195, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
2634, d3hyeZ_, 0.8352, 2.05, 0.195, 222, 195, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
2635, d3hyeL_, 0.8352, 2.05, 0.195, 222, 195, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
2636, d3gptZ_, 0.8352, 2.05, 0.195, 222, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
2637, d5l5tZ_, 0.8351, 1.88, 0.191, 222, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2638, d5l5tL_, 0.8351, 1.88, 0.191, 222, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2639, d4qvmL_, 0.8351, 2.05, 0.195, 222, 195, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
2640, p5ln37_, 0.8350, 2.40, 0.228, 218, 202, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
2641, d5l5sZ_, 0.8350, 2.05, 0.190, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
2642, d5l5sL_, 0.8350, 2.05, 0.190, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
2643, d5d0tZ_, 0.8350, 2.05, 0.195, 222, 195, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
2644, d4lqiZ_, 0.8350, 1.89, 0.196, 222, 194, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
2645, d3un8Z_, 0.8350, 2.05, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
2646, d3dy4Z_, 0.8350, 1.88, 0.196, 222, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
2647, d1z7qX1, 0.8350, 1.95, 0.196, 204, 194, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2648, p5lf6W_, 0.8349, 2.02, 0.210, 204, 195, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2649, p5lf6I_, 0.8349, 2.03, 0.210, 204, 195, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2650, d5l64I_, 0.8349, 1.94, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2651, d5l62Z_, 0.8349, 1.88, 0.191, 222, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2652, d5l62L_, 0.8349, 1.88, 0.191, 222, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2653, d5d0tL_, 0.8349, 2.05, 0.195, 222, 195, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
2654, d3hf9V_, 0.8349, 2.62, 0.232, 217, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2655, d1z7qJ1, 0.8349, 1.95, 0.196, 204, 194, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2656, d5l64W_, 0.8348, 1.94, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2657, d5l61Z_, 0.8348, 1.88, 0.191, 222, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2658, d5l61L_, 0.8348, 1.88, 0.191, 222, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2659, d5l60Z_, 0.8348, 1.89, 0.191, 222, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2660, d5l60L_, 0.8348, 1.89, 0.191, 222, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2661, p3jcpH_, 0.8348, 1.87, 0.196, 222, 194, 
2662, d3hf9E_, 0.8348, 2.58, 0.228, 216, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2663, d5l69Z_, 0.8347, 1.89, 0.191, 222, 194, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2664, d5l69L_, 0.8347, 1.89, 0.191, 222, 194, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2665, d5l63W_, 0.8347, 1.94, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2666, d5l63I_, 0.8347, 1.94, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2667, d5l5vW_, 0.8347, 1.94, 0.196, 204, 194,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2668, d5l5vI_, 0.8347, 1.94, 0.196, 204, 194,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2669, d5l5qL_, 0.8347, 2.05, 0.190, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
2670, d5l5iZ_, 0.8347, 1.89, 0.191, 222, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
2671, d5fggZ_, 0.8347, 2.04, 0.195, 222, 195, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2672, d4qwrZ_, 0.8347, 2.04, 0.195, 222, 195, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
2673, d4qwrL_, 0.8347, 2.04, 0.195, 222, 195, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
2674, d5l63Z_, 0.8346, 1.89, 0.191, 222, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2675, d5l63L_, 0.8346, 1.89, 0.191, 222, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2676, d5l61W_, 0.8346, 1.94, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2677, d5l61I_, 0.8346, 1.94, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2678, d5l5hL_, 0.8346, 2.05, 0.190, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2679, d5fggL_, 0.8346, 2.04, 0.195, 222, 195, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2680, d5dkiZ_, 0.8346, 2.05, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
2681, d5dkiL_, 0.8346, 2.05, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
2682, d5cz9Z_, 0.8346, 2.04, 0.195, 222, 195, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
2683, d5cz9L_, 0.8346, 2.04, 0.195, 222, 195, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
2684, d4qvlZ_, 0.8346, 1.89, 0.196, 222, 194, YCP IN COMPLEX WITH BORTEZOMIB
2685, p3jcpA_, 0.8346, 1.88, 0.196, 222, 194, 
2686, d2fnyZ_, 0.8346, 1.90, 0.196, 222, 194,  
2687, d2fnyL_, 0.8346, 1.89, 0.196, 222, 194,  
2688, p5mp9m_, 0.8345, 2.02, 0.195, 222, 195, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2689, d5l62W_, 0.8345, 1.94, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2690, d5l62I_, 0.8345, 1.94, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2691, d5l5xZ_, 0.8345, 1.89, 0.191, 222, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2692, d5l5hZ_, 0.8345, 2.05, 0.190, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2693, d4qvqZ_, 0.8345, 2.05, 0.195, 222, 195, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
2694, d3e47Z_, 0.8345, 1.90, 0.196, 222, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
2695, d5m2bW_, 0.8344, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
2696, d5m2bI_, 0.8344, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
2697, d5l67W_, 0.8344, 1.94, 0.196, 204, 194, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2698, d5l67I_, 0.8344, 1.94, 0.196, 204, 194, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2699, d5dkjZ_, 0.8344, 2.06, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
2700, p4y7xZ_, 0.8344, 2.05, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
2701, d4qvqL_, 0.8344, 2.05, 0.195, 222, 195, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
2702, d4qvpZ_, 0.8344, 2.06, 0.195, 222, 195, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
2703, d4qvpL_, 0.8344, 2.05, 0.195, 222, 195, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
2704, d3un8L_, 0.8344, 2.06, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
2705, d3tddZ_, 0.8344, 1.90, 0.196, 222, 194, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
2706, d3tddL_, 0.8344, 1.90, 0.196, 222, 194, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
2707, d3e47L_, 0.8344, 1.90, 0.196, 222, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
2708, p5mpa7_, 0.8343, 1.96, 0.183, 218, 197, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2709, d5l5yW_, 0.8343, 1.94, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2710, d5l5yI_, 0.8343, 1.94, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2711, d5l5qW_, 0.8343, 1.94, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
2712, d5l5qI_, 0.8343, 1.94, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
2713, d5l5oI_, 0.8343, 1.94, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2714, d5dkjL_, 0.8343, 2.06, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
2715, p4y7xL_, 0.8343, 2.05, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
2716, d4eu21_, 0.8343, 1.89, 0.196, 222, 194, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
2717, d3gpwZ_, 0.8343, 1.90, 0.196, 222, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
2718, d3gpwL_, 0.8343, 1.90, 0.196, 222, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
2719, d3gptL_, 0.8343, 1.89, 0.196, 222, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
2720, d2gplZ_, 0.8343, 1.90, 0.196, 222, 194, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
2721, d2gplL_, 0.8343, 1.90, 0.196, 222, 194, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
2722, d5l5wW_, 0.8342, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2723, d5l5wI_, 0.8342, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2724, d5l5oW_, 0.8342, 1.94, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2725, p5cghZ_, 0.8342, 2.05, 0.195, 222, 195, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
2726, p5cghL_, 0.8342, 2.05, 0.195, 222, 195, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
2727, d1g0uZ_, 0.8342, 1.89, 0.196, 222, 194, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2728, d5l6cW_, 0.8341, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2729, d5l6cI_, 0.8341, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2730, d5l60W_, 0.8341, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2731, d5l60I_, 0.8341, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2732, d5l5yZ_, 0.8341, 1.89, 0.191, 222, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2733, d5l5yL_, 0.8341, 1.89, 0.191, 222, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2734, d5l5tW_, 0.8341, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2735, d5l5tI_, 0.8341, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2736, d5l5hW_, 0.8341, 1.94, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2737, d5l5hI_, 0.8341, 1.94, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2738, d4qzwZ_, 0.8341, 2.05, 0.195, 222, 195, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2739, d4qzwL_, 0.8341, 2.05, 0.195, 222, 195, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2740, d5l6aW_, 0.8340, 1.94, 0.196, 204, 194, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2741, d5l6aI_, 0.8340, 1.94, 0.196, 204, 194, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2742, d5l5uW_, 0.8340, 1.94, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2743, d5l5uI_, 0.8340, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2744, d5cz5Z_, 0.8340, 2.05, 0.195, 222, 195, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
2745, d5cz5L_, 0.8340, 2.05, 0.195, 222, 195, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
2746, d5bxnZ_, 0.8340, 1.89, 0.196, 222, 194, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
2747, d4qw1L_, 0.8340, 1.90, 0.196, 222, 194, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
2748, d4qvnL_, 0.8340, 2.06, 0.195, 222, 195, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
2749, d4qlvL_, 0.8340, 2.05, 0.195, 222, 195, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
2750, d4qlsZ_, 0.8340, 2.05, 0.195, 222, 195, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
2751, d3oevL_, 0.8340, 2.05, 0.195, 222, 195, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
2752, d5lttW_, 0.8339, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
2753, d5l5rW_, 0.8339, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2754, d5l5pW_, 0.8339, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2755, d5l5pI_, 0.8339, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2756, d5bxnL_, 0.8339, 1.90, 0.196, 222, 194, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
2757, d4qw1Z_, 0.8339, 1.90, 0.196, 222, 194, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
2758, d4qlvZ_, 0.8339, 2.05, 0.195, 222, 195, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
2759, d4qlsL_, 0.8339, 2.05, 0.195, 222, 195, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
2760, d4eu2M_, 0.8339, 1.89, 0.196, 222, 194, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
2761, d5lttI_, 0.8338, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
2762, d5l5sW_, 0.8338, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
2763, d5l5sI_, 0.8338, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
2764, d5l5rI_, 0.8338, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2765, d5l5qZ_, 0.8338, 1.90, 0.191, 222, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
2766, d5l5bI_, 0.8338, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2767, d5jhsZ_, 0.8338, 2.05, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
2768, d5fgiZ_, 0.8338, 2.05, 0.195, 222, 195, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2769, d5fgiL_, 0.8338, 2.05, 0.195, 222, 195, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2770, d5d0vZ_, 0.8338, 2.05, 0.195, 222, 195, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
2771, d5d0sZ_, 0.8338, 2.05, 0.195, 222, 195, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
2772, d5cz8Z_, 0.8338, 2.05, 0.195, 222, 195, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
2773, d5cz8L_, 0.8338, 2.05, 0.195, 222, 195, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
2774, d4qwjZ_, 0.8338, 2.05, 0.195, 222, 195, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
2775, d4qwjL_, 0.8338, 2.05, 0.195, 222, 195, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
2776, d3dy3Z_, 0.8338, 1.90, 0.196, 222, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
2777, d2zcyZ_, 0.8338, 2.05, 0.195, 222, 195, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
2778, d2zcyL_, 0.8338, 2.05, 0.195, 222, 195, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
2779, p5vfsM_, 0.8337, 2.01, 0.200, 213, 195, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2780, d5l66W_, 0.8337, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2781, d5l66I_, 0.8337, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2782, d5l5xW_, 0.8337, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2783, d5l5xI_, 0.8337, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2784, d5l5jW_, 0.8337, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2785, d5l5jI_, 0.8337, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2786, d5l5bW_, 0.8337, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2787, d5jhsL_, 0.8337, 2.05, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
2788, d5d0zZ_, 0.8337, 2.05, 0.195, 222, 195, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
2789, d5d0zL_, 0.8337, 2.05, 0.195, 222, 195, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
2790, d5d0vL_, 0.8337, 2.05, 0.195, 222, 195, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
2791, d5d0sL_, 0.8337, 2.05, 0.195, 222, 195, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
2792, p4y8kZ_, 0.8337, 1.89, 0.196, 222, 194, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
2793, p4y8kL_, 0.8337, 1.89, 0.196, 222, 194, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
2794, d4qwsZ_, 0.8337, 2.05, 0.195, 222, 195, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
2795, d4qwsL_, 0.8337, 2.05, 0.195, 222, 195, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
2796, d4qluZ_, 0.8337, 2.05, 0.195, 222, 195, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
2797, d4qluL_, 0.8337, 2.05, 0.195, 222, 195, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
2798, d3oevZ_, 0.8337, 2.06, 0.195, 222, 195, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
2799, d3dy3L_, 0.8337, 1.90, 0.196, 222, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
2800, p5vfuDA_, 0.8336, 2.05, 0.200, 213, 195, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2801, p5vftS_, 0.8336, 2.05, 0.200, 213, 195, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2802, p5vfrs_, 0.8336, 2.04, 0.200, 213, 195, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2803, d5lf3W_, 0.8336, 2.04, 0.210, 204, 195, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
2804, d5le5I_, 0.8336, 2.04, 0.210, 204, 195, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
2805, d5l69W_, 0.8336, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2806, d5l69I_, 0.8336, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2807, d5l5zW_, 0.8336, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2808, d5l5zI_, 0.8336, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2809, p5cggZ_, 0.8336, 2.05, 0.195, 222, 195, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
2810, p5cggL_, 0.8336, 2.05, 0.195, 222, 195, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
2811, p4y8sZ_, 0.8336, 1.89, 0.196, 222, 194, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
2812, p4y8sL_, 0.8336, 1.89, 0.196, 222, 194, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
2813, p4y8qZ_, 0.8336, 2.05, 0.195, 222, 195, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
2814, p4y8qL_, 0.8336, 2.05, 0.195, 222, 195, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
2815, d4qv6Z_, 0.8336, 1.90, 0.196, 222, 194, YCP BETA5-A49V MUTANT
2816, d3nzjZ_, 0.8336, 2.06, 0.195, 222, 195, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
2817, d3nzjL_, 0.8336, 2.06, 0.195, 222, 195, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
2818, d2fakZ_, 0.8336, 1.90, 0.196, 222, 194, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
2819, d2fakL_, 0.8336, 1.90, 0.196, 222, 194, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
2820, d5lf7W_, 0.8335, 2.04, 0.210, 204, 195, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
2821, p5leyW_, 0.8335, 2.03, 0.210, 204, 195, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
2822, p5leyI_, 0.8335, 2.04, 0.210, 204, 195, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
2823, p5fmgW_, 0.8335, 1.30, 0.253, 186, 186, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
2824, p5fmgI_, 0.8335, 1.30, 0.253, 186, 186, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
2825, d4r18W_, 0.8335, 1.95, 0.196, 204, 194, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2826, d4r18I_, 0.8335, 1.95, 0.196, 204, 194, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2827, d4r02Z_, 0.8335, 1.89, 0.196, 222, 194, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
2828, d4r02L_, 0.8335, 1.89, 0.196, 222, 194, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
2829, d4qz6Z_, 0.8335, 2.06, 0.195, 222, 195, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2830, d4qwkZ_, 0.8335, 2.06, 0.195, 222, 195, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2831, d4qwkL_, 0.8335, 2.06, 0.195, 222, 195, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2832, d4qwiZ_, 0.8335, 2.06, 0.195, 222, 195, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
2833, d4qwiL_, 0.8335, 2.06, 0.195, 222, 195, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
2834, d4qv6L_, 0.8335, 1.90, 0.196, 222, 194, YCP BETA5-A49V MUTANT
2835, d3mg7Z_, 0.8335, 2.05, 0.195, 222, 195, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2836, d5l68W_, 0.8334, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2837, d5l68I_, 0.8334, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2838, d5l65I_, 0.8334, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2839, d4qz6L_, 0.8334, 2.06, 0.195, 222, 195, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2840, d4qw7Z_, 0.8334, 2.06, 0.195, 222, 195, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
2841, d4qw6Z_, 0.8334, 2.06, 0.195, 222, 195, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
2842, d4qw6L_, 0.8334, 2.06, 0.195, 222, 195, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
2843, d4qw5Z_, 0.8334, 2.06, 0.195, 222, 195, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
2844, d4qw5L_, 0.8334, 2.06, 0.195, 222, 195, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
2845, d4no8W_, 0.8334, 1.95, 0.196, 204, 194, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
2846, d4no8I_, 0.8334, 1.95, 0.196, 204, 194, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
2847, d1g0uL_, 0.8334, 1.91, 0.196, 222, 194, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2848, d5lf3I_, 0.8333, 2.05, 0.210, 204, 195, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
2849, p5lezI_, 0.8333, 2.04, 0.210, 204, 195, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
2850, d5lexI_, 0.8333, 2.04, 0.210, 204, 195, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
2851, d5lajI_, 0.8333, 1.95, 0.196, 204, 194, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2852, d5l6bW_, 0.8333, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2853, d5l6bI_, 0.8333, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2854, d5l65W_, 0.8333, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2855, d5l5fW_, 0.8333, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2856, d5l54Z_, 0.8333, 2.06, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2857, d4qw7L_, 0.8333, 2.06, 0.195, 222, 195, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
2858, p3unek_, 0.8333, 2.06, 0.215, 204, 195, MOUSE CONSTITUTIVE 20S PROTEASOME
2859, d5lf1W_, 0.8332, 2.04, 0.210, 204, 195, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
2860, d5lf1I_, 0.8332, 2.04, 0.210, 204, 195, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
2861, d5lexW_, 0.8332, 2.04, 0.210, 204, 195, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
2862, d5le5W_, 0.8332, 2.04, 0.210, 204, 195, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
2863, d5lajW_, 0.8332, 1.95, 0.196, 204, 194, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2864, d5l5fI_, 0.8332, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2865, d5l55W_, 0.8332, 1.94, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2866, d5l55I_, 0.8332, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2867, d5l54L_, 0.8332, 2.06, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2868, d5fggW_, 0.8332, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2869, d5fggI_, 0.8332, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2870, d4qv3W_, 0.8332, 1.95, 0.196, 204, 194, YCP BETA5-M45V MUTANT
2871, d4qv3I_, 0.8332, 1.95, 0.196, 204, 194, YCP BETA5-M45V MUTANT
2872, d4inrZ_, 0.8332, 2.07, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
2873, d4inrL_, 0.8332, 2.07, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
2874, p5l5ua_, 0.8331, 1.99, 0.183, 218, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2875, d5l5dW_, 0.8331, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2876, d5l5dI_, 0.8331, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2877, d5l54W_, 0.8331, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2878, p5fgga_, 0.8331, 1.99, 0.183, 218, 197, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2879, d4r02W_, 0.8331, 1.96, 0.196, 204, 194, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
2880, d4r02I_, 0.8331, 1.96, 0.196, 204, 194, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
2881, d4qzzW_, 0.8331, 1.95, 0.196, 204, 194, YCP IN COMPLEX WITH OMURALIDE
2882, d4qzzI_, 0.8331, 1.96, 0.196, 204, 194, YCP IN COMPLEX WITH OMURALIDE
2883, d4qwgZ_, 0.8331, 2.06, 0.195, 222, 195, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
2884, d4qwgL_, 0.8331, 2.06, 0.195, 222, 195, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
2885, d4qwfZ_, 0.8331, 2.06, 0.195, 222, 195, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
2886, d4qwfL_, 0.8331, 2.06, 0.195, 222, 195, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
2887, d4qvnZ_, 0.8331, 1.90, 0.196, 222, 194, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
2888, d4qv7I_, 0.8331, 1.96, 0.196, 204, 194, YCP BETA5-A50V MUTANT
2889, d4q1sW_, 0.8331, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
2890, d4jt0Z_, 0.8331, 1.91, 0.196, 222, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
2891, d4jt0L_, 0.8331, 1.91, 0.196, 222, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
2892, d3oeuZ_, 0.8331, 2.06, 0.195, 222, 195, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
2893, d3oeuL_, 0.8331, 2.06, 0.195, 222, 195, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
2894, d3h6iJ_, 0.8331, 2.53, 0.224, 215, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
2895, p5lezW_, 0.8330, 2.04, 0.210, 204, 195, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
2896, p5l5ra_, 0.8330, 2.00, 0.183, 218, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2897, d5l5iW_, 0.8330, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
2898, d5l5eW_, 0.8330, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2899, d5l5eI_, 0.8330, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2900, d5jhrZ_, 0.8330, 2.06, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
2901, d5jhrL_, 0.8330, 2.06, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
2902, d5fgfW_, 0.8330, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
2903, d5fgfI_, 0.8330, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
2904, d5fgdW_, 0.8330, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2905, d5fgdI_, 0.8330, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2906, d5d0tW_, 0.8330, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
2907, d5d0tI_, 0.8330, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
2908, p4x6zX_, 0.8330, 1.93, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
2909, d4qv7W_, 0.8330, 1.96, 0.196, 204, 194, YCP BETA5-A50V MUTANT
2910, d4qv4W_, 0.8330, 1.96, 0.196, 204, 194, YCP BETA5-M45T MUTANT
2911, d4qv4I_, 0.8330, 1.96, 0.196, 204, 194, YCP BETA5-M45T MUTANT
2912, p4q1sa_, 0.8330, 1.99, 0.188, 218, 197, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
2913, d3mg0Z_, 0.8330, 2.06, 0.195, 222, 195, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
2914, d3gpjZ_, 0.8330, 2.07, 0.195, 222, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
2915, d3gpjL_, 0.8330, 2.07, 0.195, 222, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
2916, p5mpan_, 0.8329, 2.00, 0.183, 218, 197, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2917, d5l5iI_, 0.8329, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
2918, d5jhrW_, 0.8329, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
2919, d5jhrI_, 0.8329, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
2920, d5fgeW_, 0.8329, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2921, d5fgeI_, 0.8329, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2922, p4y82Z_, 0.8329, 2.06, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
2923, p4y82L_, 0.8329, 2.06, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
2924, d4qvnW_, 0.8329, 1.95, 0.196, 204, 194, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
2925, d4g4sM_, 0.8329, 2.06, 0.195, 222, 195, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
2926, d3sdkZ_, 0.8329, 2.06, 0.195, 222, 195, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2927, d3mg0L_, 0.8329, 2.07, 0.195, 222, 195, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
2928, d5lf7I_, 0.8328, 2.05, 0.210, 204, 195, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
2929, p5l5ba_, 0.8328, 2.00, 0.183, 218, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2930, d5l54I_, 0.8328, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2931, d5l52W_, 0.8328, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2932, d5l52I_, 0.8328, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2933, d5bxnW_, 0.8328, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
2934, d5bxnI_, 0.8328, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
2935, p5bxna_, 0.8328, 2.00, 0.183, 218, 197, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
2936, p4y8lL_, 0.8328, 2.06, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
2937, d4qz7Z_, 0.8328, 2.06, 0.195, 222, 195, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2938, d4qz7L_, 0.8328, 2.06, 0.195, 222, 195, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2939, d4qwlZ_, 0.8328, 2.06, 0.195, 222, 195, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
2940, d4qwlL_, 0.8328, 2.06, 0.195, 222, 195, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
2941, d4qw4Z_, 0.8328, 2.06, 0.195, 222, 195, YCP IN COMPLEX WITH CARFILZOMIB
2942, d4qw4L_, 0.8328, 2.06, 0.195, 222, 195, YCP IN COMPLEX WITH CARFILZOMIB
2943, d4qvnI_, 0.8328, 1.95, 0.196, 204, 194, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
2944, p4qvna_, 0.8328, 1.99, 0.183, 218, 197, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
2945, d4qv5W_, 0.8328, 1.96, 0.196, 204, 194, YCP BETA5-M45I MUTANT
2946, d4qv5I_, 0.8328, 1.96, 0.196, 204, 194, YCP BETA5-M45I MUTANT
2947, d4qv1W_, 0.8328, 1.96, 0.196, 204, 194, YCP BETA5-M45A MUTANT
2948, d4qv1I_, 0.8328, 1.96, 0.196, 204, 194, YCP BETA5-M45A MUTANT
2949, d4qlsW_, 0.8328, 1.95, 0.196, 204, 194, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
2950, d4qlsI_, 0.8328, 1.95, 0.196, 204, 194, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
2951, d4nnwW_, 0.8328, 1.95, 0.196, 204, 194, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
2952, d4nnwI_, 0.8328, 1.95, 0.196, 204, 194, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
2953, d4fzcZ_, 0.8328, 2.07, 0.195, 222, 195, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
2954, d3nzjI_, 0.8328, 1.96, 0.196, 204, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
2955, d3h6fJ_, 0.8328, 2.55, 0.229, 215, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
2956, p5l61a_, 0.8327, 2.00, 0.183, 218, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2957, d5fgaW_, 0.8327, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
2958, d5fgaI_, 0.8327, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
2959, d5fg7W_, 0.8327, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME BETA2-T1A MUTANT
2960, d5fg7I_, 0.8327, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME BETA2-T1A MUTANT
2961, p5cggW_, 0.8327, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
2962, p5cggI_, 0.8327, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
2963, p5ahja_, 0.8327, 1.99, 0.183, 218, 197, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
2964, p4ya2Z_, 0.8327, 1.90, 0.196, 222, 194, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
2965, p4ya2L_, 0.8327, 1.90, 0.196, 222, 194, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
2966, p4y8pZ_, 0.8327, 2.07, 0.195, 222, 195, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
2967, p4y8lZ_, 0.8327, 2.06, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
2968, p4y81Z_, 0.8327, 2.06, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
2969, p4y7yZ_, 0.8327, 2.06, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
2970, p4y7yL_, 0.8327, 2.06, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
2971, d4qz7W_, 0.8327, 1.96, 0.196, 204, 194, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2972, d4qz7I_, 0.8327, 1.96, 0.196, 204, 194, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2973, d4qv9W_, 0.8327, 1.96, 0.196, 204, 194, YCP BETA5-C63F MUTANT
2974, d4qv9I_, 0.8327, 1.96, 0.196, 204, 194, YCP BETA5-C63F MUTANT
2975, d4fzcL_, 0.8327, 2.07, 0.195, 222, 195, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
2976, d3shjZ_, 0.8327, 1.92, 0.196, 222, 194, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
2977, d3nzjW_, 0.8327, 1.96, 0.196, 204, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
2978, p6avoX_, 0.8326, 1.90, 0.201, 213, 194, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2979, p6avoS_, 0.8326, 1.90, 0.201, 213, 194, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2980, p5mp9n_, 0.8326, 1.95, 0.184, 217, 196, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2981, p5m2ba_, 0.8326, 2.00, 0.183, 218, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
2982, d5lf4W_, 0.8326, 2.04, 0.210, 204, 195, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
2983, p5l6aa_, 0.8326, 2.00, 0.183, 218, 197, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2984, p5l63a_, 0.8326, 2.00, 0.183, 218, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2985, p5l5ta_, 0.8326, 2.00, 0.183, 218, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2986, p5l5sa_, 0.8326, 2.00, 0.183, 218, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
2987, d5fhsW_, 0.8326, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
2988, d5fhsI_, 0.8326, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
2989, d5fgiW_, 0.8326, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2990, d5fgiI_, 0.8326, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2991, p5cggM_, 0.8326, 2.00, 0.183, 218, 197, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
2992, p5cgga_, 0.8326, 2.00, 0.183, 218, 197, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
2993, d5cgfW_, 0.8326, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME BETA5-G48C MUTANT
2994, d5cgfI_, 0.8326, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME BETA5-G48C MUTANT
2995, d5bouW_, 0.8326, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
2996, d5bouI_, 0.8326, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
2997, p4ya4a_, 0.8326, 2.00, 0.183, 218, 197, YEAST 20S PROTEASOME BETA2-H114D MUTANT
2998, d4ya1I_, 0.8326, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME BETA2-H116N MUTANT
2999, p4y8pL_, 0.8326, 2.07, 0.195, 222, 195, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
3000, d4y8mW_, 0.8326, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
3001, d4y8mI_, 0.8326, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
3002, p4y81L_, 0.8326, 2.06, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
3003, p4y75W_, 0.8326, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
3004, p4y75I_, 0.8326, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
3005, d4qzxZ_, 0.8326, 2.07, 0.195, 222, 195, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3006, d4qzxL_, 0.8326, 2.07, 0.195, 222, 195, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3007, d4qv6W_, 0.8326, 1.96, 0.196, 204, 194, YCP BETA5-A49V MUTANT
3008, d4qv6I_, 0.8326, 1.96, 0.196, 204, 194, YCP BETA5-A49V MUTANT
3009, d4quyW_, 0.8326, 1.96, 0.196, 204, 194, YCP BETA5-A49S-MUTANT
3010, d4q1sI_, 0.8326, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
3011, d4no1I_, 0.8326, 1.96, 0.196, 204, 194, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
3012, d4nnnW_, 0.8326, 1.96, 0.196, 204, 194, YCP IN COMPLEX WITH MG132
3013, d4nnnI_, 0.8326, 1.96, 0.196, 204, 194, YCP IN COMPLEX WITH MG132
3014, d3unbI_, 0.8326, 2.05, 0.215, 204, 195, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3015, d3shjL_, 0.8326, 1.92, 0.196, 222, 194, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
3016, d3h6fT_, 0.8326, 2.53, 0.224, 215, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
3017, d3h6fE_, 0.8326, 2.54, 0.229, 215, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
3018, d3bdmZ_, 0.8326, 2.07, 0.195, 222, 195, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
3019, d3bdmL_, 0.8326, 2.07, 0.195, 222, 195, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
3020, p5vfqM_, 0.8325, 2.05, 0.200, 213, 195, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3021, d5lf4I_, 0.8325, 2.05, 0.210, 204, 195, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
3022, p5lf0W_, 0.8325, 2.05, 0.210, 204, 195, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
3023, p5lf0I_, 0.8325, 2.05, 0.210, 204, 195, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
3024, p5l6ca_, 0.8325, 2.00, 0.183, 218, 197, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3025, p5l66a_, 0.8325, 2.00, 0.183, 218, 197, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3026, p5l62a_, 0.8325, 2.00, 0.183, 218, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3027, p5l5ya_, 0.8325, 2.00, 0.183, 218, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3028, p5l5oa_, 0.8325, 2.00, 0.183, 218, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3029, d5l5aW_, 0.8325, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
3030, d5l5aI_, 0.8325, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
3031, d5l52Z_, 0.8325, 2.07, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3032, d5l52L_, 0.8325, 2.07, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3033, d5jhsI_, 0.8325, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
3034, d5d0sW_, 0.8325, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
3035, d5d0sI_, 0.8325, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
3036, p5cghW_, 0.8325, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
3037, p5cghI_, 0.8325, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
3038, d5bxlW_, 0.8325, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME BETA2-G170A MUTANT
3039, d5bxlI_, 0.8325, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME BETA2-G170A MUTANT
3040, d5ahjW_, 0.8325, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
3041, d4ya1W_, 0.8325, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME BETA2-H116N MUTANT
3042, p4y8tW_, 0.8325, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
3043, p4y8tI_, 0.8325, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
3044, p4y80Z_, 0.8325, 2.07, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3045, p4y80L_, 0.8325, 2.07, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3046, p4r18a_, 0.8325, 2.00, 0.183, 218, 197, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3047, d4r00W_, 0.8325, 1.96, 0.196, 204, 194, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
3048, d4r00I_, 0.8325, 1.96, 0.196, 204, 194, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
3049, p4qz7a_, 0.8325, 2.00, 0.183, 218, 197, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3050, d4qv8W_, 0.8325, 1.96, 0.196, 204, 194, YCP BETA5-C52F MUTANT
3051, d4qv8I_, 0.8325, 1.96, 0.196, 204, 194, YCP BETA5-C52F MUTANT
3052, d4qv0I_, 0.8325, 1.96, 0.196, 204, 194, YCP BETA5-A49T-A50V-DOUBLE MUTANT
3053, d4quyI_, 0.8325, 1.96, 0.196, 204, 194, YCP BETA5-A49S-MUTANT
3054, d4qltZ_, 0.8325, 2.07, 0.195, 222, 195, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
3055, d4qltL_, 0.8325, 2.07, 0.195, 222, 195, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
3056, d4no1W_, 0.8325, 1.96, 0.196, 204, 194, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
3057, d3mg4Z_, 0.8325, 1.92, 0.196, 222, 194, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
3058, d3h6iE_, 0.8325, 2.53, 0.229, 215, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
3059, p5vfpM_, 0.8324, 2.05, 0.200, 213, 195, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3060, p5l6ba_, 0.8324, 2.00, 0.183, 218, 197, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3061, p5l5pa_, 0.8324, 2.00, 0.183, 218, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3062, p5l5ja_, 0.8324, 2.00, 0.183, 218, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3063, p5l5da_, 0.8324, 2.00, 0.183, 218, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3064, d5jhsW_, 0.8324, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
3065, d5d0wW_, 0.8324, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME BETA5-T1S MUTANT
3066, d5czaW_, 0.8324, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME BETA5-D166N MUTANT
3067, d5czaI_, 0.8324, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME BETA5-D166N MUTANT
3068, p5bxla_, 0.8324, 2.00, 0.183, 218, 197, YEAST 20S PROTEASOME BETA2-G170A MUTANT
3069, d5ahjI_, 0.8324, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
3070, p4y8kW_, 0.8324, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
3071, p4y8kI_, 0.8324, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
3072, p4y8iL_, 0.8324, 2.07, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
3073, p4y8hI_, 0.8324, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
3074, p4y8gM_, 0.8324, 2.00, 0.183, 218, 197, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
3075, p4y8ga_, 0.8324, 2.00, 0.183, 218, 197, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
3076, d4qz0L_, 0.8324, 2.07, 0.195, 222, 195, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3077, p4qz0a_, 0.8324, 2.00, 0.183, 218, 197, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3078, p4qwua_, 0.8324, 2.00, 0.183, 218, 197, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
3079, d4qv0W_, 0.8324, 1.96, 0.196, 204, 194, YCP BETA5-A49T-A50V-DOUBLE MUTANT
3080, d3tddW_, 0.8324, 1.97, 0.196, 204, 194, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
3081, d3tddI_, 0.8324, 1.97, 0.196, 204, 194, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
3082, d3h6iT_, 0.8324, 2.54, 0.224, 215, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
3083, d3h6fL_, 0.8324, 2.54, 0.224, 215, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
3084, d3h6fG_, 0.8324, 2.56, 0.229, 215, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
3085, d3e47I_, 0.8324, 1.97, 0.196, 204, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
3086, d3dy4W_, 0.8324, 1.97, 0.196, 204, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
3087, d3dy4I_, 0.8324, 1.97, 0.196, 204, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
3088, d2fnyI_, 0.8324, 1.97, 0.196, 204, 194,  
3089, d2fakW_, 0.8324, 1.97, 0.196, 204, 194, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
3090, p6avoU_, 0.8323, 2.04, 0.210, 204, 195, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
3091, p5vfsLA_, 0.8323, 2.03, 0.200, 213, 195, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3092, p5vfos_, 0.8323, 2.06, 0.200, 213, 195, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3093, p5ln31_, 0.8323, 2.20, 0.268, 214, 198, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
3094, d5laiW_, 0.8323, 1.97, 0.196, 204, 194, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3095, d5laiI_, 0.8323, 1.97, 0.196, 204, 194, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3096, p5l65a_, 0.8323, 2.00, 0.183, 218, 197, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3097, p5l64a_, 0.8323, 2.00, 0.183, 218, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3098, p5l5za_, 0.8323, 2.00, 0.183, 218, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3099, p5l5ha_, 0.8323, 2.00, 0.183, 218, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3100, d5fg9I_, 0.8323, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
3101, d5d0wI_, 0.8323, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME BETA5-T1S MUTANT
3102, p5d0sa_, 0.8323, 2.00, 0.183, 218, 197, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
3103, d5cz9W_, 0.8323, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
3104, d5cz9I_, 0.8323, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
3105, d5cz7W_, 0.8323, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
3106, d5cz7I_, 0.8323, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
3107, d4ya4I_, 0.8323, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME BETA2-H114D MUTANT
3108, p4y9zZ_, 0.8323, 2.07, 0.195, 222, 195, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
3109, p4y8jZ_, 0.8323, 2.07, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
3110, p4y8jL_, 0.8323, 2.07, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
3111, p4y8iZ_, 0.8323, 2.07, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
3112, p4y8hW_, 0.8323, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
3113, p4y8hM_, 0.8323, 2.00, 0.183, 218, 197, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
3114, p4y8ha_, 0.8323, 2.00, 0.183, 218, 197, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
3115, p4y78Z_, 0.8323, 1.91, 0.196, 222, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
3116, p4y78L_, 0.8323, 1.91, 0.196, 222, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
3117, p4y77Z_, 0.8323, 2.07, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
3118, p4y77L_, 0.8323, 2.07, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
3119, p4y6aW_, 0.8323, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
3120, d4qz3Z_, 0.8323, 2.07, 0.195, 222, 195, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3121, d4qz3L_, 0.8323, 2.07, 0.195, 222, 195, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3122, d4qvpW_, 0.8323, 1.96, 0.196, 204, 194, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
3123, d4qvpI_, 0.8323, 1.96, 0.196, 204, 194, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
3124, d4qlvI_, 0.8323, 1.96, 0.196, 204, 194, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
3125, d4no1Z_, 0.8323, 1.90, 0.196, 222, 194, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
3126, d4no1L_, 0.8323, 1.90, 0.196, 222, 194, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
3127, d4intZ_, 0.8323, 2.08, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
3128, p3uneI_, 0.8323, 2.06, 0.215, 204, 195, MOUSE CONSTITUTIVE 20S PROTEASOME
3129, d3sdkL_, 0.8323, 2.06, 0.195, 222, 195, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
3130, d3mg7L_, 0.8323, 2.06, 0.195, 222, 195, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
3131, d3h6iP_, 0.8323, 2.54, 0.229, 215, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
3132, d3e47W_, 0.8323, 1.97, 0.196, 204, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
3133, d2fnyW_, 0.8323, 1.97, 0.196, 204, 194,  
3134, d1iruX_, 0.8323, 2.07, 0.210, 204, 195, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
3135, d1iruJ_, 0.8323, 2.07, 0.210, 204, 195, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
3136, p6gopW_, 0.8322, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
3137, p6gopI_, 0.8322, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
3138, p5vfoS_, 0.8322, 2.05, 0.200, 213, 195, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3139, p5l5wa_, 0.8322, 2.00, 0.183, 218, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3140, p5l5va_, 0.8322, 2.01, 0.183, 218, 197,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3141, p5l5qa_, 0.8322, 2.01, 0.183, 218, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
3142, p5jhsa_, 0.8322, 2.00, 0.183, 218, 197, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
3143, d5fg9W_, 0.8322, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
3144, d5dkjW_, 0.8322, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
3145, d5dkjI_, 0.8322, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
3146, d5d0zW_, 0.8322, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
3147, d5d0zI_, 0.8322, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
3148, p5d0wa_, 0.8322, 2.00, 0.183, 218, 197, YEAST 20S PROTEASOME BETA5-T1S MUTANT
3149, p5cgiW_, 0.8322, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
3150, p5cgiI_, 0.8322, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
3151, d5ahjZ_, 0.8322, 2.07, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
3152, d5ahjL_, 0.8322, 2.07, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
3153, d4z1lI_, 0.8322, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
3154, d4ya4W_, 0.8322, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME BETA2-H114D MUTANT
3155, p4y9zL_, 0.8322, 2.07, 0.195, 222, 195, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
3156, p4y8uI_, 0.8322, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
3157, p4y74I_, 0.8322, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
3158, p4y6aI_, 0.8322, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
3159, d4qz5Z_, 0.8322, 2.07, 0.195, 222, 195, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
3160, d4qz5L_, 0.8322, 2.07, 0.195, 222, 195, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
3161, d4qz0W_, 0.8322, 1.96, 0.196, 204, 194, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3162, d4qz0I_, 0.8322, 1.96, 0.196, 204, 194, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3163, d4qxjZ_, 0.8322, 2.07, 0.195, 222, 195, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3164, d4qxjL_, 0.8322, 2.07, 0.195, 222, 195, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3165, d4qlvW_, 0.8322, 1.96, 0.196, 204, 194, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
3166, d4qluW_, 0.8322, 1.96, 0.196, 204, 194, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
3167, d4qluI_, 0.8322, 1.96, 0.196, 204, 194, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
3168, p4qlta_, 0.8322, 2.00, 0.183, 218, 197, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
3169, p4inta_, 0.8322, 2.00, 0.183, 218, 197, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
3170, d4inrI_, 0.8322, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
3171, p4fzga_, 0.8322, 2.01, 0.183, 218, 197, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
3172, p3uneW_, 0.8322, 2.06, 0.215, 204, 195, MOUSE CONSTITUTIVE 20S PROTEASOME
3173, d3un8I_, 0.8322, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
3174, d3h6iG_, 0.8322, 2.55, 0.229, 215, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
3175, d2fakI_, 0.8322, 1.97, 0.196, 204, 194, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
3176, p5laja_, 0.8321, 2.01, 0.183, 218, 197, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3177, p5l67a_, 0.8321, 2.01, 0.183, 218, 197, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3178, p5l60a_, 0.8321, 2.01, 0.183, 218, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3179, p5l54a_, 0.8321, 2.00, 0.183, 218, 197, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3180, p5gjqc_, 0.8321, 2.06, 0.210, 204, 195, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
3181, p5czaa_, 0.8321, 2.01, 0.183, 218, 197, YEAST 20S PROTEASOME BETA5-D166N MUTANT
3182, p5cgiZ_, 0.8321, 1.91, 0.196, 222, 194, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
3183, p5cghM_, 0.8321, 2.00, 0.183, 218, 197, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
3184, p5cgha_, 0.8321, 2.00, 0.183, 218, 197, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
3185, d4z1lW_, 0.8321, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
3186, p4y8uW_, 0.8321, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
3187, p4y8oZ_, 0.8321, 2.07, 0.195, 222, 195, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
3188, p4y8oL_, 0.8321, 2.07, 0.195, 222, 195, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
3189, p4y8gW_, 0.8321, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
3190, p4y8gI_, 0.8321, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
3191, p4y7xW_, 0.8321, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
3192, p4y7xI_, 0.8321, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
3193, p4y7wZ_, 0.8321, 2.07, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
3194, p4y7wL_, 0.8321, 2.07, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
3195, p4y6zL_, 0.8321, 2.07, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
3196, p4r17a_, 0.8321, 2.00, 0.188, 218, 197, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3197, d4qz5W_, 0.8321, 1.96, 0.196, 204, 194, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
3198, d4qwlW_, 0.8321, 1.96, 0.196, 204, 194, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
3199, d4qwlI_, 0.8321, 1.96, 0.196, 204, 194, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
3200, p4qwla_, 0.8321, 2.00, 0.183, 218, 197, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
3201, p4qwfa_, 0.8321, 2.00, 0.183, 218, 197, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
3202, p4qw6a_, 0.8321, 2.00, 0.183, 218, 197, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
3203, p4qv5a_, 0.8321, 2.00, 0.183, 218, 197, YCP BETA5-M45I MUTANT
3204, d4quxW_, 0.8321, 1.97, 0.196, 204, 194, YCP BETA5-A49T-MUTANT
3205, d4quxI_, 0.8321, 1.97, 0.196, 204, 194, YCP BETA5-A49T-MUTANT
3206, d4qlqW_, 0.8321, 1.96, 0.196, 204, 194, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
3207, d4qlqI_, 0.8321, 1.96, 0.196, 204, 194, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
3208, d4j70I_, 0.8321, 1.98, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
3209, d4inrW_, 0.8321, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
3210, p3unbk_, 0.8321, 2.06, 0.215, 204, 195, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3211, d3nzwL_, 0.8321, 2.08, 0.195, 222, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
3212, d3mg7I_, 0.8321, 1.97, 0.196, 204, 194, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
3213, d3h6iX_, 0.8321, 2.55, 0.229, 215, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
3214, p5l68a_, 0.8320, 2.01, 0.183, 218, 197, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3215, d5l55Z_, 0.8320, 2.07, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3216, d5l55L_, 0.8320, 2.07, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3217, p5l55a_, 0.8320, 2.00, 0.183, 218, 197, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3218, p5jhra_, 0.8320, 2.00, 0.183, 218, 197, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
3219, p5fgia_, 0.8320, 2.00, 0.183, 217, 197, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3220, p5fgea_, 0.8320, 2.00, 0.183, 218, 197, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3221, p5d0ta_, 0.8320, 2.01, 0.183, 218, 197, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
3222, p5cz9a_, 0.8320, 2.00, 0.183, 218, 197, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
3223, p5cgiL_, 0.8320, 1.91, 0.196, 222, 194, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
3224, d4y8rW_, 0.8320, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME BETA2-H116D MUTANT
3225, p4y8qW_, 0.8320, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
3226, p4y77I_, 0.8320, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
3227, p4y74W_, 0.8320, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
3228, p4y6zW_, 0.8320, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
3229, p4r67z_, 0.8320, 2.07, 0.210, 204, 195, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3230, p4r02a_, 0.8320, 2.01, 0.183, 218, 197, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
3231, d4qz6W_, 0.8320, 1.96, 0.196, 204, 194, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3232, d4qz5I_, 0.8320, 1.96, 0.196, 204, 194, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
3233, d4qwxW_, 0.8320, 1.96, 0.196, 204, 194, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3234, d4qwxI_, 0.8320, 1.96, 0.196, 204, 194, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3235, d4qw7I_, 0.8320, 1.96, 0.196, 204, 194, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
3236, d4qvqW_, 0.8320, 1.96, 0.196, 204, 194, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
3237, d4qvqI_, 0.8320, 1.96, 0.196, 204, 194, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
3238, p4qvpa_, 0.8320, 2.00, 0.183, 218, 197, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
3239, d4qvlW_, 0.8320, 1.96, 0.196, 204, 194, YCP IN COMPLEX WITH BORTEZOMIB
3240, d4qvlI_, 0.8320, 1.96, 0.196, 204, 194, YCP IN COMPLEX WITH BORTEZOMIB
3241, p4qvla_, 0.8320, 2.01, 0.183, 218, 197, YCP IN COMPLEX WITH BORTEZOMIB
3242, p4qv3a_, 0.8320, 2.01, 0.183, 218, 197, YCP BETA5-M45V MUTANT
3243, p4qv0a_, 0.8320, 2.01, 0.183, 218, 197, YCP BETA5-A49T-A50V-DOUBLE MUTANT
3244, p4quya_, 0.8320, 2.01, 0.183, 218, 197, YCP BETA5-A49S-MUTANT
3245, d4no8Z_, 0.8320, 2.07, 0.195, 222, 195, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
3246, d4no8L_, 0.8320, 2.07, 0.195, 222, 195, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
3247, d3okjL_, 0.8320, 1.92, 0.196, 222, 194, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
3248, d3nzwZ_, 0.8320, 2.08, 0.195, 222, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
3249, d3h6iL_, 0.8320, 2.54, 0.224, 215, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
3250, d3dy3W_, 0.8320, 1.98, 0.196, 204, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
3251, d3dy3I_, 0.8320, 1.98, 0.196, 204, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
3252, p6epc5_, 0.8319, 2.05, 0.080, 201, 199, GROUND STATE 26S PROTEASOME (GS2)
3253, p6avoY_, 0.8319, 2.05, 0.210, 204, 195, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
3254, p5laia_, 0.8319, 2.01, 0.183, 218, 197, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3255, p5l69a_, 0.8319, 2.01, 0.183, 218, 197, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3256, p5l5fa_, 0.8319, 2.01, 0.183, 218, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3257, p5fhsa_, 0.8319, 2.01, 0.183, 218, 197, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
3258, p5fghW_, 0.8319, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
3259, p5fghI_, 0.8319, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
3260, p5fgfa_, 0.8319, 2.01, 0.183, 218, 197, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
3261, p5fgaa_, 0.8319, 2.01, 0.183, 218, 197, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
3262, p5dkja_, 0.8319, 2.01, 0.183, 218, 197, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
3263, p4ya9M_, 0.8319, 2.00, 0.183, 218, 197, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
3264, p4ya7W_, 0.8319, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
3265, p4ya7I_, 0.8319, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
3266, p4ya2W_, 0.8319, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
3267, p4ya2I_, 0.8319, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
3268, p4ya2a_, 0.8319, 2.01, 0.183, 218, 197, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
3269, d4y8rI_, 0.8319, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME BETA2-H116D MUTANT
3270, p4y8qI_, 0.8319, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
3271, p4y8pW_, 0.8319, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
3272, p4y8pI_, 0.8319, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
3273, p4y8nI_, 0.8319, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
3274, p4y8hZ_, 0.8319, 2.07, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
3275, p4y8hL_, 0.8319, 2.07, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
3276, p4y82I_, 0.8319, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
3277, p4y77W_, 0.8319, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
3278, p4y70L_, 0.8319, 2.07, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
3279, p4y6zI_, 0.8319, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
3280, d4rurW_, 0.8319, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
3281, d4rurI_, 0.8319, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
3282, d4r67X_, 0.8319, 2.07, 0.210, 204, 195, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3283, p4r67l_, 0.8319, 2.07, 0.210, 204, 195, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3284, d4r67J_, 0.8319, 2.07, 0.210, 204, 195, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3285, d4qz6I_, 0.8319, 1.96, 0.196, 204, 194, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3286, d4qz3W_, 0.8319, 1.96, 0.196, 204, 194, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3287, d4qw7W_, 0.8319, 1.96, 0.196, 204, 194, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
3288, p4qw7a_, 0.8319, 2.00, 0.183, 218, 197, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
3289, p4qvqa_, 0.8319, 2.01, 0.183, 218, 197, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
3290, d4qltW_, 0.8319, 1.96, 0.196, 204, 194, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
3291, d4qltI_, 0.8319, 1.96, 0.196, 204, 194, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
3292, p4no8a_, 0.8319, 2.00, 0.183, 218, 197, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
3293, d4no6W_, 0.8319, 1.97, 0.196, 204, 194, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
3294, d4no6I_, 0.8319, 1.97, 0.196, 204, 194, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
3295, d4j70W_, 0.8319, 1.98, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
3296, p4inra_, 0.8319, 2.00, 0.183, 218, 197, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
3297, d4g4sJ_, 0.8319, 1.97, 0.196, 203, 194, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
3298, d4cr26_, 0.8319, 1.90, 0.196, 222, 194, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3299, d3shjW_, 0.8319, 1.98, 0.196, 204, 194, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
3300, d3shjI_, 0.8319, 1.98, 0.196, 204, 194, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
3301, p5l5xa_, 0.8318, 2.01, 0.183, 218, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3302, p5l5ia_, 0.8318, 2.01, 0.183, 218, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
3303, p5fgda_, 0.8318, 2.01, 0.183, 218, 197, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3304, p5d0za_, 0.8318, 2.01, 0.183, 218, 197, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
3305, d5d0vW_, 0.8318, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
3306, d5d0vI_, 0.8318, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
3307, p4ya9a_, 0.8318, 2.01, 0.183, 218, 197, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
3308, p4ya2M_, 0.8318, 2.01, 0.183, 218, 197, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
3309, p4y8ra_, 0.8318, 2.01, 0.183, 218, 197, YEAST 20S PROTEASOME BETA2-H116D MUTANT
3310, p4y82W_, 0.8318, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
3311, p4y70W_, 0.8318, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
3312, d4r17W_, 0.8318, 1.97, 0.196, 204, 194, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3313, d4r17I_, 0.8318, 1.97, 0.196, 204, 194, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3314, p4qzza_, 0.8318, 2.01, 0.183, 218, 197, YCP IN COMPLEX WITH OMURALIDE
3315, d4qz3I_, 0.8318, 1.96, 0.196, 204, 194, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3316, d4qw6I_, 0.8318, 1.96, 0.196, 204, 194, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
3317, p4qw5a_, 0.8318, 2.01, 0.183, 218, 197, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
3318, p4qw1a_, 0.8318, 2.01, 0.183, 218, 197, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
3319, p4qv9a_, 0.8318, 2.01, 0.183, 218, 197, YCP BETA5-C63F MUTANT
3320, p4qv7a_, 0.8318, 2.01, 0.183, 218, 197, YCP BETA5-A50V MUTANT
3321, p4qv6a_, 0.8318, 2.01, 0.183, 218, 197, YCP BETA5-A49V MUTANT
3322, p4qv4a_, 0.8318, 2.01, 0.183, 218, 197, YCP BETA5-M45T MUTANT
3323, p4qv1a_, 0.8318, 2.01, 0.183, 218, 197, YCP BETA5-M45A MUTANT
3324, d4fzgZ_, 0.8318, 1.92, 0.196, 222, 194, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
3325, d3un8W_, 0.8318, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
3326, p5ltta_, 0.8317, 2.01, 0.183, 218, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
3327, p5fg7a_, 0.8317, 2.01, 0.183, 218, 197, YEAST 20S PROTEASOME BETA2-T1A MUTANT
3328, p5cz7a_, 0.8317, 2.01, 0.183, 218, 197, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
3329, d5cz6W_, 0.8317, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
3330, d5cz6I_, 0.8317, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
3331, d5cz5I_, 0.8317, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
3332, p5cgfa_, 0.8317, 2.01, 0.183, 218, 197, YEAST 20S PROTEASOME BETA5-G48C MUTANT
3333, p4ya1a_, 0.8317, 2.01, 0.183, 218, 197, YEAST 20S PROTEASOME BETA2-H116N MUTANT
3334, d4y9yW_, 0.8317, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME BETA2-H116E MUTANT
3335, p4y8nW_, 0.8317, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
3336, p4y8kM_, 0.8317, 2.01, 0.183, 218, 197, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
3337, p4y8ka_, 0.8317, 2.01, 0.183, 218, 197, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
3338, p4y84M_, 0.8317, 2.01, 0.183, 218, 197, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
3339, p4y84a_, 0.8317, 2.01, 0.183, 218, 197, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
3340, p4y7wW_, 0.8317, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
3341, p4y7wI_, 0.8317, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
3342, p4y75Z_, 0.8317, 2.08, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
3343, p4y75L_, 0.8317, 2.08, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
3344, p4y70I_, 0.8317, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
3345, d4qzwW_, 0.8317, 1.96, 0.196, 204, 194, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3346, d4qz4W_, 0.8317, 1.97, 0.196, 204, 194, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3347, d4qz4I_, 0.8317, 1.97, 0.196, 204, 194, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3348, p4qz1a_, 0.8317, 2.01, 0.183, 218, 197, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3349, d4qwrW_, 0.8317, 1.97, 0.196, 204, 194, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
3350, d4qwrI_, 0.8317, 1.97, 0.196, 204, 194, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
3351, d4qw6W_, 0.8317, 1.96, 0.196, 204, 194, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
3352, d4qw5W_, 0.8317, 1.96, 0.196, 204, 194, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
3353, d4qw5I_, 0.8317, 1.96, 0.196, 204, 194, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
3354, p4qvwa_, 0.8317, 2.01, 0.183, 218, 197, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
3355, p4qlsa_, 0.8317, 2.01, 0.183, 218, 197, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
3356, d4no9W_, 0.8317, 1.97, 0.196, 204, 194, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
3357, d4fzgL_, 0.8317, 1.92, 0.196, 222, 194, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
3358, d3oevI_, 0.8317, 1.97, 0.196, 204, 194, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
3359, d3h6fX_, 0.8317, 2.56, 0.229, 215, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
3360, p6gopa_, 0.8316, 2.01, 0.183, 218, 197, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
3361, p5vfqLA_, 0.8316, 2.06, 0.200, 213, 195, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3362, p5t0gP_, 0.8316, 2.10, 0.210, 204, 195, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3363, p5d0va_, 0.8316, 2.01, 0.183, 218, 197, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
3364, d5cz5W_, 0.8316, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
3365, p5boua_, 0.8316, 2.01, 0.183, 218, 197, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
3366, p4ya9I_, 0.8316, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
3367, p4y9zI_, 0.8316, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
3368, d4y9yI_, 0.8316, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME BETA2-H116E MUTANT
3369, p4y8ta_, 0.8316, 2.01, 0.183, 218, 197, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
3370, p4y8sW_, 0.8316, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
3371, p4y8sI_, 0.8316, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
3372, p4y8lW_, 0.8316, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
3373, p4y84W_, 0.8316, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
3374, p4y84I_, 0.8316, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
3375, p4y80W_, 0.8316, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3376, p4y80I_, 0.8316, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3377, d4qzxW_, 0.8316, 1.96, 0.196, 204, 194, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3378, d4qzxI_, 0.8316, 1.97, 0.196, 204, 194, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3379, d4qzwI_, 0.8316, 1.96, 0.196, 204, 194, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3380, d4qz1W_, 0.8316, 1.97, 0.196, 204, 194, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3381, d4qvyW_, 0.8316, 1.97, 0.196, 204, 194, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
3382, d4qvyI_, 0.8316, 1.97, 0.196, 204, 194, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
3383, d4qvmI_, 0.8316, 1.97, 0.196, 204, 194, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
3384, p4qlua_, 0.8316, 2.00, 0.183, 218, 197, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
3385, d4no9I_, 0.8316, 1.97, 0.196, 204, 194, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
3386, p4ltca_, 0.8316, 2.01, 0.183, 218, 197, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
3387, d4jt0W_, 0.8316, 1.98, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
3388, d4jt0I_, 0.8316, 1.98, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
3389, d3okjW_, 0.8316, 1.97, 0.196, 204, 194, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
3390, d3okjI_, 0.8316, 1.97, 0.196, 204, 194, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
3391, d3oeuI_, 0.8316, 1.97, 0.196, 204, 194, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
3392, p3jcoA_, 0.8316, 1.92, 0.196, 222, 194, 
3393, d3hyeW_, 0.8316, 1.98, 0.196, 204, 194, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
3394, d3hyeI_, 0.8316, 1.98, 0.196, 204, 194, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
3395, d3gptW_, 0.8316, 1.98, 0.196, 204, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
3396, d2f16W_, 0.8316, 1.98, 0.196, 204, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
3397, d2f16I_, 0.8316, 1.98, 0.196, 204, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
3398, p1fntX_, 0.8316, 1.98, 0.196, 204, 194, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3399, p1fntJ_, 0.8316, 1.98, 0.196, 204, 194, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3400, p6gopM_, 0.8315, 2.01, 0.183, 218, 197, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
3401, p5l5aa_, 0.8315, 2.01, 0.183, 218, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
3402, p5cgiM_, 0.8315, 2.01, 0.183, 218, 197, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
3403, p5cgia_, 0.8315, 2.01, 0.183, 218, 197, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
3404, p4y9zW_, 0.8315, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
3405, p4y9ya_, 0.8315, 2.01, 0.183, 218, 197, YEAST 20S PROTEASOME BETA2-H116E MUTANT
3406, p4y8tM_, 0.8315, 2.01, 0.183, 218, 197, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
3407, p4y8lI_, 0.8315, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
3408, p4y6vI_, 0.8315, 1.98, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
3409, p4x6zJ_, 0.8315, 1.81, 0.197, 204, 193, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
3410, d4qz1I_, 0.8315, 1.97, 0.196, 204, 194, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3411, d4qz0Z_, 0.8315, 1.92, 0.196, 222, 194, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3412, d4qwuI_, 0.8315, 1.97, 0.196, 204, 194, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
3413, d4qwfW_, 0.8315, 1.97, 0.196, 204, 194, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
3414, d4qwfI_, 0.8315, 1.97, 0.196, 204, 194, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
3415, d4qw1W_, 0.8315, 1.97, 0.196, 204, 194, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
3416, d4qw1I_, 0.8315, 1.97, 0.196, 204, 194, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
3417, d4qvmW_, 0.8315, 1.97, 0.196, 204, 194, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
3418, p4qvma_, 0.8315, 2.01, 0.183, 218, 197, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
3419, p4qv8a_, 0.8315, 2.01, 0.183, 218, 197, YCP BETA5-C52F MUTANT
3420, p4qlva_, 0.8315, 2.01, 0.183, 218, 197, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
3421, p4nnwa_, 0.8315, 2.01, 0.183, 218, 197, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
3422, d4ltcW_, 0.8315, 1.97, 0.196, 204, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
3423, d4ltcI_, 0.8315, 1.97, 0.196, 204, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
3424, d4intL_, 0.8315, 1.93, 0.196, 222, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
3425, d4eu2J_, 0.8315, 1.97, 0.196, 204, 194, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
3426, p3uney_, 0.8315, 2.07, 0.215, 204, 195, MOUSE CONSTITUTIVE 20S PROTEASOME
3427, d3sdkI_, 0.8315, 1.97, 0.196, 204, 194, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
3428, d3nzwW_, 0.8315, 1.97, 0.196, 204, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
3429, d3nzwI_, 0.8315, 1.97, 0.196, 204, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
3430, d3mg8I_, 0.8315, 1.96, 0.196, 204, 194, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
3431, d3mg4W_, 0.8315, 1.97, 0.196, 204, 194, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
3432, d3gptI_, 0.8315, 1.98, 0.196, 204, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
3433, d3d29W_, 0.8315, 1.98, 0.196, 204, 194, PROTEASOME INHIBITION BY FELLUTAMIDE B
3434, d3d29I_, 0.8315, 1.98, 0.196, 204, 194, PROTEASOME INHIBITION BY FELLUTAMIDE B
3435, p5vfoP_, 0.8314, 2.05, 0.210, 204, 195, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3436, p5nifJ_, 0.8314, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3437, p5l4gY_, 0.8314, 1.83, 0.247, 207, 194, 
3438, p5cz6a_, 0.8314, 2.02, 0.183, 218, 197, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
3439, p4ya9Z_, 0.8314, 1.92, 0.196, 222, 194, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
3440, p4ya9W_, 0.8314, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
3441, p4ya9L_, 0.8314, 1.92, 0.196, 222, 194, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
3442, p4y8jW_, 0.8314, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
3443, p4y8jI_, 0.8314, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
3444, p4y8gZ_, 0.8314, 2.08, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
3445, p4y8gL_, 0.8314, 2.08, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
3446, p4y84Z_, 0.8314, 2.08, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
3447, p4y84L_, 0.8314, 2.08, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
3448, p4y6vW_, 0.8314, 1.98, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
3449, p4y69W_, 0.8314, 1.98, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
3450, p4y69I_, 0.8314, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
3451, p4qz6a_, 0.8314, 2.01, 0.183, 218, 197, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3452, d4qz2Z_, 0.8314, 1.92, 0.196, 222, 194, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3453, d4qwuW_, 0.8314, 1.97, 0.196, 204, 194, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
3454, p4qw4a_, 0.8314, 2.01, 0.183, 218, 197, YCP IN COMPLEX WITH CARFILZOMIB
3455, p4qvya_, 0.8314, 2.01, 0.183, 218, 197, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
3456, p4quxa_, 0.8314, 2.02, 0.183, 218, 197, YCP BETA5-A49T-MUTANT
3457, p4no6a_, 0.8314, 2.01, 0.183, 218, 197, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
3458, d4lqiW_, 0.8314, 1.98, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
3459, d4lqiI_, 0.8314, 1.98, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
3460, d4inuZ_, 0.8314, 2.09, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
3461, d3oevW_, 0.8314, 1.97, 0.196, 204, 194, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
3462, d3mg6I_, 0.8314, 1.97, 0.196, 204, 194, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
3463, p3jcoH_, 0.8314, 1.92, 0.196, 222, 194, 
3464, d3h6fP_, 0.8314, 2.56, 0.224, 215, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
3465, d3gpwW_, 0.8314, 1.98, 0.196, 204, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
3466, p5vfsIA_, 0.8313, 2.06, 0.210, 204, 195, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3467, p5t0gN_, 0.8313, 1.66, 0.277, 191, 191, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3468, p5t0cHB_, 0.8313, 2.06, 0.210, 204, 195, 
3469, p5t0cBA_, 0.8313, 2.06, 0.210, 204, 195, 
3470, p5l5ea_, 0.8313, 2.02, 0.183, 218, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3471, p5fghM_, 0.8313, 2.02, 0.183, 218, 197, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
3472, p5fgha_, 0.8313, 2.02, 0.183, 218, 197, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
3473, p4ya7Z_, 0.8313, 1.92, 0.196, 222, 194, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
3474, p4ya7M_, 0.8313, 2.01, 0.183, 218, 197, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
3475, p4ya7a_, 0.8313, 2.01, 0.183, 218, 197, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
3476, p4y7yW_, 0.8313, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
3477, p4y6zZ_, 0.8313, 1.92, 0.196, 222, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
3478, p4y6aM_, 0.8313, 2.02, 0.183, 218, 197, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
3479, p4y6aa_, 0.8313, 2.02, 0.183, 218, 197, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
3480, p4x6zN_, 0.8313, 2.02, 0.183, 218, 197, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
3481, p4x6z2_, 0.8313, 2.02, 0.183, 218, 197, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
3482, d4qz2W_, 0.8313, 1.97, 0.196, 204, 194, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3483, d4qz2L_, 0.8313, 1.92, 0.196, 222, 194, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3484, d4qz2I_, 0.8313, 1.97, 0.196, 204, 194, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3485, p4qz2a_, 0.8313, 2.01, 0.183, 218, 197, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3486, p4qwra_, 0.8313, 2.01, 0.183, 218, 197, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
3487, d4qw3W_, 0.8313, 1.97, 0.196, 204, 194, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
3488, d4qw3I_, 0.8313, 1.97, 0.196, 204, 194, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
3489, d4qw0W_, 0.8313, 1.97, 0.196, 204, 194, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
3490, d4qw0I_, 0.8313, 1.97, 0.196, 204, 194, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
3491, d4qvwW_, 0.8313, 1.97, 0.196, 204, 194, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
3492, d4qvwI_, 0.8313, 1.97, 0.196, 204, 194, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
3493, p4qlqa_, 0.8313, 2.01, 0.183, 218, 197, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
3494, d4nnnZ_, 0.8313, 2.08, 0.195, 222, 195, YCP IN COMPLEX WITH MG132
3495, d4nnnL_, 0.8313, 2.08, 0.195, 222, 195, YCP IN COMPLEX WITH MG132
3496, p4nnna_, 0.8313, 2.01, 0.183, 218, 197, YCP IN COMPLEX WITH MG132
3497, p4lqia_, 0.8313, 2.02, 0.183, 218, 197, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
3498, d4jsuZ_, 0.8313, 1.93, 0.196, 222, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
3499, d4jsuL_, 0.8313, 1.93, 0.196, 222, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
3500, p4j70a_, 0.8313, 2.02, 0.183, 218, 197, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
3501, d4inuW_, 0.8313, 1.98, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
3502, p4inua_, 0.8313, 2.01, 0.183, 218, 197, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
3503, p4hrda_, 0.8313, 2.01, 0.183, 218, 197, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
3504, d3unbW_, 0.8313, 2.08, 0.215, 204, 195, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3505, p3un4M_, 0.8313, 2.01, 0.183, 218, 197, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
3506, d3sdiL_, 0.8313, 2.08, 0.195, 222, 195, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
3507, d3oeuW_, 0.8313, 1.97, 0.196, 204, 194, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
3508, d3nzxW_, 0.8313, 1.98, 0.196, 204, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
3509, d3nzxI_, 0.8313, 1.98, 0.196, 204, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
3510, d3gpwI_, 0.8313, 1.98, 0.196, 204, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
3511, d3d29Z_, 0.8313, 2.09, 0.195, 222, 195, PROTEASOME INHIBITION BY FELLUTAMIDE B
3512, p5vfqIA_, 0.8312, 2.05, 0.210, 204, 195, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3513, p5mpa6_, 0.8312, 2.03, 0.195, 222, 195, 26S PROTEASOME IN PRESENCE OF ATP (S2)
3514, p5gjrPA_, 0.8312, 2.08, 0.210, 204, 195, 
3515, d5d0xW_, 0.8312, 1.98, 0.196, 204, 194, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
3516, d5d0xI_, 0.8312, 1.98, 0.196, 204, 194, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
3517, d5cz8W_, 0.8312, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
3518, d5cz8I_, 0.8312, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
3519, p4zzgJ_, 0.8312, 1.98, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3520, p4ya7L_, 0.8312, 1.92, 0.196, 222, 194, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
3521, p4ya5W_, 0.8312, 1.98, 0.196, 204, 194, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
3522, p4ya5I_, 0.8312, 1.98, 0.196, 204, 194, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
3523, p4y81I_, 0.8312, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
3524, p4y7yI_, 0.8312, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
3525, d4r3oJ_, 0.8312, 2.08, 0.210, 204, 195, HUMAN CONSTITUTIVE 20S PROTEASOME
3526, p4r00a_, 0.8312, 2.02, 0.183, 218, 197, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
3527, d4qwkW_, 0.8312, 1.97, 0.196, 204, 194, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3528, p4qbyW_, 0.8312, 1.98, 0.196, 204, 194, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
3529, p4qbyI_, 0.8312, 1.98, 0.196, 204, 194, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
3530, p4no1a_, 0.8312, 2.02, 0.183, 218, 197, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
3531, d4jsqZ_, 0.8312, 1.93, 0.196, 222, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
3532, d4jsqW_, 0.8312, 1.98, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
3533, d4jsqL_, 0.8312, 1.93, 0.196, 222, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
3534, d4jsqI_, 0.8312, 1.98, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
3535, p4jsqa_, 0.8312, 2.01, 0.183, 218, 197, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
3536, d4inuL_, 0.8312, 2.09, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
3537, d4intI_, 0.8312, 1.98, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
3538, d4hnpZ_, 0.8312, 1.92, 0.196, 222, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
3539, d4hnpW_, 0.8312, 1.98, 0.196, 204, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
3540, p4hnpa_, 0.8312, 2.01, 0.183, 218, 197, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
3541, p3un8a_, 0.8312, 2.01, 0.183, 218, 197, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
3542, d3sdkW_, 0.8312, 1.97, 0.196, 204, 194, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
3543, d3nzxZ_, 0.8312, 2.09, 0.195, 222, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
3544, d3nzxL_, 0.8312, 2.09, 0.195, 222, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
3545, d3gpjW_, 0.8312, 1.98, 0.196, 204, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
3546, d3gpjI_, 0.8312, 1.98, 0.196, 204, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
3547, d2f16L_, 0.8312, 2.09, 0.195, 222, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
3548, p5vfrP_, 0.8311, 2.07, 0.210, 204, 195, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3549, p5mpam_, 0.8311, 2.03, 0.195, 222, 195, 26S PROTEASOME IN PRESENCE OF ATP (S2)
3550, p5fg9a_, 0.8311, 2.02, 0.183, 218, 197, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
3551, p5cz8a_, 0.8311, 2.01, 0.183, 218, 197, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
3552, p4z1la_, 0.8311, 2.02, 0.183, 218, 197, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
3553, p4y8oW_, 0.8311, 1.98, 0.196, 204, 194, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
3554, p4y8oI_, 0.8311, 1.98, 0.196, 204, 194, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
3555, p4y82M_, 0.8311, 2.01, 0.183, 218, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
3556, p4y82a_, 0.8311, 2.02, 0.183, 218, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
3557, p4y81W_, 0.8311, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
3558, p4y78I_, 0.8311, 1.98, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
3559, p4y69a_, 0.8311, 2.02, 0.183, 218, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
3560, d4r3oX_, 0.8311, 2.08, 0.210, 204, 195, HUMAN CONSTITUTIVE 20S PROTEASOME
3561, d4qxjW_, 0.8311, 1.98, 0.196, 204, 194, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3562, d4qxjI_, 0.8311, 1.98, 0.196, 204, 194, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3563, p4qwxa_, 0.8311, 2.01, 0.183, 218, 197, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3564, d4qwkI_, 0.8311, 1.97, 0.196, 204, 194, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3565, d4qwiW_, 0.8311, 1.97, 0.196, 204, 194, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
3566, d4qwiI_, 0.8311, 1.97, 0.196, 204, 194, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
3567, d4qw4I_, 0.8311, 1.97, 0.196, 204, 194, YCP IN COMPLEX WITH CARFILZOMIB
3568, p4no9a_, 0.8311, 2.02, 0.183, 218, 197, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
3569, d4intW_, 0.8311, 1.98, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
3570, d4cr27_, 0.8311, 2.37, 0.182, 233, 203, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3571, d3mg6L_, 0.8311, 2.08, 0.195, 222, 195, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
3572, d3mg4I_, 0.8311, 1.98, 0.196, 204, 194, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
3573, d3bdmW_, 0.8311, 1.99, 0.196, 204, 194, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
3574, p5vfqJ_, 0.8310, 2.06, 0.210, 204, 195, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3575, d5dkiW_, 0.8310, 1.98, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
3576, d5dkiI_, 0.8310, 1.98, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
3577, p5cz5a_, 0.8310, 2.02, 0.183, 218, 197, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
3578, p4ya3I_, 0.8310, 1.98, 0.196, 204, 194, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
3579, p4y9zM_, 0.8310, 2.01, 0.183, 218, 197, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
3580, p4y9za_, 0.8310, 2.01, 0.183, 218, 197, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
3581, p4y8uM_, 0.8310, 2.02, 0.183, 218, 197, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
3582, p4y8ua_, 0.8310, 2.02, 0.183, 218, 197, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
3583, p4y8lM_, 0.8310, 2.01, 0.183, 218, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
3584, p4y8la_, 0.8310, 2.01, 0.183, 218, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
3585, p4y70Z_, 0.8310, 1.92, 0.196, 222, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
3586, p4y6vM_, 0.8310, 2.02, 0.183, 218, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
3587, p4y6va_, 0.8310, 2.02, 0.183, 218, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
3588, p4y69M_, 0.8310, 2.02, 0.183, 218, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
3589, p4v7oJ_, 0.8310, 1.99, 0.196, 204, 194, 
3590, p4rura_, 0.8310, 2.02, 0.183, 218, 197, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
3591, p4qz3a_, 0.8310, 2.01, 0.183, 218, 197, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3592, d4qwsW_, 0.8310, 1.98, 0.196, 204, 194, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
3593, d4qwsI_, 0.8310, 1.98, 0.196, 204, 194, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
3594, d4qw4W_, 0.8310, 1.97, 0.196, 204, 194, YCP IN COMPLEX WITH CARFILZOMIB
3595, d3mg4L_, 0.8310, 1.94, 0.196, 222, 194, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
3596, d3mg0I_, 0.8310, 1.98, 0.196, 204, 194, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
3597, d3l5qN_, 0.8310, 1.99, 0.196, 204, 194,  
3598, d3bdmI_, 0.8310, 1.99, 0.196, 204, 194, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
3599, d2zcyW_, 0.8310, 1.99, 0.196, 204, 194, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
3600, d2zcyI_, 0.8310, 1.99, 0.196, 204, 194, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
3601, p5vfsJ_, 0.8309, 2.07, 0.210, 204, 195, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3602, p5vfrS_, 0.8309, 2.06, 0.200, 213, 195, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3603, p5l4gK_, 0.8309, 1.83, 0.247, 207, 194, 
3604, d5cz4W_, 0.8309, 1.99, 0.196, 204, 194, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
3605, d5cz4I_, 0.8309, 1.99, 0.196, 204, 194, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
3606, p4ya3W_, 0.8309, 1.98, 0.196, 204, 194, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
3607, p4y81a_, 0.8309, 2.02, 0.183, 218, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
3608, p4y7xa_, 0.8309, 2.02, 0.183, 218, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
3609, p4y78W_, 0.8309, 1.98, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
3610, p4v7oRA_, 0.8309, 2.00, 0.196, 204, 194, 
3611, p4qwka_, 0.8309, 2.02, 0.183, 218, 197, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3612, d4qwjW_, 0.8309, 1.98, 0.196, 204, 194, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
3613, d4qwgW_, 0.8309, 1.98, 0.196, 204, 194, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
3614, d4qwgI_, 0.8309, 1.98, 0.196, 204, 194, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
3615, p4qbyM_, 0.8309, 2.02, 0.183, 218, 197, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
3616, p4qbya_, 0.8309, 2.02, 0.183, 218, 197, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
3617, d4inuI_, 0.8309, 1.98, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
3618, p4fzca_, 0.8309, 2.02, 0.183, 218, 197, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
3619, d4eu2X_, 0.8309, 1.99, 0.196, 204, 194, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
3620, d3wxrJ_, 0.8309, 1.99, 0.196, 204, 194, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
3621, p3unhW_, 0.8309, 2.06, 0.215, 204, 195, MOUSE 20S IMMUNOPROTEASOME
3622, p3unhI_, 0.8309, 2.06, 0.215, 204, 195, MOUSE 20S IMMUNOPROTEASOME
3623, p3un4W_, 0.8309, 1.98, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
3624, p3un4I_, 0.8309, 1.98, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
3625, d3sdiI_, 0.8309, 1.98, 0.196, 204, 194, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
3626, d3mg0W_, 0.8309, 1.98, 0.201, 204, 194, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
3627, p3jcpI_, 0.8309, 2.00, 0.183, 218, 197, 
3628, p3jcpB_, 0.8309, 2.00, 0.183, 218, 197, 
3629, d1vsyJ_, 0.8309, 2.00, 0.196, 204, 194,  
3630, p5vfrp_, 0.8308, 2.06, 0.210, 204, 195, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3631, p4y81M_, 0.8308, 2.02, 0.183, 218, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
3632, p4y7xM_, 0.8308, 2.02, 0.183, 218, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
3633, p4y74M_, 0.8308, 2.02, 0.183, 218, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
3634, p4y6zM_, 0.8308, 2.02, 0.183, 218, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
3635, p4y6za_, 0.8308, 2.02, 0.183, 218, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
3636, p4qzwa_, 0.8308, 2.02, 0.183, 218, 197, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3637, d4qz1Z_, 0.8308, 1.92, 0.196, 222, 194, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3638, d4qz1L_, 0.8308, 1.92, 0.196, 222, 194, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3639, d4qwjI_, 0.8308, 1.98, 0.196, 204, 194, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
3640, p4qwia_, 0.8308, 2.02, 0.183, 218, 197, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
3641, p4qw3a_, 0.8308, 2.02, 0.183, 218, 197, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
3642, p4hrca_, 0.8308, 2.02, 0.183, 218, 197, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
3643, d4fzgW_, 0.8308, 1.99, 0.196, 204, 194, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
3644, d4fzgI_, 0.8308, 1.99, 0.196, 204, 194, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
3645, d4fzcW_, 0.8308, 1.99, 0.196, 204, 194, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
3646, d4fzcI_, 0.8308, 1.99, 0.196, 204, 194, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
3647, d3unfW_, 0.8308, 2.06, 0.215, 204, 195, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
3648, d3unfI_, 0.8308, 2.06, 0.215, 204, 195, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
3649, p3un4Z_, 0.8308, 1.93, 0.196, 222, 194, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
3650, p3un4L_, 0.8308, 1.93, 0.196, 222, 194, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
3651, p5vfop_, 0.8307, 2.06, 0.210, 204, 195, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3652, p5mpbAA_, 0.8307, 2.03, 0.195, 222, 195, 
3653, p4y8iW_, 0.8307, 1.98, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
3654, p4y8iI_, 0.8307, 1.98, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
3655, p4y74a_, 0.8307, 2.02, 0.183, 218, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
3656, p4v7oX_, 0.8307, 2.00, 0.196, 204, 194, 
3657, p4v7oFB_, 0.8307, 2.00, 0.196, 204, 194, 
3658, d4qwxZ_, 0.8307, 1.93, 0.196, 222, 194, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3659, d4qwxL_, 0.8307, 1.93, 0.196, 222, 194, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3660, p4qw0a_, 0.8307, 2.02, 0.183, 218, 197, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
3661, d4nnwZ_, 0.8307, 1.93, 0.196, 222, 194, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
3662, d4ltcZ_, 0.8307, 1.93, 0.196, 222, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
3663, d4hrcZ_, 0.8307, 1.93, 0.196, 222, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
3664, d3mg7W_, 0.8307, 1.98, 0.196, 204, 194, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
3665, d3l5qZ_, 0.8307, 2.00, 0.196, 204, 194,  
3666, d1vsyX_, 0.8307, 2.00, 0.196, 204, 194,  
3667, p5gjrSA_, 0.8306, 1.94, 0.201, 213, 194, 
3668, p5gjrEA_, 0.8306, 1.94, 0.201, 213, 194, 
3669, p5dkia_, 0.8306, 2.02, 0.183, 218, 197, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
3670, p5d0xa_, 0.8306, 2.02, 0.183, 218, 197, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
3671, p4y8iM_, 0.8306, 2.02, 0.183, 218, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
3672, p4y8ia_, 0.8306, 2.02, 0.183, 218, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
3673, d4qz4Z_, 0.8306, 1.93, 0.196, 222, 194, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3674, p4qwsa_, 0.8306, 2.02, 0.183, 218, 197, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
3675, d4qlqZ_, 0.8306, 1.93, 0.196, 222, 194, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
3676, d4qlqL_, 0.8306, 1.93, 0.196, 222, 194, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
3677, d4no9Z_, 0.8306, 1.93, 0.196, 222, 194, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
3678, d4no9L_, 0.8306, 1.93, 0.196, 222, 194, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
3679, d4nnwL_, 0.8306, 1.93, 0.196, 222, 194, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
3680, d4ltcL_, 0.8306, 1.94, 0.196, 222, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
3681, d4hnpI_, 0.8306, 1.98, 0.196, 204, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
3682, d3sdiZ_, 0.8306, 2.09, 0.195, 222, 195, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
3683, d2gplW_, 0.8306, 2.00, 0.196, 204, 194, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
3684, d2gplI_, 0.8306, 2.00, 0.196, 204, 194, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
3685, d1jd2P_, 0.8306, 1.99, 0.196, 204, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
3686, d1iruM_, 0.8306, 1.93, 0.201, 213, 194, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
3687, d1iru1_, 0.8306, 1.93, 0.201, 213, 194, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
3688, d1g65Z_, 0.8306, 1.93, 0.196, 222, 194, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
3689, d1g65L_, 0.8306, 1.93, 0.196, 222, 194, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
3690, p5vfpHA_, 0.8305, 2.05, 0.210, 204, 195, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3691, p4ya5M_, 0.8305, 2.03, 0.183, 218, 197, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
3692, p4ya5a_, 0.8305, 2.03, 0.183, 218, 197, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
3693, p4y8sM_, 0.8305, 2.02, 0.183, 218, 197, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
3694, p4y8sa_, 0.8305, 2.02, 0.183, 218, 197, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
3695, p4y74Z_, 0.8305, 1.93, 0.196, 222, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
3696, p4y74L_, 0.8305, 1.93, 0.196, 222, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
3697, d4qz4L_, 0.8305, 1.93, 0.196, 222, 194, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3698, p4qbyZ_, 0.8305, 1.93, 0.196, 222, 194, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
3699, p4qbyL_, 0.8305, 1.93, 0.196, 222, 194, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
3700, p4jt0a_, 0.8305, 2.03, 0.183, 218, 197, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
3701, p4jsua_, 0.8305, 2.02, 0.183, 218, 197, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
3702, p4gk7M_, 0.8305, 2.02, 0.183, 218, 197, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
3703, p4gk7a_, 0.8305, 2.02, 0.183, 218, 197, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
3704, d3wxrX_, 0.8305, 1.83, 0.197, 204, 193, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
3705, d3mg8W_, 0.8305, 1.97, 0.196, 204, 194, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
3706, d3mg6Z_, 0.8305, 2.09, 0.195, 222, 195, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
3707, p6epf1_, 0.8304, 2.27, 0.080, 202, 200, GROUND STATE 26S PROTEASOME (GS1)
3708, p5nifX_, 0.8304, 1.99, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3709, p5nif2_, 0.8304, 2.02, 0.183, 218, 197, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3710, p5gjrBA_, 0.8304, 1.93, 0.211, 204, 194, 
3711, p5gjqu_, 0.8304, 1.83, 0.247, 207, 194, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
3712, p4y80M_, 0.8304, 2.02, 0.183, 218, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3713, p4y80a_, 0.8304, 2.02, 0.183, 218, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3714, p4qzxa_, 0.8304, 2.02, 0.183, 218, 197, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3715, d4jsuW_, 0.8304, 1.99, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
3716, d4jsuI_, 0.8304, 1.99, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
3717, d4hnpL_, 0.8304, 1.93, 0.196, 222, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
3718, d3sdiW_, 0.8304, 1.98, 0.196, 204, 194, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
3719, d3d29L_, 0.8304, 1.93, 0.196, 222, 194, PROTEASOME INHIBITION BY FELLUTAMIDE B
3720, d2f16Z_, 0.8304, 1.94, 0.196, 222, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
3721, d1jd2I_, 0.8304, 1.98, 0.196, 204, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
3722, p4zzg2_, 0.8303, 2.02, 0.183, 218, 197, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3723, p4y8jM_, 0.8303, 2.02, 0.183, 218, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
3724, p4qwga_, 0.8303, 2.03, 0.183, 218, 197, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
3725, d4qvvW_, 0.8303, 1.99, 0.196, 204, 194, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
3726, d4qvvI_, 0.8303, 1.99, 0.196, 204, 194, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
3727, d3mg6W_, 0.8303, 1.98, 0.196, 204, 194, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
3728, d1g0uW_, 0.8303, 1.99, 0.196, 204, 194, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
3729, p4y8ja_, 0.8302, 2.02, 0.183, 218, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
3730, p4y7wM_, 0.8302, 2.03, 0.183, 218, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
3731, p4y7wa_, 0.8302, 2.03, 0.183, 218, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
3732, p4y70M_, 0.8302, 2.03, 0.183, 218, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
3733, p4y70a_, 0.8302, 2.02, 0.183, 218, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
3734, d4no6Z_, 0.8302, 1.93, 0.196, 222, 194, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
3735, d4no6L_, 0.8302, 1.93, 0.196, 222, 194, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
3736, d4hrdZ_, 0.8302, 1.93, 0.196, 222, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
3737, p4gk7Z_, 0.8302, 1.94, 0.196, 222, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
3738, p5vfuOA_, 0.8301, 2.07, 0.210, 204, 195, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3739, p5vftp_, 0.8301, 2.07, 0.210, 204, 195, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3740, p4ya0W_, 0.8301, 1.99, 0.196, 204, 194, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
3741, p4ya0I_, 0.8301, 1.99, 0.196, 204, 194, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
3742, p4gk7L_, 0.8301, 1.94, 0.196, 222, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
3743, d3mg8Z_, 0.8301, 1.93, 0.196, 222, 194, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
3744, p5vfpJ_, 0.8300, 2.07, 0.210, 204, 195, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3745, p4zzgX_, 0.8300, 1.99, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3746, p4y7yM_, 0.8300, 2.03, 0.183, 218, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
3747, p4qwja_, 0.8300, 2.03, 0.183, 218, 197, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
3748, d4hrdI_, 0.8300, 1.99, 0.196, 204, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
3749, d4hrcI_, 0.8300, 1.99, 0.196, 204, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
3750, p4gk7I_, 0.8300, 1.99, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
3751, d1rypX_, 0.8300, 1.99, 0.196, 204, 194, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
3752, d1rypJ_, 0.8300, 1.99, 0.196, 204, 194, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
3753, p5vfuRA_, 0.8299, 2.05, 0.200, 213, 195, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3754, p5vfts_, 0.8299, 2.05, 0.200, 213, 195, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3755, p5mp97_, 0.8299, 2.03, 0.183, 218, 197, 26S PROTEASOME IN PRESENCE OF ATP (S1)
3756, p5cz4a_, 0.8299, 2.03, 0.183, 218, 197, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
3757, p4y7ya_, 0.8299, 2.03, 0.183, 218, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
3758, p4gk7W_, 0.8299, 1.99, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
3759, d3mg8L_, 0.8299, 1.94, 0.196, 222, 194, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
3760, p4y78M_, 0.8298, 2.03, 0.183, 218, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
3761, p4y78a_, 0.8298, 2.03, 0.183, 218, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
3762, d4r3oM_, 0.8298, 1.95, 0.201, 213, 194, HUMAN CONSTITUTIVE 20S PROTEASOME
3763, p4qvva_, 0.8298, 2.03, 0.183, 218, 197, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
3764, p3hf9c_, 0.8298, 2.54, 0.225, 214, 200, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
3765, d1g0uI_, 0.8298, 1.99, 0.196, 204, 194, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
3766, p5l4gV_, 0.8297, 2.08, 0.200, 213, 195, 
3767, d1jd2S_, 0.8297, 2.10, 0.195, 222, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
3768, p4ya3a_, 0.8296, 2.04, 0.183, 218, 197, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
3769, d4r3o1_, 0.8296, 1.96, 0.201, 213, 194, HUMAN CONSTITUTIVE 20S PROTEASOME
3770, p5wvkC_, 0.8295, 1.86, 0.197, 204, 193, 
3771, p4ya3M_, 0.8295, 2.04, 0.183, 218, 197, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
3772, d1g65W_, 0.8295, 1.98, 0.196, 204, 194, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
3773, p5vfpKA_, 0.8294, 1.93, 0.201, 213, 194, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3774, p5t0iO_, 0.8293, 1.81, 0.259, 193, 193, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3775, p5gjqt_, 0.8293, 1.95, 0.201, 213, 194, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
3776, p4ya0M_, 0.8293, 2.04, 0.183, 218, 197, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
3777, p4ya0a_, 0.8293, 2.04, 0.183, 218, 197, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
3778, d4hrdL_, 0.8293, 1.94, 0.196, 222, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
3779, p6avoW_, 0.8292, 1.80, 0.249, 206, 193, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
3780, p6avoa_, 0.8292, 1.80, 0.249, 206, 193, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
3781, p5mpcN_, 0.8292, 2.02, 0.183, 218, 197, 
3782, p5gjqq_, 0.8292, 2.11, 0.210, 204, 195, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
3783, d4hrcW_, 0.8292, 2.00, 0.196, 204, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
3784, p3unby_, 0.8292, 2.11, 0.215, 204, 195, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3785, p3jcpSA_, 0.8292, 2.00, 0.196, 204, 194, 
3786, p3jcpE_, 0.8292, 2.00, 0.196, 204, 194, 
3787, p5gjqr_, 0.8291, 2.05, 0.179, 199, 196, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
3788, p5gjqf_, 0.8291, 1.96, 0.201, 213, 194, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
3789, d3okj1_, 0.8291, 2.32, 0.180, 228, 200, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
3790, d1jd2L_, 0.8291, 2.10, 0.195, 222, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
3791, p5vfuAA_, 0.8290, 2.10, 0.210, 204, 195, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3792, p5vftP_, 0.8290, 2.10, 0.210, 204, 195, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3793, p5l4gH_, 0.8289, 2.10, 0.200, 213, 195, 
3794, d4hrdW_, 0.8289, 2.01, 0.196, 204, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
3795, p3uneL_, 0.8289, 1.96, 0.196, 213, 194, MOUSE CONSTITUTIVE 20S PROTEASOME
3796, p5mpbM_, 0.8288, 2.02, 0.195, 222, 195, 
3797, p3unen_, 0.8288, 1.97, 0.196, 213, 194, MOUSE CONSTITUTIVE 20S PROTEASOME
3798, d3h6f2_, 0.8288, 2.53, 0.230, 214, 200, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
3799, d3okjZ_, 0.8287, 1.98, 0.196, 221, 194, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
3800, d3h6i2_, 0.8287, 2.53, 0.225, 214, 200, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
3801, d1g65I_, 0.8287, 1.99, 0.196, 204, 194, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
3802, p5gjrTA_, 0.8286, 1.85, 0.247, 207, 194, 
3803, p5gjqd_, 0.8285, 2.05, 0.179, 199, 196, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
3804, d4hrcL_, 0.8285, 1.95, 0.196, 222, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
3805, p3un4a_, 0.8285, 1.99, 0.184, 217, 196, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
3806, d3h6iC_, 0.8282, 2.54, 0.220, 214, 200, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
3807, p3une2_, 0.8281, 1.97, 0.196, 213, 194, MOUSE CONSTITUTIVE 20S PROTEASOME
3808, p5gjrQA_, 0.8278, 1.92, 0.179, 199, 195, 
3809, p5m32M_, 0.8277, 1.80, 0.249, 206, 193, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
3810, p5l4gW_, 0.8277, 2.06, 0.179, 199, 196, 
3811, p5gjrCA_, 0.8277, 1.92, 0.179, 199, 195, 
3812, d3h6iZ_, 0.8275, 2.54, 0.225, 214, 200, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
3813, d3h6fZ_, 0.8275, 2.56, 0.230, 214, 200, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
3814, p5fmgY_, 0.8274, 1.76, 0.156, 194, 192, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
3815, p5fmgK_, 0.8274, 1.76, 0.156, 194, 192, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
3816, p5m32a_, 0.8273, 1.80, 0.249, 206, 193, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
3817, p3uneZ_, 0.8273, 1.97, 0.196, 213, 194, MOUSE CONSTITUTIVE 20S PROTEASOME
3818, d3h6fC_, 0.8273, 2.56, 0.225, 214, 200, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
3819, p5nifN_, 0.8272, 2.01, 0.184, 216, 196, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3820, p5mp93_, 0.8272, 2.01, 0.196, 204, 194, 26S PROTEASOME IN PRESENCE OF ATP (S1)
3821, p3hf9h_, 0.8272, 2.52, 0.226, 213, 199, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
3822, p4r67p_, 0.8271, 1.87, 0.247, 207, 194, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3823, p4r67b_, 0.8271, 1.87, 0.247, 207, 194, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3824, p1z7qb_, 0.8271, 2.02, 0.184, 217, 196, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3825, p5t0cKB_, 0.8270, 1.98, 0.201, 213, 194, 
3826, p5t0cEA_, 0.8270, 1.98, 0.201, 213, 194, 
3827, p4zzgN_, 0.8270, 2.01, 0.184, 216, 196, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3828, d4r3oK_, 0.8270, 1.93, 0.179, 199, 195, HUMAN CONSTITUTIVE 20S PROTEASOME
3829, d4r3oY_, 0.8269, 1.93, 0.179, 199, 195, HUMAN CONSTITUTIVE 20S PROTEASOME
3830, p5mp9j_, 0.8268, 2.00, 0.196, 204, 194, 26S PROTEASOME IN PRESENCE OF ATP (S1)
3831, p5t0iN_, 0.8266, 1.71, 0.277, 191, 191, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3832, p5l4gJ_, 0.8266, 2.09, 0.210, 204, 195, 
3833, p4r67o_, 0.8266, 1.99, 0.201, 213, 194, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3834, d4r67M_, 0.8266, 1.99, 0.201, 213, 194, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3835, p4r67a_, 0.8266, 1.99, 0.201, 213, 194, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3836, d4r671_, 0.8266, 1.99, 0.201, 213, 194, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3837, p1fntN_, 0.8266, 2.02, 0.184, 217, 196, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3838, p1fntb_, 0.8266, 2.01, 0.184, 217, 196, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3839, p5lf6Z_, 0.8262, 1.99, 0.201, 213, 194, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
3840, d5le5Z_, 0.8261, 1.99, 0.201, 213, 194, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
3841, d3unbZ_, 0.8261, 1.99, 0.196, 213, 194, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3842, p5lf6L_, 0.8260, 1.99, 0.201, 213, 194, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
3843, p5gjqg_, 0.8260, 1.83, 0.249, 206, 193, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
3844, d3unb2_, 0.8259, 2.00, 0.196, 213, 194, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3845, p5l4gI_, 0.8258, 2.07, 0.179, 199, 196, 
3846, d3unbL_, 0.8257, 2.00, 0.196, 213, 194, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3847, d5le5L_, 0.8256, 2.00, 0.201, 213, 194, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
3848, p3jcoSA_, 0.8256, 2.02, 0.196, 204, 194, 
3849, p3jcoE_, 0.8256, 2.02, 0.196, 204, 194, 
3850, d5lexZ_, 0.8255, 2.00, 0.201, 213, 194, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
3851, d5lexL_, 0.8255, 2.00, 0.201, 213, 194, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
3852, p5l4gX_, 0.8255, 2.13, 0.210, 204, 195, 
3853, d5lf1Z_, 0.8254, 2.00, 0.201, 213, 194, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
3854, p3unhZ_, 0.8254, 2.00, 0.196, 213, 194, MOUSE 20S IMMUNOPROTEASOME
3855, p3unhL_, 0.8254, 2.00, 0.196, 213, 194, MOUSE 20S IMMUNOPROTEASOME
3856, p3unbn_, 0.8254, 2.00, 0.196, 213, 194, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3857, d5lf1L_, 0.8253, 2.00, 0.201, 213, 194, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
3858, p3unfa_, 0.8250, 1.86, 0.249, 206, 193, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
3859, p5mpcX_, 0.8249, 2.04, 0.196, 204, 194, 
3860, p5gjrFA_, 0.8249, 1.85, 0.249, 206, 193, 
3861, p3unhM_, 0.8248, 1.86, 0.249, 206, 193, MOUSE 20S IMMUNOPROTEASOME
3862, p3unha_, 0.8248, 1.86, 0.249, 206, 193, MOUSE 20S IMMUNOPROTEASOME
3863, p5le5a_, 0.8247, 1.86, 0.249, 206, 193, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
3864, p5mpcBA_, 0.8246, 2.08, 0.183, 218, 197, 
3865, d5lf7Z_, 0.8246, 2.01, 0.201, 213, 194, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
3866, p5leyZ_, 0.8246, 2.01, 0.201, 213, 194, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
3867, p3unea_, 0.8246, 1.86, 0.249, 206, 193, MOUSE CONSTITUTIVE 20S PROTEASOME
3868, d5lf4Z_, 0.8245, 2.01, 0.201, 213, 194, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
3869, p5t0gS_, 0.8244, 2.01, 0.201, 213, 194, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3870, p4v7oN_, 0.8244, 2.05, 0.184, 217, 196, 
3871, p4v7oJB_, 0.8244, 2.05, 0.184, 217, 196, 
3872, p4v7oBA_, 0.8244, 2.05, 0.184, 217, 196, 
3873, p5lf7a_, 0.8243, 1.86, 0.249, 206, 193, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
3874, p5lf0Z_, 0.8243, 2.01, 0.201, 213, 194, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
3875, p5leyL_, 0.8243, 2.01, 0.201, 213, 194, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
3876, d5lf4L_, 0.8242, 2.01, 0.201, 213, 194, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
3877, d5lf3Z_, 0.8242, 2.01, 0.201, 213, 194, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
3878, p4v7oVA_, 0.8242, 2.05, 0.184, 217, 196, 
3879, d3unfL_, 0.8242, 2.01, 0.196, 213, 194, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
3880, p6avoT_, 0.8241, 1.84, 0.181, 196, 193, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
3881, p5vfuEA_, 0.8241, 1.82, 0.250, 205, 192, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3882, p5vftT_, 0.8241, 1.82, 0.250, 205, 192, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3883, p5lf3a_, 0.8241, 1.86, 0.249, 206, 193, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
3884, p5leyM_, 0.8241, 1.86, 0.249, 206, 193, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
3885, p4qxja_, 0.8241, 1.99, 0.185, 216, 195, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3886, d3unfZ_, 0.8241, 2.01, 0.196, 213, 194, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
3887, p6avoV_, 0.8240, 1.84, 0.181, 196, 193, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
3888, d5lf3L_, 0.8240, 2.01, 0.201, 213, 194, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
3889, p5lf0L_, 0.8240, 2.01, 0.201, 213, 194, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
3890, p5lezZ_, 0.8240, 2.01, 0.201, 213, 194, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
3891, p5lezL_, 0.8240, 2.01, 0.201, 213, 194, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
3892, p5vfsN_, 0.8239, 1.82, 0.250, 205, 192, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3893, p5lf4a_, 0.8239, 1.86, 0.249, 206, 193, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
3894, p5leya_, 0.8239, 1.86, 0.249, 206, 193, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
3895, p5vfoT_, 0.8238, 1.81, 0.250, 205, 192, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3896, d5lf7L_, 0.8238, 2.02, 0.201, 213, 194, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
3897, p5lf6M_, 0.8236, 1.87, 0.249, 206, 193, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
3898, p5vfoQ_, 0.8235, 2.01, 0.179, 199, 196, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3899, p5vfpN_, 0.8234, 1.82, 0.250, 205, 192, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3900, p5vfoq_, 0.8234, 2.01, 0.179, 199, 196, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3901, p5m32Z_, 0.8234, 1.98, 0.201, 213, 194, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
3902, p5m32L_, 0.8234, 1.98, 0.201, 213, 194, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
3903, p5lf6a_, 0.8234, 1.87, 0.249, 206, 193, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
3904, p5lf1a_, 0.8234, 1.87, 0.249, 206, 193, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
3905, d4r67Y_, 0.8234, 1.97, 0.179, 199, 195, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3906, p4r67m_, 0.8234, 1.97, 0.179, 199, 195, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3907, d4r67K_, 0.8234, 1.97, 0.179, 199, 195, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3908, d4r670_, 0.8234, 1.97, 0.179, 199, 195, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3909, p3une3_, 0.8234, 1.88, 0.249, 206, 193, MOUSE CONSTITUTIVE 20S PROTEASOME
3910, p5vfrQ_, 0.8232, 2.01, 0.179, 199, 196, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3911, p5vfsMA_, 0.8231, 1.83, 0.250, 205, 192, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3912, p5lf0a_, 0.8231, 1.87, 0.249, 206, 193, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
3913, p5mpa3_, 0.8230, 2.05, 0.196, 204, 194, 26S PROTEASOME IN PRESENCE OF ATP (S2)
3914, p5lf0M_, 0.8230, 1.88, 0.249, 206, 193, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
3915, p3uneM_, 0.8228, 1.88, 0.249, 206, 193, MOUSE CONSTITUTIVE 20S PROTEASOME
3916, p5vfuSA_, 0.8227, 1.83, 0.250, 205, 192, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3917, p5vftt_, 0.8227, 1.83, 0.250, 205, 192, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3918, p5vfpLA_, 0.8227, 1.83, 0.250, 205, 192, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3919, p4cr46_, 0.8227, 2.08, 0.195, 222, 195, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3920, p5lezM_, 0.8225, 1.88, 0.249, 206, 193, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
3921, p5vfot_, 0.8224, 1.83, 0.250, 205, 192, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3922, p5lexa_, 0.8224, 1.88, 0.249, 206, 193, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
3923, p5vfuBA_, 0.8223, 2.08, 0.179, 199, 196, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3924, p5vftQ_, 0.8223, 2.08, 0.179, 199, 196, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3925, p5mpbX_, 0.8221, 2.10, 0.191, 204, 194, 
3926, p3unba_, 0.8221, 1.89, 0.249, 206, 193, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3927, p5l52a_, 0.8220, 1.97, 0.186, 215, 194, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3928, d3h6fN_, 0.8220, 2.53, 0.227, 212, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
3929, p5vfpIA_, 0.8219, 2.03, 0.179, 199, 196, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3930, d1iruY_, 0.8219, 1.99, 0.179, 199, 195, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
3931, d1iruK_, 0.8219, 1.99, 0.179, 199, 195, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
3932, p5leza_, 0.8218, 1.89, 0.249, 206, 193, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
3933, p3uneo_, 0.8217, 1.90, 0.249, 206, 193, MOUSE CONSTITUTIVE 20S PROTEASOME
3934, d3h6iN_, 0.8217, 2.53, 0.227, 212, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
3935, p5vfqJA_, 0.8216, 2.03, 0.179, 199, 196, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3936, p5vfrT_, 0.8215, 1.84, 0.250, 205, 192, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3937, p5vfpK_, 0.8215, 2.03, 0.179, 199, 196, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3938, p5m32W_, 0.8215, 2.15, 0.210, 204, 195, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
3939, p5m32I_, 0.8215, 2.15, 0.210, 204, 195, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
3940, p3unbo_, 0.8215, 1.90, 0.249, 206, 193, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3941, p5wvkJ_, 0.8214, 1.93, 0.197, 204, 193, 
3942, p5vfqMA_, 0.8213, 1.85, 0.250, 205, 192, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3943, p4qz4a_, 0.8213, 1.97, 0.186, 215, 194, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3944, p5vfqN_, 0.8210, 1.85, 0.250, 205, 192, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3945, p5t0jN_, 0.8210, 1.82, 0.277, 191, 191, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3946, d3h6fH_, 0.8209, 2.55, 0.227, 212, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
3947, p5vfuPA_, 0.8208, 2.10, 0.179, 199, 196, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3948, p5vftq_, 0.8208, 2.10, 0.179, 199, 196, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3949, d3h6iH_, 0.8208, 2.54, 0.227, 212, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
3950, p4qz5a_, 0.8206, 1.98, 0.186, 215, 194, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
3951, p5t0iP_, 0.8205, 2.08, 0.211, 204, 194, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3952, p5vfrt_, 0.8203, 1.86, 0.250, 205, 192, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3953, p5vfqK_, 0.8203, 2.04, 0.179, 199, 196, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3954, p3unez_, 0.8203, 1.89, 0.187, 196, 193, MOUSE CONSTITUTIVE 20S PROTEASOME
3955, p5vfrq_, 0.8201, 2.05, 0.179, 199, 196, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3956, p5mpcJ_, 0.8199, 2.06, 0.196, 204, 194, 
3957, p5mpaj_, 0.8199, 2.05, 0.196, 204, 194, 26S PROTEASOME IN PRESENCE OF ATP (S2)
3958, p5fmgM_, 0.8198, 1.72, 0.190, 199, 189, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
3959, p5fmga_, 0.8198, 1.72, 0.190, 199, 189, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
3960, p5a5bG_, 0.8198, 2.78, 0.146, 245, 199, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
3961, p4cr3G_, 0.8198, 2.78, 0.146, 245, 199, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3962, p5t0hN_, 0.8197, 1.81, 0.277, 191, 191, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3963, p3unhX_, 0.8195, 1.89, 0.187, 196, 193, MOUSE 20S IMMUNOPROTEASOME
3964, p3unhJ_, 0.8195, 1.89, 0.187, 196, 193, MOUSE 20S IMMUNOPROTEASOME
3965, p5gjqn_, 0.8194, 2.69, 0.135, 243, 200, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
3966, p5ln36_, 0.8193, 2.22, 0.200, 213, 195, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
3967, p5gjqX_, 0.8193, 2.74, 0.135, 243, 200, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
3968, p3jcoI_, 0.8193, 2.07, 0.184, 217, 196, 
3969, p3jcoB_, 0.8193, 2.07, 0.184, 217, 196, 
3970, d4r3oU_, 0.8192, 2.74, 0.130, 245, 200, HUMAN CONSTITUTIVE 20S PROTEASOME
3971, p5vfsK_, 0.8191, 2.13, 0.179, 199, 196, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3972, d3unfX_, 0.8190, 1.90, 0.187, 196, 193, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
3973, d3unfJ_, 0.8190, 1.90, 0.187, 196, 193, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
3974, d4r3oG_, 0.8189, 2.74, 0.135, 245, 200, HUMAN CONSTITUTIVE 20S PROTEASOME
3975, p5vfsJA_, 0.8188, 2.14, 0.179, 199, 196, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3976, p3uneJ_, 0.8186, 1.91, 0.187, 196, 193, MOUSE CONSTITUTIVE 20S PROTEASOME
3977, p3uneX_, 0.8185, 1.92, 0.187, 196, 193, MOUSE CONSTITUTIVE 20S PROTEASOME
3978, p5gjrY_, 0.8183, 2.72, 0.130, 243, 200, 
3979, p5gjrMA_, 0.8183, 2.62, 0.131, 243, 199, 
3980, p5t0hS_, 0.8181, 2.08, 0.201, 213, 194, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3981, p5t0hP_, 0.8181, 2.10, 0.206, 204, 194, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3982, p5wviKA_, 0.8180, 2.08, 0.179, 217, 196, 
3983, p5nywM_, 0.8180, 3.02, 0.179, 222, 207, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
3984, p5fmgX_, 0.8177, 1.73, 0.201, 191, 189, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
3985, p5fmgJ_, 0.8177, 1.73, 0.201, 191, 189, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
3986, p5wvkG_, 0.8176, 2.10, 0.179, 217, 196, 
3987, p3unel_, 0.8176, 1.92, 0.187, 196, 193, MOUSE CONSTITUTIVE 20S PROTEASOME
3988, p5nyw1_, 0.8174, 3.01, 0.179, 223, 207, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
3989, d5le5J_, 0.8173, 1.95, 0.181, 195, 193, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
3990, p4y8pM_, 0.8173, 1.97, 0.187, 214, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
3991, p5nywX_, 0.8172, 3.01, 0.179, 225, 207, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
3992, p4y8pa_, 0.8172, 1.97, 0.187, 214, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
3993, p3unbl_, 0.8172, 1.93, 0.187, 196, 193, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3994, d5le5X_, 0.8171, 1.95, 0.181, 195, 193, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
3995, d3unbJ_, 0.8170, 1.93, 0.187, 196, 193, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3996, p5t0jS_, 0.8169, 2.09, 0.201, 213, 194, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3997, p4y75M_, 0.8169, 1.98, 0.187, 214, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
3998, p4y75a_, 0.8169, 1.98, 0.187, 214, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
3999, d4r67G_, 0.8169, 2.76, 0.135, 245, 200, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
4000, d3unbX_, 0.8169, 1.93, 0.187, 196, 193, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
4001, p5nywB_, 0.8168, 3.03, 0.179, 222, 207, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
4002, p5lf0X_, 0.8168, 1.95, 0.181, 195, 193, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
4003, p4r67i_, 0.8168, 2.66, 0.136, 245, 199, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
4004, p5mpbBA_, 0.8167, 2.16, 0.188, 218, 197, 
4005, p5lf0J_, 0.8167, 1.95, 0.181, 195, 193, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
4006, d5lexX_, 0.8167, 1.95, 0.181, 195, 193, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
4007, d5lexJ_, 0.8167, 1.96, 0.181, 195, 193, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
4008, p4y77M_, 0.8167, 1.98, 0.187, 214, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
4009, d5lf1J_, 0.8166, 1.96, 0.181, 195, 193, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
4010, p5leyX_, 0.8166, 1.95, 0.181, 195, 193, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
4011, p3unbz_, 0.8166, 1.94, 0.187, 196, 193, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
4012, d5lf7X_, 0.8165, 1.96, 0.181, 195, 193, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
4013, d5lf7J_, 0.8165, 1.96, 0.181, 195, 193, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
4014, d5lf1X_, 0.8165, 1.96, 0.181, 195, 193, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
4015, p4r67w_, 0.8165, 2.66, 0.136, 245, 199, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
4016, d4r67U_, 0.8165, 2.66, 0.136, 245, 199, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
4017, d5lf4J_, 0.8163, 1.96, 0.181, 195, 193, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
4018, d5lf3X_, 0.8163, 1.96, 0.181, 195, 193, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
4019, p4y8nM_, 0.8163, 1.99, 0.187, 214, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
4020, d5lf4X_, 0.8162, 1.96, 0.181, 195, 193, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
4021, p5leyJ_, 0.8162, 1.96, 0.181, 195, 193, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
4022, p4cr47_, 0.8162, 2.27, 0.186, 220, 199, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4023, p5nywQ_, 0.8161, 3.00, 0.179, 227, 207, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
4024, d5lf3J_, 0.8161, 1.96, 0.181, 195, 193, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
4025, p5l4gG_, 0.8161, 2.82, 0.130, 242, 200, 
4026, p5a5b6_, 0.8161, 2.06, 0.196, 222, 194, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
4027, p4cr36_, 0.8161, 2.06, 0.196, 222, 194, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4028, p5nywZ_, 0.8160, 3.01, 0.179, 225, 207, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
4029, p5lezJ_, 0.8160, 1.96, 0.181, 195, 193, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
4030, p5m32J_, 0.8159, 1.94, 0.187, 196, 193, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
4031, p4v7oUA_, 0.8159, 1.96, 0.196, 199, 189, 
4032, p5lf6J_, 0.8158, 1.96, 0.181, 195, 193, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
4033, p5lezX_, 0.8158, 1.96, 0.181, 195, 193, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
4034, d4cr2G_, 0.8158, 2.79, 0.146, 245, 199, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4035, p5m32X_, 0.8157, 1.94, 0.187, 196, 193, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
4036, d4cr23_, 0.8157, 2.03, 0.197, 204, 193, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4037, p5nywJ_, 0.8156, 3.03, 0.179, 224, 207, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
4038, p5nywC_, 0.8156, 3.03, 0.179, 225, 207, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
4039, p5lf6X_, 0.8156, 1.96, 0.181, 195, 193, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
4040, p5wviPA_, 0.8155, 2.11, 0.179, 217, 196, 
4041, p5nywU_, 0.8154, 3.02, 0.179, 224, 207, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
4042, p5nywG_, 0.8154, 3.05, 0.179, 223, 207, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
4043, p5l4gU_, 0.8153, 2.77, 0.130, 241, 200, 
4044, p6epe1_, 0.8152, 2.38, 0.080, 202, 201, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
4045, p5nywD_, 0.8152, 3.03, 0.179, 223, 207, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
4046, p5t0cIB_, 0.8150, 2.17, 0.179, 199, 196, 
4047, p5t0cCA_, 0.8150, 2.17, 0.179, 199, 196, 
4048, p5nywL_, 0.8150, 3.02, 0.179, 227, 207, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
4049, p5nywS_, 0.8148, 3.04, 0.184, 224, 207, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
4050, p5nywF_, 0.8148, 3.05, 0.179, 223, 207, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
4051, d5lf3F_, 0.8146, 2.73, 0.131, 239, 199, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
4052, p5leyF_, 0.8145, 2.73, 0.131, 239, 199, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
4053, p5t0cLB_, 0.8144, 1.92, 0.250, 205, 192, 
4054, p5t0cFA_, 0.8144, 1.92, 0.250, 205, 192, 
4055, p5nywV_, 0.8144, 3.03, 0.179, 224, 207, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
4056, p5nywT_, 0.8144, 3.04, 0.179, 224, 207, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
4057, d5lf7F_, 0.8144, 2.74, 0.131, 239, 199, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
4058, p5mpbJ_, 0.8143, 2.12, 0.196, 204, 194, 
4059, p5lf6F_, 0.8143, 2.74, 0.131, 239, 199, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
4060, d5lf1F_, 0.8143, 2.74, 0.131, 239, 199, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
4061, p5lf0F_, 0.8143, 2.74, 0.131, 239, 199, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
4062, d5lexT_, 0.8142, 2.73, 0.131, 240, 199, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
4063, d5le5F_, 0.8142, 2.73, 0.131, 239, 199, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
4064, d5lf4F_, 0.8140, 2.74, 0.131, 239, 199, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
4065, d5lexF_, 0.8140, 2.74, 0.131, 239, 199, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
4066, d3sdkX_, 0.8140, 2.02, 0.227, 198, 194, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
4067, p5nywR_, 0.8139, 3.07, 0.184, 226, 207, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
4068, d3mg8X_, 0.8139, 2.03, 0.227, 198, 194, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
4069, p3unhT_, 0.8138, 2.76, 0.136, 244, 199, MOUSE 20S IMMUNOPROTEASOME
4070, p3unhF_, 0.8138, 2.76, 0.136, 244, 199, MOUSE 20S IMMUNOPROTEASOME
4071, d3sdkJ_, 0.8138, 2.05, 0.227, 198, 194, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
4072, p4cr4E_, 0.8136, 3.03, 0.207, 243, 203, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4073, d3mg7X_, 0.8135, 2.03, 0.227, 198, 194, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
4074, d3mg7J_, 0.8135, 2.06, 0.227, 198, 194, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
4075, p5vfuLA_, 0.8134, 2.88, 0.140, 240, 200, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4076, p5vftm_, 0.8134, 2.88, 0.140, 240, 200, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4077, d3unfT_, 0.8134, 2.76, 0.131, 244, 199, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
4078, d3unfF_, 0.8134, 2.76, 0.131, 244, 199, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
4079, p3unbh_, 0.8134, 2.65, 0.131, 244, 198, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
4080, d3oevJ_, 0.8134, 2.05, 0.227, 198, 194, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
4081, d1iruU_, 0.8134, 2.78, 0.135, 245, 200, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
4082, d1iruG_, 0.8134, 2.78, 0.135, 245, 200, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
4083, d4ltcJ_, 0.8133, 2.07, 0.227, 198, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
4084, d4intX_, 0.8133, 2.08, 0.227, 198, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
4085, p4cr43_, 0.8133, 2.05, 0.202, 204, 193, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4086, p3uneT_, 0.8133, 2.76, 0.136, 244, 199, MOUSE CONSTITUTIVE 20S PROTEASOME
4087, d3mg6X_, 0.8133, 2.03, 0.227, 198, 194, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
4088, p5m32T_, 0.8132, 2.87, 0.130, 240, 200, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
4089, d4jsqX_, 0.8132, 2.08, 0.227, 198, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
4090, d4jsqJ_, 0.8132, 2.08, 0.227, 198, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
4091, d4intJ_, 0.8132, 2.08, 0.227, 198, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
4092, p5lf6T_, 0.8131, 2.75, 0.131, 240, 199, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
4093, d5lf1T_, 0.8131, 2.75, 0.131, 240, 199, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
4094, p5lezT_, 0.8131, 2.75, 0.131, 240, 199, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
4095, p5lezF_, 0.8131, 2.75, 0.131, 239, 199, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
4096, d5lf3T_, 0.8130, 2.76, 0.131, 240, 199, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
4097, p5lf0T_, 0.8130, 2.76, 0.131, 240, 199, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
4098, d3mg8J_, 0.8130, 2.07, 0.227, 198, 194, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
4099, d5lf7T_, 0.8129, 2.76, 0.131, 240, 199, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
4100, p5leyT_, 0.8129, 2.75, 0.131, 240, 199, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
4101, d3oeuX_, 0.8129, 2.04, 0.227, 198, 194, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
4102, d5lf4T_, 0.8128, 2.75, 0.131, 240, 199, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
4103, d3mg6J_, 0.8128, 2.07, 0.227, 198, 194, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
4104, d4ltcX_, 0.8127, 2.07, 0.227, 198, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
4105, p4gk7J_, 0.8127, 2.08, 0.227, 198, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
4106, d4fzgJ_, 0.8127, 2.08, 0.227, 198, 194, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
4107, p3unbv_, 0.8127, 2.77, 0.131, 244, 199, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
4108, p4gk7X_, 0.8126, 2.08, 0.227, 198, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
4109, d4fzgX_, 0.8126, 2.08, 0.227, 198, 194, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
4110, d3unbF_, 0.8126, 2.67, 0.131, 244, 198, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
4111, d3un8X_, 0.8126, 2.08, 0.227, 198, 194, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
4112, p5nygB_, 0.8125, 2.66, 0.174, 216, 201, ANBU (GLY-1) MUTANT FROM HYPHOMICROBIUM SP. STRAIN MC1 - SG P2(1)2(1) 2(1)
4113, p5nygA_, 0.8125, 2.76, 0.173, 220, 202, ANBU (GLY-1) MUTANT FROM HYPHOMICROBIUM SP. STRAIN MC1 - SG P2(1)2(1) 2(1)
4114, d4jsuJ_, 0.8125, 2.09, 0.227, 198, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
4115, d4inuJ_, 0.8125, 2.09, 0.227, 198, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
4116, d3unbT_, 0.8125, 2.77, 0.136, 244, 199, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
4117, d3un8J_, 0.8125, 2.09, 0.227, 198, 194, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
4118, d3okjJ_, 0.8125, 2.09, 0.227, 198, 194, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
4119, d1rypY_, 0.8125, 2.09, 0.227, 198, 194, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
4120, d5le5T_, 0.8124, 2.75, 0.131, 240, 199, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
4121, d4jsuX_, 0.8124, 2.09, 0.227, 198, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
4122, d4inrJ_, 0.8124, 2.09, 0.227, 198, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
4123, d3wxrY_, 0.8124, 2.09, 0.227, 198, 194, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
4124, d3tddX_, 0.8124, 2.09, 0.227, 198, 194, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
4125, d3tddJ_, 0.8124, 2.09, 0.227, 198, 194, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
4126, p3uneh_, 0.8123, 2.77, 0.131, 244, 199, MOUSE CONSTITUTIVE 20S PROTEASOME
4127, d3okjX_, 0.8123, 2.09, 0.227, 198, 194, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
4128, d3mg4J_, 0.8123, 2.08, 0.227, 198, 194, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
4129, d4lqiX_, 0.8121, 2.09, 0.227, 198, 194, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
4130, d4lqiJ_, 0.8121, 2.09, 0.227, 198, 194, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
4131, d4jt0X_, 0.8121, 2.09, 0.227, 198, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
4132, d4jt0J_, 0.8121, 2.09, 0.227, 198, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
4133, d4inrX_, 0.8121, 2.09, 0.227, 198, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
4134, p3unev_, 0.8121, 2.77, 0.131, 244, 199, MOUSE CONSTITUTIVE 20S PROTEASOME
4135, p3uneF_, 0.8121, 2.67, 0.136, 244, 198, MOUSE CONSTITUTIVE 20S PROTEASOME
4136, p3un4J_, 0.8121, 2.09, 0.227, 198, 194, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
4137, d3oevX_, 0.8121, 2.05, 0.227, 197, 194, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
4138, d3oeuJ_, 0.8121, 2.08, 0.227, 198, 194, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
4139, d3nzxJ_, 0.8121, 2.09, 0.227, 198, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
4140, d3gpjX_, 0.8121, 2.09, 0.227, 198, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
4141, d3gpjJ_, 0.8121, 2.09, 0.227, 198, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
4142, p5vfoM_, 0.8120, 2.76, 0.145, 240, 200, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4143, p5nygC_, 0.8120, 2.67, 0.174, 216, 201, ANBU (GLY-1) MUTANT FROM HYPHOMICROBIUM SP. STRAIN MC1 - SG P2(1)2(1) 2(1)
4144, d4q1sX_, 0.8120, 2.08, 0.227, 198, 194, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
4145, p3un4X_, 0.8120, 2.09, 0.227, 198, 194, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
4146, d3nzxX_, 0.8120, 2.09, 0.227, 198, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
4147, d3mg0X_, 0.8120, 2.09, 0.227, 198, 194, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
4148, d1rypK_, 0.8120, 2.09, 0.227, 198, 194, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
4149, d3nzwX_, 0.8119, 2.09, 0.227, 198, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
4150, d3nzwJ_, 0.8119, 2.09, 0.227, 198, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
4151, p6avoQ_, 0.8118, 2.74, 0.131, 239, 199, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
4152, p6avoJ_, 0.8118, 2.74, 0.131, 239, 199, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
4153, d4inuX_, 0.8118, 2.10, 0.227, 198, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
4154, d2gplX_, 0.8118, 2.10, 0.227, 198, 194, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
4155, p5vfpG_, 0.8117, 2.76, 0.145, 240, 200, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4156, d4hrdX_, 0.8117, 2.09, 0.227, 198, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
4157, d4hrcX_, 0.8117, 2.08, 0.227, 198, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
4158, p4cr4G_, 0.8117, 2.76, 0.146, 245, 198, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4159, d3nzjX_, 0.8117, 2.09, 0.227, 198, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
4160, d3nzjJ_, 0.8117, 2.09, 0.227, 198, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
4161, d3gptX_, 0.8117, 2.10, 0.227, 198, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
4162, d3gptJ_, 0.8117, 2.10, 0.227, 198, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
4163, d3bdmJ_, 0.8117, 2.10, 0.227, 198, 194, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
4164, d2gplJ_, 0.8117, 2.10, 0.227, 198, 194, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
4165, d1jd2Q_, 0.8117, 2.08, 0.227, 198, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
4166, d1jd2J_, 0.8117, 2.08, 0.227, 198, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
4167, d4hrdJ_, 0.8116, 2.10, 0.227, 198, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
4168, d4hnpJ_, 0.8116, 2.08, 0.227, 198, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
4169, d3mg0J_, 0.8116, 2.09, 0.227, 198, 194, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
4170, d3bdmX_, 0.8116, 2.10, 0.227, 198, 194, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
4171, d2fakX_, 0.8116, 2.10, 0.227, 198, 194, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
4172, d2fakJ_, 0.8116, 2.10, 0.227, 198, 194, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
4173, d2f16X_, 0.8116, 2.10, 0.227, 198, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
4174, d2f16J_, 0.8116, 2.10, 0.227, 198, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
4175, p5t0gT_, 0.8115, 1.96, 0.250, 205, 192, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4176, d4fzcJ_, 0.8115, 2.10, 0.227, 198, 194, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
4177, d3sdiX_, 0.8115, 2.09, 0.227, 198, 194, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
4178, d3hyeX_, 0.8115, 2.10, 0.227, 198, 194, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
4179, d3hyeJ_, 0.8115, 2.10, 0.227, 198, 194, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
4180, d4q1sJ_, 0.8114, 2.11, 0.227, 198, 194, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
4181, d4hnpX_, 0.8114, 2.08, 0.227, 198, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
4182, d4fzcX_, 0.8114, 2.10, 0.227, 198, 194, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
4183, d3gpwX_, 0.8114, 2.10, 0.227, 198, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
4184, d3d29J_, 0.8114, 2.10, 0.227, 198, 194, PROTEASOME INHIBITION BY FELLUTAMIDE B
4185, p5vfrM_, 0.8113, 2.74, 0.145, 240, 200, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4186, d3wxrK_, 0.8113, 2.10, 0.227, 197, 194, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
4187, d3gpwJ_, 0.8113, 2.10, 0.227, 198, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
4188, d3d29X_, 0.8113, 2.10, 0.227, 198, 194, PROTEASOME INHIBITION BY FELLUTAMIDE B
4189, d4hrcJ_, 0.8112, 2.09, 0.227, 198, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
4190, d3shjJ_, 0.8112, 2.10, 0.227, 198, 194, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
4191, p6epe5_, 0.8111, 2.35, 0.085, 201, 199, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
4192, d3shjX_, 0.8111, 2.10, 0.227, 198, 194, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
4193, d3e47X_, 0.8110, 2.12, 0.227, 198, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
4194, d3e47J_, 0.8110, 2.12, 0.227, 198, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
4195, p5nygH_, 0.8109, 2.71, 0.174, 216, 201, ANBU (GLY-1) MUTANT FROM HYPHOMICROBIUM SP. STRAIN MC1 - SG P2(1)2(1) 2(1)
4196, p5dsvF_, 0.8109, 2.66, 0.136, 244, 198, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
4197, p5vfuX_, 0.8108, 2.69, 0.141, 240, 198, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4198, p5vftM_, 0.8108, 2.69, 0.141, 240, 198, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4199, d2fnyX_, 0.8108, 2.12, 0.227, 198, 194,  
4200, d2fnyJ_, 0.8108, 2.12, 0.227, 198, 194,  
4201, d1g65J_, 0.8108, 2.11, 0.227, 198, 194, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
4202, p5dsvL_, 0.8107, 2.66, 0.136, 245, 198, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
4203, d3sdiJ_, 0.8107, 2.11, 0.227, 198, 194, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
4204, p5vfqG_, 0.8106, 2.77, 0.145, 240, 200, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4205, p5nygD_, 0.8106, 2.69, 0.174, 216, 201, ANBU (GLY-1) MUTANT FROM HYPHOMICROBIUM SP. STRAIN MC1 - SG P2(1)2(1) 2(1)
4206, p5dsvB_, 0.8106, 2.66, 0.136, 245, 198, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
4207, p5vfsG_, 0.8104, 2.82, 0.140, 240, 200, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4208, d4j70J_, 0.8104, 2.11, 0.227, 198, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
4209, p5vfqFA_, 0.8103, 2.77, 0.145, 240, 200, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4210, d4j70X_, 0.8103, 2.11, 0.227, 198, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
4211, d1g65X_, 0.8103, 2.12, 0.227, 198, 194, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
4212, d1g0uR_, 0.8103, 2.98, 0.204, 230, 201, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
4213, d1g0uJ_, 0.8103, 2.13, 0.227, 198, 194, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
4214, p5vfom_, 0.8102, 2.78, 0.145, 240, 200, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4215, p5dsvA_, 0.8101, 2.66, 0.136, 244, 198, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
4216, d3mg8R_, 0.8101, 2.87, 0.205, 242, 200, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
4217, p5nygE_, 0.8100, 2.72, 0.174, 215, 201, ANBU (GLY-1) MUTANT FROM HYPHOMICROBIUM SP. STRAIN MC1 - SG P2(1)2(1) 2(1)
4218, p5dsvN_, 0.8100, 2.67, 0.136, 244, 198, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
4219, d3mg7R_, 0.8100, 2.87, 0.205, 242, 200, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
4220, d3mg7D_, 0.8100, 2.96, 0.204, 242, 201, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
4221, d3dy3X_, 0.8100, 2.12, 0.227, 198, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
4222, d2zcyX_, 0.8100, 2.11, 0.227, 198, 194, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
4223, d2zcyJ_, 0.8100, 2.11, 0.227, 198, 194, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
4224, d3oevR_, 0.8099, 2.92, 0.205, 242, 200, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
4225, d3mg6R_, 0.8099, 2.86, 0.205, 242, 200, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
4226, d3dy3J_, 0.8099, 2.12, 0.227, 198, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
4227, d3dy4J_, 0.8098, 2.12, 0.227, 198, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
4228, p5vfsFA_, 0.8097, 2.83, 0.140, 240, 200, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4229, p5t0iT_, 0.8097, 1.98, 0.250, 205, 192, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4230, p5mpcU_, 0.8097, 2.77, 0.146, 243, 198, 
4231, p5dsvE_, 0.8097, 2.67, 0.136, 245, 198, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
4232, d3mg4X_, 0.8097, 2.10, 0.227, 198, 194, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
4233, d3dy4X_, 0.8097, 2.12, 0.227, 198, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
4234, p5dsvD_, 0.8096, 2.67, 0.136, 244, 198, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
4235, d1g0uX_, 0.8096, 2.15, 0.227, 198, 194, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
4236, d1g0uD_, 0.8096, 3.00, 0.204, 230, 201, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
4237, d3sdkR_, 0.8095, 2.87, 0.205, 232, 200, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
4238, p5dsvG_, 0.8094, 2.67, 0.136, 242, 198, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
4239, p4v7oY_, 0.8093, 2.13, 0.227, 198, 194, 
4240, p4v7oK_, 0.8093, 2.13, 0.227, 198, 194, 
4241, p4v7oGB_, 0.8093, 2.13, 0.227, 198, 194, 
4242, d3oeuR_, 0.8093, 2.95, 0.204, 236, 201, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
4243, d3l5qO_, 0.8093, 2.13, 0.227, 198, 194,  
4244, d3l5q1_, 0.8093, 2.13, 0.227, 198, 194,  
4245, d1vsyY_, 0.8093, 2.13, 0.227, 198, 194,  
4246, p5mp9G_, 0.8092, 2.78, 0.146, 243, 198, 26S PROTEASOME IN PRESENCE OF ATP (S1)
4247, p4v7oSA_, 0.8092, 2.13, 0.227, 198, 194, 
4248, p3jcpTA_, 0.8092, 2.11, 0.227, 198, 194, 
4249, p3jcpF_, 0.8092, 2.11, 0.227, 198, 194, 
4250, d1vsyK_, 0.8092, 2.13, 0.227, 198, 194,  
4251, d3mg4R_, 0.8089, 2.88, 0.205, 242, 200, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
4252, p5mpaG_, 0.8088, 2.77, 0.146, 243, 198, 26S PROTEASOME IN PRESENCE OF ATP (S2)
4253, d3sdiR_, 0.8088, 2.96, 0.205, 229, 200, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
4254, p1fntK_, 0.8088, 2.15, 0.227, 198, 194, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
4255, d1z7qY1, 0.8087, 2.17, 0.227, 197, 194, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
4256, d1z7qK1, 0.8087, 2.17, 0.227, 197, 194, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
4257, p1fntY_, 0.8087, 2.15, 0.227, 198, 194, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
4258, p5vfrm_, 0.8086, 2.79, 0.145, 240, 200, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4259, p5vfpEA_, 0.8086, 2.79, 0.145, 240, 200, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4260, p5t0gQ_, 0.8086, 2.24, 0.179, 199, 196, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4261, d2f16R_, 0.8085, 3.01, 0.204, 242, 201, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
4262, d2f16D_, 0.8084, 3.01, 0.204, 242, 201, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
4263, d3mg8D_, 0.8083, 2.91, 0.205, 242, 200, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
4264, p5t0cY_, 0.8082, 2.75, 0.146, 240, 199, 
4265, p5t0cEB_, 0.8082, 2.75, 0.146, 240, 199, 
4266, p5wvkK_, 0.8081, 2.19, 0.227, 198, 194, 
4267, p5mp9g_, 0.8081, 2.81, 0.146, 243, 198, 26S PROTEASOME IN PRESENCE OF ATP (S1)
4268, d3oevD_, 0.8081, 2.96, 0.205, 242, 200, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
4269, d3oeuD_, 0.8081, 2.96, 0.205, 242, 200, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
4270, d2gplR_, 0.8081, 3.02, 0.204, 242, 201, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
4271, d2gplD_, 0.8081, 3.02, 0.204, 242, 201, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
4272, p4x6zY_, 0.8080, 1.98, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
4273, d3tddR_, 0.8080, 3.02, 0.204, 242, 201, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
4274, d3tddD_, 0.8080, 3.02, 0.204, 242, 201, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
4275, d3shjR_, 0.8080, 2.97, 0.204, 242, 201, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
4276, d3shjD_, 0.8080, 2.97, 0.204, 242, 201, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
4277, d2fakR_, 0.8080, 3.02, 0.204, 242, 201, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
4278, d2fakD_, 0.8080, 3.02, 0.204, 242, 201, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
4279, d1z7qS1, 0.8080, 2.92, 0.206, 242, 199, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
4280, p5mpag_, 0.8079, 2.82, 0.146, 243, 198, 26S PROTEASOME IN PRESENCE OF ATP (S2)
4281, d3okjR_, 0.8079, 2.96, 0.204, 242, 201, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
4282, d3okjD_, 0.8079, 2.96, 0.204, 242, 201, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
4283, d1z7qE1, 0.8079, 2.92, 0.206, 242, 199, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
4284, p5nifY_, 0.8078, 2.00, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
4285, p4zzgY_, 0.8078, 2.00, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
4286, d4eu2K_, 0.8077, 2.00, 0.229, 196, 192, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
4287, d3mg4D_, 0.8076, 2.97, 0.205, 242, 200, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
4288, p5dsvK_, 0.8075, 2.66, 0.137, 244, 197, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
4289, p4inuR_, 0.8075, 3.04, 0.204, 242, 201, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
4290, d4hnpF_, 0.8075, 2.77, 0.152, 244, 197, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
4291, d4qlvR_, 0.8074, 2.95, 0.205, 235, 200, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
4292, d4qlvD_, 0.8074, 2.95, 0.205, 235, 200, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
4293, d4qlsR_, 0.8074, 2.95, 0.205, 235, 200, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
4294, d4qlsD_, 0.8074, 2.95, 0.205, 235, 200, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
4295, d3gptR_, 0.8074, 3.03, 0.204, 242, 201, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
4296, d1rypS_, 0.8074, 2.94, 0.205, 242, 200, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
4297, d4eu2G_, 0.8073, 2.80, 0.146, 244, 198, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
4298, d3gptD_, 0.8073, 3.03, 0.204, 242, 201, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
4299, p3e47R_, 0.8073, 3.03, 0.204, 242, 201, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
4300, p5dsvI_, 0.8072, 2.66, 0.137, 244, 197, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
4301, p5cgiR_, 0.8072, 2.90, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
4302, p5cgiD_, 0.8072, 2.90, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
4303, p4zzgD_, 0.8072, 2.97, 0.175, 241, 200, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
4304, p4inuD_, 0.8072, 3.05, 0.204, 242, 201, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
4305, d3mg6D_, 0.8072, 2.96, 0.205, 242, 200, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
4306, p3e47D_, 0.8072, 3.03, 0.204, 242, 201, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
4307, d1rypE_, 0.8072, 2.95, 0.205, 242, 200, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
4308, d5fggX_, 0.8071, 1.94, 0.230, 195, 191, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4309, d5fggJ_, 0.8071, 1.94, 0.230, 195, 191, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4310, d4r02R_, 0.8071, 2.96, 0.205, 235, 200, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
4311, d4qz7R_, 0.8071, 2.95, 0.205, 235, 200, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4312, d4qz7D_, 0.8071, 2.95, 0.205, 235, 200, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4313, d4no8R_, 0.8071, 2.90, 0.205, 235, 200, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
4314, d4no8D_, 0.8071, 2.90, 0.205, 235, 200, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
4315, p5mpcG_, 0.8070, 2.79, 0.146, 243, 198, 
4316, p4x6zK_, 0.8070, 2.00, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
4317, d2zcyQ_, 0.8070, 2.94, 0.175, 241, 200, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
4318, d2zcyC_, 0.8070, 2.94, 0.175, 241, 200, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
4319, d5lajR_, 0.8069, 2.89, 0.205, 235, 200, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
4320, d5cgfR_, 0.8069, 2.90, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-G48C MUTANT
4321, d3bdmQ_, 0.8069, 2.95, 0.180, 241, 200, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
4322, d3bdmC_, 0.8069, 2.95, 0.180, 241, 200, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
4323, p5nifD_, 0.8068, 2.98, 0.175, 241, 200, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
4324, d5d0zR_, 0.8068, 2.90, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
4325, d5d0zD_, 0.8068, 2.90, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
4326, d5d0sR_, 0.8068, 2.90, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
4327, d5d0sD_, 0.8068, 2.90, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
4328, p4ya7R_, 0.8068, 2.90, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
4329, p4ya2R_, 0.8068, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
4330, p4ya2D_, 0.8068, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
4331, p4y9zR_, 0.8068, 2.90, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
4332, d4qzxR_, 0.8068, 2.90, 0.205, 235, 200, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4333, d4qzxD_, 0.8068, 2.91, 0.205, 235, 200, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4334, d4qz3R_, 0.8068, 2.90, 0.205, 235, 200, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4335, d4qz3D_, 0.8068, 2.90, 0.205, 235, 200, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4336, p4qw5R_, 0.8068, 2.90, 0.205, 235, 200, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
4337, d4hrdR_, 0.8068, 2.94, 0.205, 242, 200, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
4338, d3nzwR_, 0.8068, 2.95, 0.205, 242, 200, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
4339, d3mg0R_, 0.8068, 2.96, 0.205, 242, 200, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
4340, p5wviGA_, 0.8067, 2.24, 0.196, 204, 194, 
4341, p5nifK_, 0.8067, 2.02, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
4342, d5jhsR_, 0.8067, 2.90, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
4343, d5jhsD_, 0.8067, 2.90, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
4344, d5jhrD_, 0.8067, 2.90, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
4345, d5fgfR_, 0.8067, 2.90, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
4346, p4zzgK_, 0.8067, 2.02, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
4347, p4ya7D_, 0.8067, 2.90, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
4348, p4y8jR_, 0.8067, 2.90, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
4349, p4y70R_, 0.8067, 2.90, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
4350, d4r17R_, 0.8067, 2.96, 0.205, 235, 200, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
4351, d4r17D_, 0.8067, 2.96, 0.205, 235, 200, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
4352, d4qz5R_, 0.8067, 2.88, 0.205, 235, 200, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
4353, d4qxjR_, 0.8067, 2.91, 0.205, 235, 200, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4354, d4qxjD_, 0.8067, 2.91, 0.205, 235, 200, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4355, p4qbyR_, 0.8067, 2.95, 0.205, 235, 200, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
4356, p4qbyD_, 0.8067, 2.95, 0.205, 235, 200, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
4357, d4no9T_, 0.8067, 2.80, 0.146, 243, 198, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
4358, d4no9F_, 0.8067, 2.80, 0.146, 243, 198, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
4359, p4no6R_, 0.8067, 2.90, 0.205, 235, 200, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
4360, p4no6D_, 0.8067, 2.90, 0.205, 235, 200, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
4361, d3wxrS_, 0.8067, 2.88, 0.205, 238, 200, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
4362, d3nzwD_, 0.8067, 2.95, 0.205, 242, 200, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
4363, d3gpwR_, 0.8067, 2.95, 0.205, 242, 200, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
4364, p6epd5_, 0.8066, 2.30, 0.081, 201, 198, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
4365, d5lajD_, 0.8066, 2.96, 0.205, 235, 200, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
4366, d5l6bR_, 0.8066, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
4367, d5l6bD_, 0.8066, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
4368, d5jhrR_, 0.8066, 2.90, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
4369, p5gjqm_, 0.8066, 2.97, 0.141, 238, 198, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
4370, d5bxnX_, 0.8066, 1.95, 0.230, 195, 191, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
4371, d5bxnJ_, 0.8066, 1.95, 0.230, 195, 191, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
4372, p4y7wR_, 0.8066, 2.90, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
4373, p4y7wD_, 0.8066, 2.90, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
4374, p4y70D_, 0.8066, 2.90, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
4375, d4r18R_, 0.8066, 2.96, 0.205, 235, 200, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
4376, d4r18D_, 0.8066, 2.96, 0.205, 235, 200, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
4377, d4qz5D_, 0.8066, 2.88, 0.205, 235, 200, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
4378, p4qz0R_, 0.8066, 2.96, 0.205, 235, 200, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4379, p4qz0D_, 0.8066, 2.96, 0.205, 235, 200, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4380, d4qw7D_, 0.8066, 2.90, 0.205, 235, 200, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
4381, d4qv9R_, 0.8066, 2.90, 0.205, 235, 200, YCP BETA5-C63F MUTANT
4382, d4qv9D_, 0.8066, 2.90, 0.205, 235, 200, YCP BETA5-C63F MUTANT
4383, d4qltR_, 0.8066, 2.96, 0.205, 235, 200, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
4384, d4qltD_, 0.8066, 2.96, 0.205, 235, 200, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
4385, p4fzgR_, 0.8066, 2.97, 0.205, 242, 200, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
4386, p4fzgD_, 0.8066, 2.97, 0.205, 242, 200, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
4387, d3gpwD_, 0.8066, 2.95, 0.205, 242, 200, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
4388, p5wviE_, 0.8065, 2.24, 0.196, 204, 194, 
4389, d5l65R_, 0.8065, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
4390, d5l65D_, 0.8065, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
4391, d5l63X_, 0.8065, 1.95, 0.230, 195, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4392, d5l63J_, 0.8065, 1.95, 0.230, 195, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4393, d5l55R_, 0.8065, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4394, d5l55D_, 0.8065, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4395, d5l54R_, 0.8065, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4396, d5l54D_, 0.8065, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4397, d5l52R_, 0.8065, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4398, d5l52D_, 0.8065, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4399, d5ahjX_, 0.8065, 1.95, 0.230, 195, 191, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
4400, d5ahjJ_, 0.8065, 1.95, 0.230, 195, 191, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
4401, d4ya4X_, 0.8065, 1.95, 0.230, 195, 191, YEAST 20S PROTEASOME BETA2-H114D MUTANT
4402, d4ya4J_, 0.8065, 1.95, 0.230, 195, 191, YEAST 20S PROTEASOME BETA2-H114D MUTANT
4403, p4y8lD_, 0.8065, 2.91, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
4404, p4y7yR_, 0.8065, 2.88, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
4405, p4y7yD_, 0.8065, 2.89, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
4406, p4v7oG_, 0.8065, 2.77, 0.146, 244, 198, 
4407, p4qz4R_, 0.8065, 2.96, 0.205, 235, 200, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4408, p4qz4D_, 0.8065, 2.96, 0.205, 235, 200, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4409, d4qwxR_, 0.8065, 2.96, 0.205, 235, 200, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4410, d4qwxD_, 0.8065, 2.96, 0.205, 235, 200, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4411, d4qwiR_, 0.8065, 2.89, 0.205, 235, 200, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
4412, d4qwiD_, 0.8065, 2.89, 0.205, 235, 200, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
4413, d4qw7R_, 0.8065, 2.90, 0.205, 235, 200, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
4414, d4qw1R_, 0.8065, 2.97, 0.205, 235, 200, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
4415, d4qw1D_, 0.8065, 2.97, 0.205, 235, 200, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
4416, d4qvnX_, 0.8065, 1.95, 0.230, 195, 191, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
4417, d4qvnJ_, 0.8065, 1.95, 0.230, 195, 191, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
4418, d4no9R_, 0.8065, 2.88, 0.205, 235, 200, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
4419, d4no9D_, 0.8065, 2.88, 0.205, 235, 200, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
4420, d4eu2Y_, 0.8065, 2.01, 0.229, 196, 192, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
4421, d3l5qL_, 0.8065, 2.77, 0.146, 244, 198,  
4422, d3hyeR_, 0.8065, 2.95, 0.205, 242, 200, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
4423, d3hyeD_, 0.8065, 2.95, 0.205, 242, 200, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
4424, d3dy3C_, 0.8065, 2.95, 0.180, 241, 200, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
4425, d5l68R_, 0.8064, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4426, d5l68D_, 0.8064, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4427, d5l5oR_, 0.8064, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4428, d5l5jT_, 0.8064, 2.80, 0.146, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4429, d5l5jR_, 0.8064, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4430, d5l5jF_, 0.8064, 2.80, 0.146, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4431, d5l5jD_, 0.8064, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4432, d5l5eR_, 0.8064, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
4433, d5l5eD_, 0.8064, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
4434, d5l5dR_, 0.8064, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
4435, d5l5dD_, 0.8064, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
4436, d5jhrX_, 0.8064, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
4437, p5gjrX_, 0.8064, 2.94, 0.141, 238, 198, 
4438, d5fggR_, 0.8064, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4439, d5fggD_, 0.8064, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4440, d5d0vX_, 0.8064, 1.95, 0.230, 195, 191, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
4441, d5d0vJ_, 0.8064, 1.95, 0.230, 195, 191, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
4442, d5cz8R_, 0.8064, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
4443, d5cz8D_, 0.8064, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
4444, d5cz5R_, 0.8064, 2.89, 0.205, 235, 200, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
4445, p5cggD_, 0.8064, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
4446, d4ya1R_, 0.8064, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H116N MUTANT
4447, d4ya1D_, 0.8064, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H116N MUTANT
4448, p4y8tX_, 0.8064, 1.95, 0.230, 195, 191, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
4449, p4y8tJ_, 0.8064, 1.95, 0.230, 195, 191, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
4450, p4y8lR_, 0.8064, 2.91, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
4451, p4y8jD_, 0.8064, 2.89, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
4452, p4y80R_, 0.8064, 2.89, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
4453, p4y80D_, 0.8064, 2.89, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
4454, p4v7oU_, 0.8064, 2.77, 0.146, 244, 198, 
4455, p4v7oCB_, 0.8064, 2.77, 0.146, 244, 198, 
4456, d4qz2R_, 0.8064, 2.96, 0.205, 235, 200, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4457, d4qz2D_, 0.8064, 2.96, 0.205, 235, 200, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4458, d4qwlR_, 0.8064, 2.96, 0.205, 235, 200, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
4459, d4qwlD_, 0.8064, 2.96, 0.205, 235, 200, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
4460, d4qwkT_, 0.8064, 2.83, 0.146, 243, 198, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4461, d4qwkF_, 0.8064, 2.83, 0.146, 243, 198, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4462, d4qwgT_, 0.8064, 2.82, 0.146, 243, 198, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
4463, d4qw1J_, 0.8064, 1.95, 0.230, 195, 191, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
4464, p4gk7R_, 0.8064, 2.97, 0.205, 242, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
4465, p4gk7D_, 0.8064, 2.97, 0.205, 242, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
4466, d3l5qX_, 0.8064, 2.77, 0.146, 244, 198,  
4467, d3dy3Q_, 0.8064, 2.95, 0.180, 241, 200, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
4468, d1vsyU_, 0.8064, 2.77, 0.146, 244, 198,  
4469, p6gopX_, 0.8063, 1.95, 0.230, 195, 191, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
4470, d5laiR_, 0.8063, 2.98, 0.205, 235, 200, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
4471, d5laiD_, 0.8063, 2.98, 0.205, 235, 200, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
4472, d5l68F_, 0.8063, 2.80, 0.146, 243, 198, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4473, d5l5tT_, 0.8063, 2.81, 0.146, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4474, d5l5tR_, 0.8063, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4475, d5l5tF_, 0.8063, 2.81, 0.146, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4476, d5l5tD_, 0.8063, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4477, d5l5rD_, 0.8063, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
4478, d5l5oD_, 0.8063, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4479, d5l5bR_, 0.8063, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
4480, d5l5bD_, 0.8063, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
4481, d5jhrJ_, 0.8063, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
4482, d5fgeJ_, 0.8063, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4483, d5fgaJ_, 0.8063, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
4484, d5d0wR_, 0.8063, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-T1S MUTANT
4485, d5d0wD_, 0.8063, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-T1S MUTANT
4486, d5cz5D_, 0.8063, 2.89, 0.205, 235, 200, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
4487, p5cggR_, 0.8063, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
4488, d5cgfD_, 0.8063, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-G48C MUTANT
4489, p4y9zD_, 0.8063, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
4490, d4y9yR_, 0.8063, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H116E MUTANT
4491, d4y9yD_, 0.8063, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H116E MUTANT
4492, p4y8sR_, 0.8063, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
4493, p4y8sD_, 0.8063, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
4494, d4y8rR_, 0.8063, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H116D MUTANT
4495, d4y8rD_, 0.8063, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H116D MUTANT
4496, p4y8qR_, 0.8063, 2.91, 0.205, 235, 200, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
4497, d4r02F_, 0.8063, 2.70, 0.147, 243, 197, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
4498, d4qz6R_, 0.8063, 2.96, 0.205, 235, 200, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4499, d4qz6D_, 0.8063, 2.96, 0.205, 235, 200, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4500, d4qwlX_, 0.8063, 1.95, 0.230, 195, 191, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
4501, d4qwlJ_, 0.8063, 1.95, 0.230, 195, 191, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
4502, d4qwgF_, 0.8063, 2.82, 0.146, 243, 198, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
4503, d4qw1X_, 0.8063, 1.95, 0.230, 195, 191, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
4504, p4qvwR_, 0.8063, 2.97, 0.205, 235, 200, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
4505, p4qvwD_, 0.8063, 2.97, 0.205, 235, 200, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
4506, d4qv5X_, 0.8063, 1.96, 0.230, 195, 191, YCP BETA5-M45I MUTANT
4507, d4qv5J_, 0.8063, 1.96, 0.230, 195, 191, YCP BETA5-M45I MUTANT
4508, p4qv0R_, 0.8063, 2.96, 0.205, 235, 200, YCP BETA5-A49T-A50V-DOUBLE MUTANT
4509, p4qv0D_, 0.8063, 2.97, 0.205, 235, 200, YCP BETA5-A49T-A50V-DOUBLE MUTANT
4510, d4j70R_, 0.8063, 2.96, 0.205, 242, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
4511, d4eu2E_, 0.8063, 3.05, 0.204, 242, 201, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
4512, p3un4R_, 0.8063, 2.96, 0.205, 242, 200, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
4513, p3un4D_, 0.8063, 2.96, 0.205, 242, 200, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
4514, d3gpjQ_, 0.8063, 2.95, 0.180, 241, 200, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
4515, d3gpjC_, 0.8063, 2.95, 0.180, 241, 200, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
4516, d3d29R_, 0.8063, 3.04, 0.204, 242, 201, PROTEASOME INHIBITION BY FELLUTAMIDE B
4517, p6gopJ_, 0.8062, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
4518, d5l6cR_, 0.8062, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4519, d5l6cD_, 0.8062, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4520, d5l6aR_, 0.8062, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4521, d5l6aD_, 0.8062, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4522, d5l68T_, 0.8062, 2.80, 0.146, 243, 198, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4523, d5l67R_, 0.8062, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
4524, d5l67D_, 0.8062, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
4525, d5l60T_, 0.8062, 2.81, 0.146, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
4526, d5l60F_, 0.8062, 2.81, 0.146, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
4527, d5l5uR_, 0.8062, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4528, d5l5rR_, 0.8062, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
4529, d5l5pR_, 0.8062, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4530, d5l5pD_, 0.8062, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4531, d5l5iR_, 0.8062, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
4532, d5l5iD_, 0.8062, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
4533, d5l5fR_, 0.8062, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
4534, d5l5aR_, 0.8062, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
4535, d5l5aD_, 0.8062, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
4536, d5fgiF_, 0.8062, 2.82, 0.146, 243, 198, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4537, d5fgeX_, 0.8062, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4538, d5fg7R_, 0.8062, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-T1A MUTANT
4539, d5fg7D_, 0.8062, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-T1A MUTANT
4540, d5d0vR_, 0.8062, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
4541, d5d0vD_, 0.8062, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
4542, d5czaR_, 0.8062, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-D166N MUTANT
4543, d5czaD_, 0.8062, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-D166N MUTANT
4544, d5cz9R_, 0.8062, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
4545, d5cz9D_, 0.8062, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
4546, d5cz6R_, 0.8062, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
4547, d5cz6D_, 0.8062, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
4548, p5cggX_, 0.8062, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
4549, p5cggJ_, 0.8062, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
4550, d5bxnR_, 0.8062, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
4551, d5bxnD_, 0.8062, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
4552, d5ahjR_, 0.8062, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
4553, d5ahjD_, 0.8062, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
4554, d4z1lR_, 0.8062, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
4555, d4z1lD_, 0.8062, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
4556, d4ya4R_, 0.8062, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H114D MUTANT
4557, d4ya4D_, 0.8062, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H114D MUTANT
4558, p4v7oOA_, 0.8062, 2.77, 0.146, 244, 198, 
4559, p4qwfR_, 0.8062, 2.97, 0.205, 235, 200, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
4560, p4qwfD_, 0.8062, 2.97, 0.205, 235, 200, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
4561, d4qw6R_, 0.8062, 2.96, 0.205, 235, 200, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
4562, d4qw6D_, 0.8062, 2.96, 0.205, 235, 200, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
4563, p4qw5D_, 0.8062, 2.96, 0.205, 235, 200, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
4564, d4qvlR_, 0.8062, 2.97, 0.205, 235, 200, YCP IN COMPLEX WITH BORTEZOMIB
4565, d4qvlJ_, 0.8062, 1.95, 0.230, 195, 191, YCP IN COMPLEX WITH BORTEZOMIB
4566, d4qvlD_, 0.8062, 2.97, 0.205, 235, 200, YCP IN COMPLEX WITH BORTEZOMIB
4567, d4qv7R_, 0.8062, 2.97, 0.205, 235, 200, YCP BETA5-A50V MUTANT
4568, d4qv7D_, 0.8062, 2.97, 0.205, 235, 200, YCP BETA5-A50V MUTANT
4569, d4qv5R_, 0.8062, 2.97, 0.205, 235, 200, YCP BETA5-M45I MUTANT
4570, d4qv5D_, 0.8062, 2.97, 0.205, 235, 200, YCP BETA5-M45I MUTANT
4571, p4qv3R_, 0.8062, 2.96, 0.205, 235, 200, YCP BETA5-M45V MUTANT
4572, p4qv3D_, 0.8062, 2.96, 0.205, 235, 200, YCP BETA5-M45V MUTANT
4573, d4qlqR_, 0.8062, 2.96, 0.205, 235, 200, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
4574, d4nnwR_, 0.8062, 2.88, 0.205, 235, 200, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
4575, d4lqiR_, 0.8062, 2.96, 0.205, 242, 200, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
4576, d3sdiT_, 0.8062, 2.80, 0.146, 242, 198, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
4577, d3nzxR_, 0.8062, 2.95, 0.205, 242, 200, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
4578, d3d29D_, 0.8062, 3.04, 0.204, 242, 201, PROTEASOME INHIBITION BY FELLUTAMIDE B
4579, d1vsyG_, 0.8062, 2.77, 0.146, 244, 198,  
4580, d5m2bR_, 0.8061, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
4581, d5m2bD_, 0.8061, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
4582, d5lttD_, 0.8061, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
4583, d5l66R_, 0.8061, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
4584, d5l66D_, 0.8061, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
4585, d5l5wX_, 0.8061, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
4586, d5l5wJ_, 0.8061, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
4587, d5l5uD_, 0.8061, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4588, d5l5fD_, 0.8061, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
4589, d5fgfD_, 0.8061, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
4590, d5fgdT_, 0.8061, 2.83, 0.146, 243, 198, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4591, d5fgdF_, 0.8061, 2.83, 0.146, 243, 198, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4592, d5fgaX_, 0.8061, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
4593, d5fgaR_, 0.8061, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
4594, d5fgaD_, 0.8061, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
4595, d5fg9R_, 0.8061, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
4596, d5fg9D_, 0.8061, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
4597, d5d0tR_, 0.8061, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
4598, d5d0tD_, 0.8061, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
4599, d5czaX_, 0.8061, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME BETA5-D166N MUTANT
4600, d5czaJ_, 0.8061, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME BETA5-D166N MUTANT
4601, d5bxlR_, 0.8061, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-G170A MUTANT
4602, d5bxlD_, 0.8061, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-G170A MUTANT
4603, p4zzgU_, 0.8061, 2.67, 0.147, 244, 197, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
4604, d4y8mR_, 0.8061, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
4605, d4y8mD_, 0.8061, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
4606, p4y75R_, 0.8061, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
4607, p4y75D_, 0.8061, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
4608, p4x6zS_, 0.8061, 2.91, 0.205, 242, 200, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
4609, p4qz1R_, 0.8061, 2.98, 0.205, 235, 200, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4610, p4qz1D_, 0.8061, 2.98, 0.205, 235, 200, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4611, d4qvyR_, 0.8061, 2.97, 0.205, 235, 200, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
4612, d4qvyD_, 0.8061, 2.97, 0.205, 235, 200, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
4613, d4qvpR_, 0.8061, 2.97, 0.205, 235, 200, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
4614, d4qvpD_, 0.8061, 2.97, 0.205, 235, 200, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
4615, d4qvnR_, 0.8061, 2.97, 0.205, 235, 200, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
4616, d4qvnD_, 0.8061, 2.97, 0.205, 235, 200, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
4617, d4qvlX_, 0.8061, 1.96, 0.230, 195, 191, YCP IN COMPLEX WITH BORTEZOMIB
4618, d4qv6X_, 0.8061, 1.96, 0.230, 195, 191, YCP BETA5-A49V MUTANT
4619, d4qv6J_, 0.8061, 1.96, 0.230, 195, 191, YCP BETA5-A49V MUTANT
4620, d4qv4R_, 0.8061, 2.97, 0.205, 235, 200, YCP BETA5-M45T MUTANT
4621, d4qv4D_, 0.8061, 2.97, 0.205, 235, 200, YCP BETA5-M45T MUTANT
4622, d4quyR_, 0.8061, 2.96, 0.205, 235, 200, YCP BETA5-A49S-MUTANT
4623, d4quyD_, 0.8061, 2.96, 0.205, 235, 200, YCP BETA5-A49S-MUTANT
4624, p4quxR_, 0.8061, 2.97, 0.205, 235, 200, YCP BETA5-A49T-MUTANT
4625, d4qlqD_, 0.8061, 2.96, 0.205, 235, 200, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
4626, d4no8X_, 0.8061, 1.96, 0.230, 195, 191, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
4627, d4no8J_, 0.8061, 1.96, 0.230, 195, 191, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
4628, d4no1X_, 0.8061, 1.96, 0.230, 195, 191, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
4629, d4no1J_, 0.8061, 1.96, 0.230, 195, 191, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
4630, d4nnwD_, 0.8061, 2.88, 0.205, 235, 200, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
4631, d4lqiD_, 0.8061, 2.96, 0.205, 242, 200, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
4632, d4inrR_, 0.8061, 2.97, 0.205, 242, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
4633, d3nzxD_, 0.8061, 2.96, 0.205, 242, 200, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
4634, d3gpjR_, 0.8061, 3.03, 0.204, 242, 201, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
4635, d3dy4Q_, 0.8061, 2.95, 0.180, 241, 200, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
4636, d3dy4C_, 0.8061, 2.95, 0.180, 241, 200, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
4637, d5lttR_, 0.8060, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
4638, d5l69R_, 0.8060, 2.99, 0.205, 235, 200, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4639, d5l69D_, 0.8060, 2.99, 0.205, 235, 200, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4640, d5l63R_, 0.8060, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4641, d5l62R_, 0.8060, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4642, d5l62D_, 0.8060, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4643, d5l61X_, 0.8060, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4644, d5l61R_, 0.8060, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4645, d5l61J_, 0.8060, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4646, d5l61D_, 0.8060, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4647, d5l5xR_, 0.8060, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
4648, d5l5xD_, 0.8060, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
4649, d5l5sR_, 0.8060, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
4650, d5l5sD_, 0.8060, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
4651, d5l5qR_, 0.8060, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
4652, d5l5qD_, 0.8060, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
4653, d5l5oT_, 0.8060, 2.81, 0.146, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4654, d5l5oF_, 0.8060, 2.81, 0.146, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4655, d5l5iT_, 0.8060, 2.81, 0.146, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
4656, d5l5iF_, 0.8060, 2.81, 0.146, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
4657, d5l5hR_, 0.8060, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
4658, d5l5hD_, 0.8060, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
4659, d5fhsR_, 0.8060, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
4660, d5fhsD_, 0.8060, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
4661, d5fgiT_, 0.8060, 2.82, 0.146, 243, 198, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4662, p5fghT_, 0.8060, 2.82, 0.146, 243, 198, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
4663, d5d0xR_, 0.8060, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
4664, d5d0xD_, 0.8060, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
4665, d5cz7R_, 0.8060, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
4666, d5cz7D_, 0.8060, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
4667, p5cghR_, 0.8060, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
4668, p5cghD_, 0.8060, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
4669, p4ya9X_, 0.8060, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
4670, p4ya9J_, 0.8060, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
4671, p4y8pR_, 0.8060, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
4672, p4y8pD_, 0.8060, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
4673, p4y77R_, 0.8060, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
4674, p4y77D_, 0.8060, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
4675, p4y6vR_, 0.8060, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
4676, p4y6vD_, 0.8060, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
4677, d4rurR_, 0.8060, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
4678, d4qzzR_, 0.8060, 2.97, 0.205, 235, 200, YCP IN COMPLEX WITH OMURALIDE
4679, p4qzwR_, 0.8060, 2.97, 0.205, 235, 200, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4680, p4qzwD_, 0.8060, 2.97, 0.205, 235, 200, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4681, p4qwuR_, 0.8060, 2.97, 0.205, 235, 200, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
4682, p4qwuD_, 0.8060, 2.97, 0.205, 235, 200, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
4683, d4qw4R_, 0.8060, 2.97, 0.205, 235, 200, YCP IN COMPLEX WITH CARFILZOMIB
4684, d4qw4D_, 0.8060, 2.97, 0.205, 235, 200, YCP IN COMPLEX WITH CARFILZOMIB
4685, d4qvmT_, 0.8060, 2.82, 0.146, 243, 198, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
4686, d4qvmF_, 0.8060, 2.82, 0.146, 243, 198, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
4687, d4qv1R_, 0.8060, 2.97, 0.205, 235, 200, YCP BETA5-M45A MUTANT
4688, d4qv1D_, 0.8060, 2.97, 0.205, 235, 200, YCP BETA5-M45A MUTANT
4689, p4quxD_, 0.8060, 2.97, 0.205, 235, 200, YCP BETA5-A49T-MUTANT
4690, d4q1sR_, 0.8060, 2.96, 0.205, 242, 200, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
4691, d3gpjD_, 0.8060, 3.03, 0.204, 242, 201, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
4692, d2zcyR_, 0.8060, 3.04, 0.204, 242, 201, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
4693, d2zcyD_, 0.8060, 3.04, 0.204, 242, 201, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
4694, d1g65R_, 0.8060, 2.96, 0.205, 242, 200, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
4695, d1g0uT_, 0.8060, 2.72, 0.147, 242, 197, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
4696, d1g0uF_, 0.8060, 2.72, 0.147, 242, 197, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
4697, p6gopR_, 0.8059, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
4698, p6gopD_, 0.8059, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
4699, p5ln3G_, 0.8059, 3.12, 0.134, 242, 202, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
4700, d5l63D_, 0.8059, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4701, d5l5zR_, 0.8059, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
4702, d5l5zD_, 0.8059, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
4703, d5l5yR_, 0.8059, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
4704, d5l5yD_, 0.8059, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
4705, d5l5wR_, 0.8059, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
4706, d5l5wD_, 0.8059, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
4707, p5fghR_, 0.8059, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
4708, p5fghD_, 0.8059, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
4709, d5fgfX_, 0.8059, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
4710, d5fgfJ_, 0.8059, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
4711, d5fgeR_, 0.8059, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4712, d5fgdR_, 0.8059, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4713, d5fgdD_, 0.8059, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4714, d5dkjR_, 0.8059, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
4715, d5dkjD_, 0.8059, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
4716, d5d0wX_, 0.8059, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME BETA5-T1S MUTANT
4717, d5d0wJ_, 0.8059, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME BETA5-T1S MUTANT
4718, d5bouT_, 0.8059, 2.81, 0.146, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
4719, d5bouR_, 0.8059, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
4720, d5bouF_, 0.8059, 2.81, 0.146, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
4721, d5bouD_, 0.8059, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
4722, p4ya9R_, 0.8059, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
4723, p4ya9D_, 0.8059, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
4724, p4ya5R_, 0.8059, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
4725, p4ya5D_, 0.8059, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
4726, p4y8tR_, 0.8059, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
4727, p4y8tD_, 0.8059, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
4728, p4y8oR_, 0.8059, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
4729, p4y8oD_, 0.8059, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
4730, p4y8nR_, 0.8059, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
4731, p4y8nD_, 0.8059, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
4732, p4y84R_, 0.8059, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
4733, p4y84D_, 0.8059, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
4734, p4y74R_, 0.8059, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
4735, p4y74D_, 0.8059, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
4736, d4rurT_, 0.8059, 2.81, 0.146, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
4737, d4rurF_, 0.8059, 2.81, 0.146, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
4738, d4rurD_, 0.8059, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
4739, d4qzzD_, 0.8059, 2.97, 0.205, 235, 200, YCP IN COMPLEX WITH OMURALIDE
4740, d4qz7T_, 0.8059, 2.71, 0.147, 243, 197, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4741, d4qz7F_, 0.8059, 2.71, 0.147, 243, 197, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4742, d4qwrR_, 0.8059, 2.96, 0.205, 235, 200, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
4743, d4qwrD_, 0.8059, 2.96, 0.205, 235, 200, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
4744, d4qwkR_, 0.8059, 2.97, 0.205, 235, 200, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4745, d4qwkD_, 0.8059, 2.97, 0.205, 235, 200, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4746, d4qwjR_, 0.8059, 2.97, 0.205, 235, 200, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
4747, d4qwjD_, 0.8059, 2.97, 0.205, 235, 200, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
4748, d4qvmR_, 0.8059, 2.98, 0.205, 235, 200, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
4749, d4qvmD_, 0.8059, 2.98, 0.205, 235, 200, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
4750, d4qv8R_, 0.8059, 2.97, 0.205, 235, 200, YCP BETA5-C52F MUTANT
4751, d4qv8D_, 0.8059, 2.97, 0.205, 235, 200, YCP BETA5-C52F MUTANT
4752, d4qlvT_, 0.8059, 2.80, 0.146, 243, 198, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
4753, d4qlvF_, 0.8059, 2.80, 0.146, 243, 198, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
4754, d4nnnR_, 0.8059, 2.96, 0.205, 235, 200, YCP IN COMPLEX WITH MG132
4755, d4nnnD_, 0.8059, 2.96, 0.205, 235, 200, YCP IN COMPLEX WITH MG132
4756, d4inrD_, 0.8059, 2.97, 0.205, 242, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
4757, d3sdiF_, 0.8059, 2.71, 0.147, 242, 197, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
4758, d3nzjR_, 0.8059, 2.96, 0.205, 242, 200, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
4759, d3mg8T_, 0.8059, 2.81, 0.146, 237, 198, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
4760, p3jcoMA_, 0.8059, 2.97, 0.180, 241, 200, 
4761, p3jcoM_, 0.8059, 2.97, 0.180, 241, 200, 
4762, d3dy3R_, 0.8059, 3.04, 0.204, 242, 201, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
4763, d3dy3D_, 0.8059, 3.04, 0.204, 242, 201, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
4764, d5laiT_, 0.8058, 2.81, 0.146, 243, 198, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
4765, d5laiF_, 0.8058, 2.81, 0.146, 243, 198, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
4766, d5l69F_, 0.8058, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4767, d5l62X_, 0.8058, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4768, d5l5vR_, 0.8058, 2.98, 0.205, 235, 200,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4769, d5l5vD_, 0.8058, 2.98, 0.205, 235, 200,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4770, d5fgiR_, 0.8058, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4771, d5fgiD_, 0.8058, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4772, p5fghF_, 0.8058, 2.82, 0.146, 243, 198, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
4773, d5fgeD_, 0.8058, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4774, d5d0sX_, 0.8058, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
4775, d5d0sJ_, 0.8058, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
4776, d5bxlX_, 0.8058, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME BETA2-G170A MUTANT
4777, d5bxlJ_, 0.8058, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME BETA2-G170A MUTANT
4778, p4y8uR_, 0.8058, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
4779, p4y8uD_, 0.8058, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
4780, p4y8qD_, 0.8058, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
4781, p4y8kR_, 0.8058, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
4782, p4y8kD_, 0.8058, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
4783, p4y8iR_, 0.8058, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
4784, p4y8hR_, 0.8058, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
4785, p4y8hD_, 0.8058, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
4786, p4y8gR_, 0.8058, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
4787, p4y8gD_, 0.8058, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
4788, p4y82R_, 0.8058, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
4789, p4y82D_, 0.8058, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
4790, p4y6vT_, 0.8058, 2.81, 0.146, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
4791, p4y6vF_, 0.8058, 2.81, 0.146, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
4792, p4y69R_, 0.8058, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
4793, p4y69D_, 0.8058, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
4794, p4x6zU_, 0.8058, 2.71, 0.147, 244, 197, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
4795, d4r18T_, 0.8058, 2.70, 0.147, 243, 197, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
4796, d4r18F_, 0.8058, 2.70, 0.147, 243, 197, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
4797, d4r00R_, 0.8058, 2.97, 0.205, 235, 200, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
4798, d4r00D_, 0.8058, 2.97, 0.205, 235, 200, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
4799, d4qz1T_, 0.8058, 2.72, 0.147, 243, 197, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4800, d4qz1F_, 0.8058, 2.72, 0.147, 243, 197, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4801, d4qz0X_, 0.8058, 1.96, 0.230, 195, 191, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4802, d4qz0J_, 0.8058, 1.96, 0.230, 195, 191, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4803, d4qxjT_, 0.8058, 2.83, 0.146, 243, 198, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4804, d4qxjF_, 0.8058, 2.83, 0.146, 243, 198, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4805, d4qw6X_, 0.8058, 1.96, 0.230, 195, 191, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
4806, d4qw6J_, 0.8058, 1.96, 0.230, 195, 191, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
4807, d4qw3T_, 0.8058, 2.83, 0.146, 243, 198, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
4808, d4qw3F_, 0.8058, 2.83, 0.146, 243, 198, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
4809, d4qw0T_, 0.8058, 2.82, 0.146, 243, 198, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
4810, d4qw0R_, 0.8058, 2.98, 0.205, 235, 200, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
4811, d4qw0F_, 0.8058, 2.82, 0.146, 243, 198, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
4812, d4qw0D_, 0.8058, 2.98, 0.205, 235, 200, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
4813, d4qvwJ_, 0.8058, 1.96, 0.230, 195, 191, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
4814, d4qvvR_, 0.8058, 2.98, 0.205, 235, 200, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
4815, d4qvvD_, 0.8058, 2.98, 0.205, 235, 200, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
4816, d4qvqR_, 0.8058, 2.98, 0.205, 235, 200, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
4817, d4qvqD_, 0.8058, 2.98, 0.205, 235, 200, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
4818, d4qvpJ_, 0.8058, 1.96, 0.230, 195, 191, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
4819, d4qv9J_, 0.8058, 1.96, 0.230, 195, 191, YCP BETA5-C63F MUTANT
4820, d4qv6R_, 0.8058, 2.97, 0.205, 235, 200, YCP BETA5-A49V MUTANT
4821, d4qv6D_, 0.8058, 2.97, 0.205, 235, 200, YCP BETA5-A49V MUTANT
4822, d4qv4J_, 0.8058, 1.96, 0.230, 195, 191, YCP BETA5-M45T MUTANT
4823, d4qluR_, 0.8058, 2.96, 0.205, 235, 200, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
4824, d4qluD_, 0.8058, 2.96, 0.205, 235, 200, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
4825, d4qlsT_, 0.8058, 2.79, 0.146, 243, 198, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
4826, d4qlsF_, 0.8058, 2.79, 0.146, 243, 198, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
4827, d4no1R_, 0.8058, 2.97, 0.205, 235, 200, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
4828, d4j70D_, 0.8058, 2.97, 0.205, 242, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
4829, d4hrdF_, 0.8058, 2.73, 0.147, 244, 197, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
4830, d4hrcR_, 0.8058, 2.95, 0.205, 242, 200, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
4831, d4g4sK_, 0.8058, 1.98, 0.230, 195, 191, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
4832, d3nzjD_, 0.8058, 2.97, 0.205, 242, 200, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
4833, d3dy4R_, 0.8058, 3.04, 0.204, 242, 201, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
4834, d3dy4D_, 0.8058, 3.04, 0.204, 242, 201, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
4835, p5nifE_, 0.8057, 2.96, 0.205, 236, 200, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
4836, d5l69T_, 0.8057, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4837, d5l64R_, 0.8057, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4838, d5l64D_, 0.8057, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4839, d5l62J_, 0.8057, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4840, d5dkiR_, 0.8057, 2.99, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
4841, d5dkiF_, 0.8057, 2.83, 0.146, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
4842, d5dkiD_, 0.8057, 2.99, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
4843, d5cz4R_, 0.8057, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
4844, d5cz4D_, 0.8057, 2.99, 0.205, 235, 200, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
4845, p4zzgE_, 0.8057, 2.95, 0.205, 236, 200, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
4846, p4ya5T_, 0.8057, 2.82, 0.146, 243, 198, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
4847, p4ya5F_, 0.8057, 2.82, 0.146, 243, 198, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
4848, d4y8rX_, 0.8057, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME BETA2-H116D MUTANT
4849, d4y8rJ_, 0.8057, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME BETA2-H116D MUTANT
4850, p4y8oT_, 0.8057, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
4851, p4y8oF_, 0.8057, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
4852, p4y8iD_, 0.8057, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
4853, p4y81R_, 0.8057, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
4854, p4y78R_, 0.8057, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
4855, p4y6zT_, 0.8057, 2.82, 0.146, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
4856, p4y6zF_, 0.8057, 2.82, 0.146, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
4857, d4r18X_, 0.8057, 1.97, 0.230, 195, 191, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
4858, d4r18J_, 0.8057, 1.97, 0.230, 195, 191, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
4859, p4qwsR_, 0.8057, 2.98, 0.205, 235, 200, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
4860, p4qwsD_, 0.8057, 2.98, 0.205, 235, 200, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
4861, d4qw5X_, 0.8057, 1.96, 0.230, 195, 191, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
4862, d4qvwT_, 0.8057, 2.81, 0.146, 243, 198, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
4863, d4qvpX_, 0.8057, 1.96, 0.230, 195, 191, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
4864, d4qvmX_, 0.8057, 1.96, 0.230, 195, 191, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
4865, d4qvmJ_, 0.8057, 1.96, 0.230, 195, 191, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
4866, d4qv9X_, 0.8057, 1.96, 0.230, 195, 191, YCP BETA5-C63F MUTANT
4867, d4quyX_, 0.8057, 1.96, 0.230, 195, 191, YCP BETA5-A49S-MUTANT
4868, d4quyJ_, 0.8057, 1.96, 0.230, 195, 191, YCP BETA5-A49S-MUTANT
4869, d4quxT_, 0.8057, 2.81, 0.146, 243, 198, YCP BETA5-A49T-MUTANT
4870, d4quxF_, 0.8057, 2.81, 0.146, 243, 198, YCP BETA5-A49T-MUTANT
4871, d4no6J_, 0.8057, 1.97, 0.230, 195, 191, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
4872, d4no1D_, 0.8057, 2.97, 0.205, 235, 200, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
4873, d4ltcR_, 0.8057, 2.96, 0.205, 242, 200, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
4874, p4jt0R_, 0.8057, 2.97, 0.205, 242, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
4875, p4jt0D_, 0.8057, 2.97, 0.205, 242, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
4876, d4jsuR_, 0.8057, 2.97, 0.205, 242, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
4877, d4intR_, 0.8057, 2.97, 0.205, 242, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
4878, d4intD_, 0.8057, 2.98, 0.205, 242, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
4879, d4hnpR_, 0.8057, 2.95, 0.205, 242, 200, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
4880, d4fzcR_, 0.8057, 2.96, 0.205, 242, 200, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
4881, d1rypU_, 0.8057, 2.69, 0.147, 244, 197, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
4882, p5nifU_, 0.8056, 2.67, 0.147, 244, 197, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
4883, d5l64X_, 0.8056, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4884, d5l5eT_, 0.8056, 2.81, 0.146, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
4885, d5l5eF_, 0.8056, 2.81, 0.146, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
4886, d5dkiT_, 0.8056, 2.83, 0.146, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
4887, d5cz9X_, 0.8056, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
4888, d5cz9J_, 0.8056, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
4889, d5cz5T_, 0.8056, 2.83, 0.146, 243, 198, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
4890, d5cz5F_, 0.8056, 2.83, 0.146, 243, 198, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
4891, p4ya3R_, 0.8056, 2.99, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
4892, p4ya3D_, 0.8056, 2.99, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
4893, p4ya0R_, 0.8056, 2.99, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
4894, p4ya0D_, 0.8056, 2.99, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
4895, p4y8gX_, 0.8056, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
4896, p4y8gJ_, 0.8056, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
4897, p4y81T_, 0.8056, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
4898, p4y81F_, 0.8056, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
4899, p4y81D_, 0.8056, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
4900, p4y7xR_, 0.8056, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
4901, p4y7xD_, 0.8056, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
4902, p4y78D_, 0.8056, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
4903, p4y6zR_, 0.8056, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
4904, p4y6zD_, 0.8056, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
4905, p4y6aR_, 0.8056, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
4906, p4y69T_, 0.8056, 2.82, 0.146, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
4907, p4y69F_, 0.8056, 2.82, 0.146, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
4908, d4qz6X_, 0.8056, 1.96, 0.230, 195, 191, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4909, d4qz6J_, 0.8056, 1.96, 0.230, 195, 191, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4910, d4qwuJ_, 0.8056, 1.96, 0.230, 195, 191, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
4911, d4qw4T_, 0.8056, 2.72, 0.147, 243, 197, YCP IN COMPLEX WITH CARFILZOMIB
4912, d4qw4F_, 0.8056, 2.72, 0.147, 243, 197, YCP IN COMPLEX WITH CARFILZOMIB
4913, d4qvwF_, 0.8056, 2.81, 0.146, 243, 198, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
4914, d4qv1X_, 0.8056, 1.96, 0.230, 195, 191, YCP BETA5-M45A MUTANT
4915, d4qv1J_, 0.8056, 1.96, 0.230, 195, 191, YCP BETA5-M45A MUTANT
4916, d4qluX_, 0.8056, 1.96, 0.230, 195, 191, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
4917, d4qluJ_, 0.8056, 1.96, 0.230, 195, 191, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
4918, d4no6X_, 0.8056, 1.97, 0.230, 195, 191, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
4919, d4nnwT_, 0.8056, 2.71, 0.147, 243, 197, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
4920, d4nnwF_, 0.8056, 2.71, 0.147, 243, 197, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
4921, d4jsuD_, 0.8056, 2.97, 0.205, 242, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
4922, d4hrdD_, 0.8056, 2.97, 0.205, 242, 200, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
4923, d4fzcD_, 0.8056, 2.96, 0.205, 242, 200, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
4924, d4eu2S_, 0.8056, 2.95, 0.205, 242, 200, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
4925, d3bdmR_, 0.8056, 3.05, 0.204, 242, 201, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
4926, d3bdmD_, 0.8056, 3.05, 0.204, 242, 201, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
4927, d1g65D_, 0.8056, 2.96, 0.205, 242, 200, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
4928, d5lajT_, 0.8055, 2.71, 0.147, 243, 197, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
4929, d5lajF_, 0.8055, 2.71, 0.147, 243, 197, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
4930, d5l64J_, 0.8055, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4931, d5l60R_, 0.8055, 2.99, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
4932, d5l60D_, 0.8055, 2.99, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
4933, d5l5zX_, 0.8055, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
4934, d5l55X_, 0.8055, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4935, d5l55J_, 0.8055, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4936, d5dkjT_, 0.8055, 2.82, 0.146, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
4937, d5dkjF_, 0.8055, 2.82, 0.146, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
4938, d5d0xT_, 0.8055, 2.83, 0.146, 243, 198, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
4939, d5d0xF_, 0.8055, 2.83, 0.146, 243, 198, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
4940, d5cz6J_, 0.8055, 1.97, 0.230, 195, 191, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
4941, p5cghX_, 0.8055, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
4942, p5cghJ_, 0.8055, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
4943, p4y75T_, 0.8055, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
4944, p4y75F_, 0.8055, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
4945, p4y6aD_, 0.8055, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
4946, d4qz1X_, 0.8055, 1.97, 0.230, 195, 191, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4947, d4qz1J_, 0.8055, 1.97, 0.230, 195, 191, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4948, d4qwuX_, 0.8055, 1.96, 0.230, 195, 191, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
4949, d4qwfX_, 0.8055, 1.97, 0.230, 195, 191, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
4950, d4qwfT_, 0.8055, 2.72, 0.147, 243, 197, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
4951, d4qwfJ_, 0.8055, 1.97, 0.230, 195, 191, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
4952, d4qwfF_, 0.8055, 2.72, 0.147, 243, 197, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
4953, d4qw7X_, 0.8055, 1.96, 0.230, 195, 191, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
4954, d4qw5J_, 0.8055, 1.96, 0.230, 195, 191, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
4955, d4qw3R_, 0.8055, 2.99, 0.205, 235, 200, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
4956, d4qw3D_, 0.8055, 2.99, 0.205, 235, 200, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
4957, d4qvwX_, 0.8055, 1.96, 0.230, 195, 191, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
4958, d4qvvT_, 0.8055, 2.84, 0.146, 243, 198, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
4959, d4qv4X_, 0.8055, 1.97, 0.230, 195, 191, YCP BETA5-M45T MUTANT
4960, d4qv3X_, 0.8055, 1.97, 0.230, 195, 191, YCP BETA5-M45V MUTANT
4961, d4qv3J_, 0.8055, 1.96, 0.230, 195, 191, YCP BETA5-M45V MUTANT
4962, d4qv0X_, 0.8055, 1.97, 0.230, 195, 191, YCP BETA5-A49T-A50V-DOUBLE MUTANT
4963, d4qv0J_, 0.8055, 1.97, 0.230, 195, 191, YCP BETA5-A49T-A50V-DOUBLE MUTANT
4964, d4jsqR_, 0.8055, 2.97, 0.205, 242, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
4965, d4jsqD_, 0.8055, 2.97, 0.205, 242, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
4966, d4hnpT_, 0.8055, 2.81, 0.146, 244, 198, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
4967, d4fzgF_, 0.8055, 2.72, 0.147, 244, 197, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
4968, d3oeuT_, 0.8055, 2.82, 0.146, 237, 198, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
4969, d3mg0D_, 0.8055, 2.98, 0.205, 242, 200, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
4970, d3gptC_, 0.8055, 2.96, 0.180, 241, 200, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
4971, d5l63T_, 0.8054, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4972, d5l63F_, 0.8054, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4973, d5l61F_, 0.8054, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4974, d5l5zJ_, 0.8054, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
4975, d5l5yT_, 0.8054, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
4976, d5l5yF_, 0.8054, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
4977, d5l5xX_, 0.8054, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
4978, d5fgdX_, 0.8054, 1.97, 0.230, 195, 191, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4979, d5fgdJ_, 0.8054, 1.97, 0.230, 195, 191, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4980, d5d0zX_, 0.8054, 1.97, 0.230, 195, 191, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
4981, d5d0zJ_, 0.8054, 1.97, 0.230, 195, 191, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
4982, d5cz7T_, 0.8054, 2.82, 0.146, 243, 198, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
4983, d5cz7F_, 0.8054, 2.82, 0.146, 243, 198, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
4984, d5cz6X_, 0.8054, 1.97, 0.230, 195, 191, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
4985, d5cz4T_, 0.8054, 2.83, 0.146, 243, 198, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
4986, d5cz4F_, 0.8054, 2.83, 0.146, 243, 198, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
4987, d5bouX_, 0.8054, 1.97, 0.230, 195, 191, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
4988, d5bouJ_, 0.8054, 1.97, 0.230, 195, 191, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
4989, p4ya2X_, 0.8054, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
4990, p4ya2J_, 0.8054, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
4991, p4y8uT_, 0.8054, 2.82, 0.146, 243, 198, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
4992, p4y8uF_, 0.8054, 2.82, 0.146, 243, 198, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
4993, p4y7xT_, 0.8054, 2.73, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
4994, p4y7xF_, 0.8054, 2.73, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
4995, d4r02T_, 0.8054, 2.70, 0.147, 243, 197, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
4996, d4r02D_, 0.8054, 2.99, 0.205, 235, 200, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
4997, d4qz4X_, 0.8054, 1.97, 0.230, 195, 191, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4998, d4qz4T_, 0.8054, 2.71, 0.147, 243, 197, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4999, d4qz4J_, 0.8054, 1.97, 0.230, 195, 191, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
5000, d4qz4F_, 0.8054, 2.71, 0.147, 243, 197, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
